data_2ckn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ckn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.647 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.775 HG22 ' CB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CD2' ' HG ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.426 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.416 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.661 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.661 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.452 HG12 ' HG1' ' A' ' 92' ' ' THR . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 94' ' ' SER . 18.9 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.554 HD13 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.818 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.615 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.563 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 5.0 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.615 HD23 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG22 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.402 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.565 ' HB ' ' CG1' ' A' ' 77' ' ' VAL . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.655 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.597 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.46 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.416 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' CE2' ' A' ' 55' ' ' TRP . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB2' HG22 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.818 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.523 HG23 HD12 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.868 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.868 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.775 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.699 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.561 ' HG ' ' CD2' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.556 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.47 ' HD3' HG23 ' A' ' 92' ' ' THR . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.487 HD22 ' CB ' ' A' ' 73' ' ' GLU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.502 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.485 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 14.3 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.676 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.711 ' NE1' HG22 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.58 HD23 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.691 ' HB ' ' CD1' ' A' ' 70' ' ' ILE . 4.5 m . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.527 ' HB ' HG13 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.711 HG22 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.676 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.587 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.43 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.456 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.586 ' HB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.778 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.621 ' CG2' ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.553 ' O ' HG21 ' A' ' 29' ' ' VAL . 4.0 mt-10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.413 HD22 HD12 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.649 ' C ' HD22 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.68 HD21 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.706 ' CE2' HG22 ' A' ' 75' ' ' VAL . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.679 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' CA ' HD22 ' A' ' 56' ' ' LEU . 4.3 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.157 0.503 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' HG1' HG13 ' A' ' 77' ' ' VAL . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.621 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.61 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.68 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 ' CE2' ' A' ' 55' ' ' TRP . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.575 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.575 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' HG22 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.654 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.56 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.605 HG21 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.504 HD22 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.715 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.774 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.62 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.506 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.57 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' NH1' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.516 HE21 ' HD3' ' A' ' 95' ' ' PRO . 19.9 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.439 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.79 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.597 HD13 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.609 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.609 HD23 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG2' HD12 ' A' ' 70' ' ' ILE . 2.1 p . . . . . 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.445 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.499 ' HB ' ' CG1' ' A' ' 77' ' ' VAL . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.61 HD12 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 55' ' ' TRP . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.538 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HB3' HG22 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD13 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HD3' HE21 ' A' ' 51' ' ' GLN . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.628 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.715 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.669 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 91.6 mt-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 37.3 m170 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.67 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.58 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.43 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.686 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.491 ' HD3' ' OE1' ' A' ' 74' ' ' GLU . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.641 HH11 ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.413 ' HA ' HG23 ' A' ' 50' ' ' VAL . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.571 ' O ' ' C ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' ASP . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.551 HG21 ' SG ' ' A' ' 90' ' ' CYS . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.761 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.611 HD22 ' CA ' ' A' ' 61' ' ' GLN . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.611 ' CA ' HD22 ' A' ' 56' ' ' LEU . 3.1 tm0? -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.492 HD23 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.518 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.418 ' CG2' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.491 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG22 ' CE2' ' A' ' 55' ' ' TRP . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.67 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.52 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.622 ' CE1' HG23 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 102' ' ' TYR . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.761 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.584 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 29' ' ' VAL . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.622 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.58 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.688 ' N ' ' HB2' ' A' ' 102' ' ' TYR . 9.5 tp10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.693 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.869 ' HG ' ' HG ' ' A' ' 104' ' ' SER . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.494 ' HB ' ' CB ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.545 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 79' ' ' ASP . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 2.9 pm0 -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.737 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' NH2' ' CB ' ' A' ' 99' ' ' ASP . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.493 HD13 ' N ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.493 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 47' ' ' ARG . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.511 HG13 ' HG1' ' A' ' 92' ' ' THR . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.502 ' NE2' ' CD ' ' A' ' 95' ' ' PRO . 12.4 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.429 ' CB ' HE22 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.82 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.56 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.585 ' CB ' HD12 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.404 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.0 tpp180 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.42 ' CB ' HG12 ' A' ' 77' ' ' VAL . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.713 HG22 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.494 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.568 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 105' ' ' VAL . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.82 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.65 ' HG1' HH21 ' A' ' 45' ' ' ARG . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.565 ' CB ' ' HG ' ' A' ' 98' ' ' SER . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.502 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 93' ' ' SER . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.685 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 29' ' ' VAL . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.869 ' HG ' ' HG ' ' A' ' 31' ' ' SER . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.734 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CB ' HD22 ' A' ' 106' ' ' ASN . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.705 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.443 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.612 ' H ' ' HG ' ' A' ' 94' ' ' SER . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.6 ' C ' ' O ' ' A' ' 49' ' ' ASP . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.66 HD13 ' N ' ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.705 ' CE3' HD13 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.597 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' HA ' HD22 ' A' ' 56' ' ' LEU . 3.0 tm0? -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.72 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.2 m . . . . . 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HD3' ' OD1' ' A' ' 79' ' ' ASP . 12.7 mtt180 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.522 ' OG1' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.642 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.416 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.601 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.601 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.541 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.612 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.734 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.701 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 33' ' ' LEU . 7.0 p-10 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.608 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.692 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.51 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.624 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 45' ' ' ARG . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.409 HD12 ' HB3' ' A' ' 73' ' ' GLU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.527 HG12 ' HG1' ' A' ' 92' ' ' THR . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 26.8 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.646 HG21 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.783 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.76 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 8.7 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.632 HD12 ' HB ' ' A' ' 63' ' ' VAL . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.683 HG22 ' NE1' ' A' ' 55' ' ' TRP . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.66 ' CD1' HG21 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.783 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HD12 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.66 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.692 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.515 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.66 HG21 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.418 HG22 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.713 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.727 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG13 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 66.7 m170 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.68 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.411 HH11 ' HD3' ' A' ' 43' ' ' ARG . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HE ' ' HG1' ' A' ' 101' ' ' THR . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' O ' ' C ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 49' ' ' ASP . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 50' ' ' VAL . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.68 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.644 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.624 ' CG2' HD12 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.9 mtt-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.503 ' HB ' HG11 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.624 HD12 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.597 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.66 HG21 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.503 HG11 ' HB ' ' A' ' 68' ' ' THR . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.607 ' C ' HG22 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.623 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.595 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.589 ' CG2' HD13 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.882 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.882 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.647 ' HG1' ' HE ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.713 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.727 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.607 HG22 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.782 HG12 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.489 ' CZ ' HG21 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.516 HG12 ' HG1' ' A' ' 92' ' ' THR . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.533 HE21 ' HD3' ' A' ' 95' ' ' PRO . 36.8 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.792 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.504 HD22 ' CA ' ' A' ' 61' ' ' GLN . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HE ' ' HH ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.504 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG2' HD12 ' A' ' 70' ' ' ILE . 18.0 m . . . . . 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.477 ' CB ' ' HA ' ' A' ' 77' ' ' VAL . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.604 HD12 ' CG2' ' A' ' 63' ' ' VAL . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 55' ' ' TRP . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.524 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HH ' ' HE ' ' A' ' 57' ' ' ARG . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.792 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.533 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.492 HG21 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.559 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.782 ' CE2' HG12 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 81' ' ' ILE . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.66 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.735 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.689 ' N ' HG13 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.536 ' H ' HD22 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.58 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.703 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.859 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.703 ' CE3' HD13 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.522 ' HB ' HG13 ' A' ' 77' ' ' VAL . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.689 HG21 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.58 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.593 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.518 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.619 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 56' ' ' LEU . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.859 ' HG ' ' HG ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.802 ' OG1' ' SG ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.706 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.656 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 79.4 mt-10 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.717 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.723 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.408 ' NH1' ' CD ' ' A' ' 73' ' ' GLU . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HD2' HG22 ' A' ' 101' ' ' THR . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.674 HH12 ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 16.6 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.798 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.531 ' CB ' HD23 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.52 ' CB ' ' HD3' ' A' ' 57' ' ' ARG . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' HD12 ' A' ' 70' ' ' ILE . 8.2 m . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.451 ' HD2' ' NH1' ' A' ' 78' ' ' ARG . 27.2 mtm-85 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.498 HG21 ' HA ' ' A' ' 77' ' ' VAL . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.563 HD12 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.687 HG22 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' SER . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.798 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.576 ' CG2' HD12 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.558 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.554 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . 0.504 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.63 ' CA ' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.745 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.727 ' N ' ' O ' ' A' ' 102' ' ' TYR . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.413 ' N ' HG13 ' A' ' 29' ' ' VAL . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.452 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' C ' HD22 ' A' ' 39' ' ' LEU . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.555 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.581 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.701 HH22 ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.586 HD22 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.482 ' O ' ' OG ' ' A' ' 94' ' ' SER . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.45 HE21 ' HG ' ' A' ' 94' ' ' SER . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.49 ' C ' HD13 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.49 HD13 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 61' ' ' GLN . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.49 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.566 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.535 ' H ' ' CG ' ' A' ' 62' ' ' LEU . 34.8 m . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.511 HG21 HG23 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 55' ' ' TRP . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.61 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.542 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.581 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 HG22 HD12 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.701 ' HG1' HH22 ' A' ' 45' ' ' ARG . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.581 ' OG1' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.702 ' CE2' HG12 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.697 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.69 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 . . . . . 0 C--O 1.214 -0.783 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.785 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG13 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.523 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.1 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.482 ' NE ' ' CG2' ' A' ' 101' ' ' THR . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.487 ' NE2' ' CD ' ' A' ' 95' ' ' PRO . 12.5 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.54 ' HG ' ' HB2' ' A' ' 93' ' ' SER . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.765 ' CZ3' ' HB3' ' A' ' 90' ' ' CYS . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.564 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 3.2 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.52 HG11 ' NE2' ' A' ' 61' ' ' GLN . 2.8 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.458 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.633 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.458 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.541 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.674 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 83' ' ' ALA . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.69 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.68 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 81.8 mt-10 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.646 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.584 ' CB ' HD22 ' A' ' 106' ' ' ASN . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.55 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.66 ' HE ' ' HG1' ' A' ' 101' ' ' THR . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD21 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG12 ' HG1' ' A' ' 92' ' ' THR . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.516 HE21 ' HD3' ' A' ' 95' ' ' PRO . 31.6 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.537 ' C ' HD13 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.567 HG21 ' SG ' ' A' ' 90' ' ' CYS . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.76 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.566 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.674 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.674 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 70' ' ' ILE . 1.9 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.5 mtp85 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.612 HD12 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.658 HG22 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.547 HH21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' HG23 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.76 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 HD12 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HD3' HE21 ' A' ' 51' ' ' GLN . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.66 ' HG1' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.68 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 33' ' ' LEU . 7.1 p-10 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.65 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.714 HG12 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.532 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.559 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.722 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.519 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' HG1' ' A' ' 92' ' ' THR . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.436 HE21 ' HD3' ' A' ' 95' ' ' PRO . 29.2 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.578 HG21 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.766 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 88' ' ' TYR . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 4.7 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 70' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' O ' HG21 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.704 HG22 ' NE1' ' A' ' 55' ' ' TRP . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 40' ' ' LEU . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.564 ' C ' HG23 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.573 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 105' ' ' VAL . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.513 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.766 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.683 ' CG2' HD12 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.727 HG21 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.889 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.889 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.65 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.714 ' CE2' HG12 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.564 HG23 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.604 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.736 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.505 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' C ' HD22 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.463 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 17.7 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.453 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.812 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.607 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.8 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.711 0.767 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.427 ' HB ' HG12 ' A' ' 77' ' ' VAL . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.618 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.704 HG22 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.427 HG12 ' HB ' ' A' ' 68' ' ' THR . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.601 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.567 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.812 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.732 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 6.6 p-10 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.731 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.545 ' N ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' HD22 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.453 ' C ' HD22 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' N ' ' A' ' 48' ' ' ASP . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.56 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.409 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.574 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 14.4 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.586 ' C ' HD13 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.659 HG21 ' SG ' ' A' ' 44' ' ' CYS . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.651 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.523 ' CA ' HD22 ' A' ' 56' ' ' LEU . 2.8 tm0? -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.606 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 p . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' HG11 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 55' ' ' TRP . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.502 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.491 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.574 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 91' ' ' VAL . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.567 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.731 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.698 ' CE2' HG12 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.512 HD22 ' CB ' ' A' ' 33' ' ' LEU . 8.5 p-10 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.74 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.748 HG12 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.534 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.539 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.588 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.735 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.429 HD13 ' CB ' ' A' ' 73' ' ' GLU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.673 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.623 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.496 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.5 ' C ' HD13 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.572 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.511 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 2.0 tm0? -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.63 ' CG2' ' CD1' ' A' ' 70' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.63 ' CD1' ' CG2' ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.575 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.575 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.488 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HD12 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.478 HG23 ' SG ' ' A' ' 44' ' ' CYS . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.496 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.445 ' OG1' HG21 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.566 HG21 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.74 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CE2' HG12 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.488 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.417 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.685 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.664 HG12 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 79' ' ' ASP . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.506 ' CG ' ' HB ' ' A' ' 77' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' HG21 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.414 HH12 ' CD ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HG1' ' A' ' 92' ' ' THR . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.732 HG21 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . 0.679 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.627 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 27.2 m . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.372 0.606 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.404 ' OG1' HG22 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.594 HG23 ' CA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.661 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.614 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.58 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.58 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.613 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.679 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG2' HD12 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.522 ' HG1' HG12 ' A' ' 50' ' ' VAL . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.873 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.873 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . 0.601 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.685 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.617 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.84 0 CA-C-O 121.39 0.496 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.554 ' HA ' ' CB ' ' A' ' 47' ' ' ARG . 4.8 p -138.08 139.98 39.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.629 -1.229 . . . . 0.0 110.269 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.559 HD13 ' N ' ' A' ' 16' ' ' LEU . 3.7 mp -117.97 86.45 25.53 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.421 ' O ' ' HB3' ' A' ' 45' ' ' ARG . 7.4 Cg_endo -67.59 -41.89 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.835 2.356 . . . . 0.0 110.913 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.4 62.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.545 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.73 41.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 109.519 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' HB3' ' HG2' ' A' ' 43' ' ' ARG . . . -156.43 -86.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.638 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . 36.5 mm-40 -143.08 157.15 61.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.08 64.66 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.098 1.865 . . . . 0.0 111.282 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.499 ' O ' HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -126.11 50.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.382 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.18 90.2 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.437 HG21 ' HB2' ' A' ' 28' ' ' GLU . 27.5 m -128.3 150.22 73.54 Favored Pre-proline 0 N--CA 1.492 1.662 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.428 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 19.8 Cg_exo -42.69 -44.4 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.854 2.369 . . . . 0.0 113.523 -152.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 t -143.11 38.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.541 1.162 . . . . 0.0 108.201 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.647 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 -151.43 167.47 27.87 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.514 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.775 HG22 ' CB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.593 ' N ' HG13 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.561 ' CD2' ' HG ' ' A' ' 108' ' ' SER . 0.2 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.528 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.732 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.661 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.661 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.452 HG12 ' HG1' ' A' ' 92' ' ' THR . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.427 HE21 ' HB2' ' A' ' 94' ' ' SER . 18.9 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.554 ' C ' HD13 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.554 HD13 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.818 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.563 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.615 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.515 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.563 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 5.0 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.615 HD23 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG22 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p -162.73 92.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.618 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 55.8 mt-10 -97.26 -140.43 0.29 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.904 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.452 ' HG ' ' H ' ' A' ' 66' ' ' ASN . 6.0 p -157.75 -73.98 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.829 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.507 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 15.8 t-20 -43.94 117.49 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.198 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER 80.31 -41.3 0.2 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.108 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.618 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.655 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.597 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.46 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.416 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.736 HG22 ' CE2' ' A' ' 55' ' ' TRP . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.581 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.581 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.507 ' HB2' HG22 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.454 ' HA2' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.459 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.818 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.523 HG23 HD12 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.868 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.868 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.775 ' CB ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.699 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.65 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.437 ' N ' ' OD1' ' A' ' 106' ' ' ASN . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.561 ' HG ' ' CD2' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 109.753 -0.903 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 -158.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.722 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' LEU . 12.7 mt -160.46 -72.42 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.71 76.87 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.215 2.61 . . . . 0.0 112.067 -113.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -160.9 -84.79 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 22' ' ' PRO . 3.2 tp-100 -140.72 134.27 30.07 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 117.496 -1.682 . . . . 0.0 111.892 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.28 -52.2 8.44 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.765 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.574 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 8.4 mm100 -146.7 -64.95 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.286 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 17.9 Cg_endo -73.63 131.47 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.015 1.81 . . . . 0.0 111.173 174.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.472 ' CA ' ' CE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -116.23 -128.56 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.24 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.88 -75.75 1.03 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.43 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG22 ' H ' ' A' ' 27' ' ' VAL . 19.3 m -86.81 153.27 54.91 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.624 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.81 28.84 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.415 2.743 . . . . 0.0 111.352 164.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.437 HG11 ' HG3' ' A' ' 28' ' ' GLU . 19.0 t -120.34 -67.86 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.96 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.556 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 -136.76 -76.04 0.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.259 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.751 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' HG13 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.494 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.594 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.5 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.441 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' HA ' ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' LEU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.502 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' CB ' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.502 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.485 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 14.3 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.598 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.676 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.711 ' NE1' HG22 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.549 HD21 ' N ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.594 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.551 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.58 HD23 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.691 ' HB ' ' CD1' ' A' ' 70' ' ' ILE . 4.5 m -160.11 -153.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 24.8 pt-20 -47.44 158.9 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 123.188 1.471 . . . . 0.0 113.247 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 p -110.76 -80.35 0.58 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 111.306 -2.679 . . . . 0.0 110.741 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.07 -57.61 1.77 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.029 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.96 56.63 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.527 ' HB ' HG13 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.691 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.711 HG22 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.594 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.503 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CD1' ' CG2' ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.662 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.676 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.587 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.43 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.456 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.586 ' HB ' HG22 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.778 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.621 ' CG2' ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG13 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 CA-C-O 120.768 0.237 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -136.74 116.52 13.09 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 16' ' ' LEU . 3.0 mp -121.6 91.23 48.44 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -84.62 87.46 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.165 2.576 . . . . 0.0 111.317 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' CB ' HE22 ' A' ' 19' ' ' GLN . 1.8 mp0 -92.1 -10.69 38.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.004 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 22.0 mp0 -116.86 138.05 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.975 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.52 -90.61 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.551 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.408 ' N ' ' CA ' ' A' ' 22' ' ' PRO . 80.0 mt-30 -137.95 66.37 47.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.676 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' CA ' ' N ' ' A' ' 21' ' ' GLN . 5.2 Cg_exo -51.9 -162.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.329 -1.53 . . . . 0.0 112.5 -51.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.495 ' CD1' ' HA ' ' A' ' 19' ' ' GLN . 7.1 p-90 -97.43 19.49 13.21 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.57 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.69 -64.97 0.12 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.12 150.79 72.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.429 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -79.02 33.07 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.357 2.038 . . . . 0.0 111.217 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.69 -67.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.136 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.553 ' O ' HG21 ' A' ' 29' ' ' VAL . 4.0 mt-10 -103.66 -99.91 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.74 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.413 HD22 HD12 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.504 ' CD2' HD22 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.432 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.552 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.517 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.682 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.649 ' C ' HD22 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.68 HD21 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.603 ' C ' ' H ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.706 ' CE2' HG22 ' A' ' 75' ' ' VAL . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.679 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' CA ' HD22 ' A' ' 56' ' ' LEU . 4.3 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.679 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.634 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -162.28 110.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.547 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 45.7 mm-40 -97.18 -136.12 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.362 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t 178.52 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.992 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -43.54 -90.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.23 2.6 43.15 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.192 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.547 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.481 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.621 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.61 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.68 ' CB ' HD21 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 ' CE2' ' A' ' 55' ' ' TRP . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.575 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.575 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' HG22 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.585 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.654 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.56 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.56 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.605 HG21 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.74 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.504 HD22 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.826 0 CA-C-O 121.085 0.369 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.5 p -122.14 134.72 54.74 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.53 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.0 mp -134.96 111.21 11.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -75.97 -35.64 2.39 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.016 2.477 . . . . 0.0 111.427 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.446 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 25.1 pt-20 -135.36 68.31 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.548 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.13 54.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.878 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.73 -83.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.404 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 69.9 mt-30 -128.85 65.68 73.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.3 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.446 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -51.05 95.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.609 2.206 . . . . 0.0 111.704 -125.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.44 ' CE2' ' HE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -122.59 63.37 0.97 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.127 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.1 88.8 0.8 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.474 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 28.0 m -91.6 158.49 40.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.848 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -77.63 30.22 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.107 2.538 . . . . 0.0 111.207 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.432 ' H ' ' C ' ' A' ' 25' ' ' VAL . 47.1 t -128.9 -71.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.0 0.905 . . . . 0.0 108.601 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.715 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 -143.87 -98.23 0.11 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.774 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.682 ' N ' HG13 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.444 ' O ' HD13 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.552 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.409 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.62 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.62 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.552 ' HB2' HG22 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.506 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.79 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.57 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' NH1' ' HA ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.506 ' HA ' HG23 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.516 HE21 ' HD3' ' A' ' 95' ' ' PRO . 19.9 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.439 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.79 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.597 HD13 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.609 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.609 HD23 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' CG2' HD12 ' A' ' 70' ' ' ILE . 2.1 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.624 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.3 OUTLIER -97.14 -136.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.43 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 19.4 p -154.78 -174.27 4.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.298 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 67' ' ' ARG . 52.2 t30 27.68 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.361 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -26.03 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.624 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.61 HD12 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.673 HG21 ' CD1' ' A' ' 55' ' ' TRP . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.499 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.538 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.538 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.457 ' HB3' HG22 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.575 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.488 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.745 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD13 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HD3' HE21 ' A' ' 51' ' ' GLN . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.617 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.476 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.628 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.715 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.774 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 111.447 -0.251 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.661 ' HG1' HH21 ' A' ' 47' ' ' ARG . 11.1 p -122.97 146.42 47.63 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.52 HD11 ' N ' ' A' ' 16' ' ' LEU . 2.9 mp -140.11 109.01 6.94 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' C ' ' HG2' ' A' ' 45' ' ' ARG . 9.9 Cg_endo -74.88 2.05 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.594 2.196 . . . . 0.0 110.773 168.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -149.63 67.89 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.812 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -80.58 -21.3 41.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.513 ' HB3' ' HE ' ' A' ' 43' ' ' ARG . . . -117.84 -71.85 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.443 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 3.2 mp0 -119.38 140.65 29.42 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.021 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 19.5 Cg_endo -74.79 67.26 5.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.359 2.039 . . . . 0.0 111.799 -166.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.508 ' CD1' HG11 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -131.21 73.71 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.48 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 80.21 0.28 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 28' ' ' GLU . 33.8 m -123.78 145.53 47.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.542 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -46.49 -37.89 20.49 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.89 2.393 . . . . 0.0 113.675 -150.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.457 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 30.8 m -145.42 35.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.247 1.022 . . . . 0.0 108.714 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.669 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 91.6 mt-10 -150.96 157.03 42.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.191 -1.822 . . . . 0.0 107.692 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.643 ' HB3' ' CD2' ' A' ' 103' ' ' PHE . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.58 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 37.3 m170 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.67 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.58 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.43 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.686 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.513 ' HE ' ' HB3' ' A' ' 20' ' ' ALA . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.5 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.641 HH11 ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.413 ' HA ' HG23 ' A' ' 50' ' ' VAL . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.661 HH21 ' HG1' ' A' ' 15' ' ' THR . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.449 ' C ' ' O ' ' A' ' 49' ' ' ASP . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.55 ' C ' HD13 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.551 HG21 ' SG ' ' A' ' 90' ' ' CYS . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.761 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.611 HD22 ' CA ' ' A' ' 61' ' ' GLN . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.57 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.611 ' CA ' HD22 ' A' ' 56' ' ' LEU . 3.1 tm0? -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.492 HD23 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.518 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.7 p -162.55 102.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' N ' HG12 ' A' ' 70' ' ' ILE . 6.9 mm-40 -89.33 -140.98 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.724 -1.191 . . . . 0.0 112.548 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.433 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 16.6 p 168.17 28.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.288 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 1.5 m-20 -118.77 -81.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.605 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 -95.86 1.24 52.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.418 ' CG2' HG12 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.623 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.623 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.491 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG22 ' CE2' ' A' ' 55' ' ' TRP . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.453 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.67 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.522 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.486 ' HB3' HG22 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.52 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.622 ' CE1' HG23 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.449 ' HB2' ' CE2' ' A' ' 102' ' ' TYR . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.761 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.609 ' CG2' HD12 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.553 ' C ' ' H ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.553 ' H ' ' C ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.479 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.584 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.687 ' O ' ' N ' ' A' ' 29' ' ' VAL . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.651 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.622 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.58 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.843 -0.484 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.542 ' C ' HD11 ' A' ' 16' ' ' LEU . 18.0 p -129.74 163.29 26.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD11 ' C ' ' A' ' 15' ' ' THR . 5.8 mp -125.85 132.51 24.34 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 117.516 -1.673 . . . . 0.0 112.597 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -42.79 48.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 125.219 3.946 . . . . 0.0 115.179 -112.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.676 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 13.8 mp0 -146.0 -80.15 0.16 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.443 ' HG3' ' N ' ' A' ' 20' ' ' ALA . 2.0 tp-100 -161.14 -118.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.473 -1.691 . . . . 0.0 109.107 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.443 ' N ' ' HG3' ' A' ' 19' ' ' GLN . . . -160.56 -78.3 0.05 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.615 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.632 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 3.3 tp60 -109.71 -63.57 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.166 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.452 ' CD ' ' N ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -65.44 7.77 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.118 1.879 . . . . 0.0 111.889 -155.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' N ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t-105 -93.22 -20.58 20.31 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' HA3' ' CG2' ' A' ' 101' ' ' THR . . . -82.06 96.26 1.8 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG21 ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -106.14 131.98 21.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.643 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -46.31 -39.78 21.69 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.037 2.491 . . . . 0.0 113.766 -137.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.543 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 8.7 p -149.95 35.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.511 1.148 . . . . 0.0 109.037 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.688 ' N ' ' HB2' ' A' ' 102' ' ' TYR . 9.5 tp10 -158.82 153.82 25.12 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.594 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.693 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG13 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.869 ' HG ' ' HG ' ' A' ' 104' ' ' SER . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.421 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.461 HD11 ' C ' ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.494 ' HB ' ' CB ' ' A' ' 80' ' ' SER . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.545 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.443 ' O ' ' N ' ' A' ' 79' ' ' ASP . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 2.9 pm0 -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.737 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.491 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.616 ' SG ' HG21 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.676 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.517 ' HG ' ' CB ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.493 ' N ' HD13 ' A' ' 46' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.41 ' H ' ' CG ' ' A' ' 47' ' ' ARG . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.458 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.511 HG13 ' HG1' ' A' ' 92' ' ' THR . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.502 ' NE2' ' CD ' ' A' ' 95' ' ' PRO . 12.4 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.429 ' CB ' HE22 ' A' ' 61' ' ' GLN . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.82 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.56 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.585 ' CB ' HD12 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.585 HD12 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.526 ' HA ' HG22 ' A' ' 70' ' ' ILE . 1.6 p -163.24 97.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 2.1 tm-20 -97.0 -141.06 0.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.651 -1.22 . . . . 0.0 111.467 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' H ' ' HB3' ' A' ' 64' ' ' GLU . 36.7 t -167.94 -32.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.744 -179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 68' ' ' THR . 45.0 t30 -91.88 126.13 36.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.746 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.0 tpp180 77.94 -30.95 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.543 ' H ' ' C ' ' A' ' 66' ' ' ASN . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.648 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.578 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.578 ' N ' ' O ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.713 HG22 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.421 ' CG ' HD12 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.465 HG21 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.494 ' CB ' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.568 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 105' ' ' VAL . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.423 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.82 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.482 HG23 HD12 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.65 ' HG1' HH21 ' A' ' 45' ' ' ARG . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.565 ' CB ' ' HG ' ' A' ' 98' ' ' SER . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.502 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.565 ' HG ' ' CB ' ' A' ' 93' ' ' SER . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.685 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.693 ' O ' ' N ' ' A' ' 29' ' ' VAL . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.632 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.869 ' HG ' ' HG ' ' A' ' 31' ' ' SER . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 111.288 -0.312 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.488 ' C ' HD23 ' A' ' 16' ' ' LEU . 5.6 t -142.21 138.33 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.011 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.508 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 2.9 mm? -122.46 99.66 42.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 16' ' ' LEU . 25.0 Cg_endo -83.43 -38.81 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.785 2.324 . . . . 0.0 111.85 -165.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -138.0 79.37 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.673 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -85.29 -3.18 58.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.792 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -124.41 -79.29 0.61 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.982 179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.596 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 71.6 mt-30 -136.11 152.08 74.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 20.8 Cg_endo -81.08 64.76 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.383 2.056 . . . . 0.0 112.04 -160.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.596 ' CH2' ' HB2' ' A' ' 21' ' ' GLN . 1.1 p90 -121.61 132.4 54.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.554 -1.258 . . . . 0.0 111.847 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.21 49.41 0.38 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.421 HG22 ' C ' ' A' ' 28' ' ' GLU . 32.7 m -96.71 142.05 23.97 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 114.732 -0.734 . . . . 0.0 112.073 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -46.61 -40.59 23.87 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.879 2.386 . . . . 0.0 113.296 -150.391 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.09 37.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.383 1.087 . . . . 0.0 108.962 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.734 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 -151.29 169.12 22.71 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.477 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.701 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.604 ' N ' HG13 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.464 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.568 ' CB ' HD22 ' A' ' 106' ' ' ASN . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.47 ' O ' ' HG ' ' A' ' 40' ' ' LEU . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.705 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.537 ' N ' HD22 ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.505 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.443 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.612 ' H ' ' HG ' ' A' ' 94' ' ' SER . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.6 ' C ' ' O ' ' A' ' 49' ' ' ASP . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.66 HD13 ' N ' ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.705 ' CE3' HD13 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.567 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.597 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' HA ' HD22 ' A' ' 56' ' ' LEU . 3.0 tm0? -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.72 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.72 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 4.2 m -156.79 -159.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.664 ' HA ' ' CG2' ' A' ' 68' ' ' THR . 22.5 pt-20 -33.25 132.82 0.16 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.969 0.89 . . . . 0.0 112.487 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 19.6 m -137.03 75.7 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.6 t30 78.3 134.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' C ' ' O ' ' A' ' 66' ' ' ASN . 12.7 mtt180 25.42 53.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.664 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.642 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.55 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.55 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.416 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.601 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.603 HD23 ' N ' ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.601 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.541 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.639 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.484 ' CG2' HD12 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.612 ' HG ' ' H ' ' A' ' 49' ' ' ASP . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.646 ' HB ' HG23 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.734 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.701 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.464 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.549 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.568 HD22 ' CB ' ' A' ' 33' ' ' LEU . 7.0 p-10 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.527 HG22 ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.0 -178.02 4.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.678 ' HB2' ' CB ' ' A' ' 46' ' ' LEU . 6.9 mp -110.14 115.6 54.5 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -83.81 65.3 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.652 2.901 . . . . 0.0 111.237 -110.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.696 ' CB ' ' NE2' ' A' ' 19' ' ' GLN . 4.1 mm-40 -115.51 -67.82 0.97 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.349 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.709 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -145.01 107.83 4.48 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.496 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.41 -29.64 42.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.182 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.582 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 4.0 mt-30 -160.1 -58.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.313 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 16.8 Cg_endo -74.81 138.95 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.918 1.745 . . . . 0.0 111.949 172.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.709 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -111.77 -149.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.318 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.98 -80.95 0.79 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 m -94.7 149.63 36.74 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.702 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -82.63 30.53 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.559 2.172 . . . . 0.0 112.254 -159.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -150.03 -69.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.661 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.608 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 -80.47 -102.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.692 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.684 ' N ' HG13 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.515 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.478 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.51 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.478 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.624 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.671 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.57 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.595 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.678 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.527 HG12 ' HG1' ' A' ' 92' ' ' THR . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 26.8 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.646 HG21 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.783 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.595 HD12 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.76 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.76 ' H ' ' CD1' ' A' ' 62' ' ' LEU . 8.7 m -155.66 -148.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.645 ' N ' HG23 ' A' ' 70' ' ' ILE . 10.8 pt-20 -44.25 156.43 0.07 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.876 1.322 . . . . 0.0 112.88 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.0 t -108.22 -85.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -108.74 -70.27 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 -124.52 71.43 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.515 ' HB ' HG13 ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.645 HG23 ' N ' ' A' ' 64' ' ' GLU . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.683 HG22 ' NE1' ' A' ' 55' ' ' TRP . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.624 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.643 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.449 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB3' HG22 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.66 ' CD1' HG21 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.783 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.595 ' CG2' HD12 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.563 HG21 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.647 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.66 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.692 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.515 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.66 HG21 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 HG22 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.893 0 CA-C-O 121.439 0.516 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.717 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -142.53 164.94 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.558 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.477 HD13 ' N ' ' A' ' 16' ' ' LEU . 5.8 mp -121.44 101.84 43.2 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' O ' ' CD ' ' A' ' 45' ' ' ARG . 16.3 Cg_endo -76.9 3.57 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.93 2.42 . . . . 0.0 111.132 -169.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -160.35 59.19 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.011 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.494 HE22 HH22 ' A' ' 43' ' ' ARG . 0.5 OUTLIER -86.67 47.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.739 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.31 -128.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.542 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.7 mm100 -115.66 78.01 6.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.13 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.663 2.242 . . . . 0.0 111.73 -113.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.542 ' CZ3' ' HB2' ' A' ' 21' ' ' GLN . 0.1 OUTLIER -114.93 74.44 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.415 ' HA3' ' CZ ' ' A' ' 45' ' ' ARG . . . -103.36 85.91 0.51 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.587 -1.292 . . . . 0.0 109.99 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.3 m -104.37 158.06 32.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.843 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -83.51 21.88 0.99 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.415 2.744 . . . . 0.0 111.363 163.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.3 t -115.83 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.713 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 -148.83 -105.58 0.08 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.727 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG13 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 66.7 m170 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.455 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.491 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.68 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.494 HH22 HE22 ' A' ' 19' ' ' GLN . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.647 ' HE ' ' HG1' ' A' ' 101' ' ' THR . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.717 ' HE ' ' CB ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.512 ' C ' ' O ' ' A' ' 49' ' ' ASP . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.413 ' N ' HG23 ' A' ' 50' ' ' VAL . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.574 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.462 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.68 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.589 HD13 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.644 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.525 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.644 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.624 ' CG2' HD12 ' A' ' 70' ' ' ILE . 1.6 p -162.79 103.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' N ' HG22 ' A' ' 70' ' ' ILE . 60.0 mm-40 -97.27 -138.94 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.466 ' HG ' ' H ' ' A' ' 66' ' ' ASN . 9.1 t -160.07 -168.44 2.21 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.7 m120 27.57 -107.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.1 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ASN . 55.9 mtt-85 -29.9 -41.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.573 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.624 HD12 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.597 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.574 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.597 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.66 HG21 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.503 HG11 ' HB ' ' A' ' 68' ' ' THR . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.607 ' C ' HG22 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.623 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.623 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.429 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.525 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.527 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.595 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.589 ' CG2' HD13 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.882 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.433 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.882 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.647 ' HG1' ' HE ' ' A' ' 45' ' ' ARG . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.713 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.727 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.607 HG22 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.48 0.732 0 CA-C-O 121.113 0.38 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.529 ' HG1' ' HE ' ' A' ' 47' ' ' ARG . 1.7 t -114.8 128.2 56.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.967 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.51 ' CB ' HD11 ' A' ' 46' ' ' LEU . 3.2 mp -130.12 86.9 52.91 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.05 67.96 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.522 2.814 . . . . 0.0 110.212 -162.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.714 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -79.67 -59.62 2.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.77 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 7.6 mp0 -142.62 127.75 18.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.321 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.9 45.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.665 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 mt-30 -160.07 -55.49 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.016 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.665 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 37.9 Cg_endo -88.64 135.44 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.082 1.854 . . . . 0.0 112.629 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.77 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -115.64 -125.96 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.28 45.52 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 105.787 -2.925 . . . . 0.0 105.787 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' CG2' ' HB2' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -154.83 132.34 6.38 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.641 -1.28 . . . . 0.0 108.135 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -39.23 -54.75 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.459 2.106 . . . . 0.0 113.442 -150.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 29.6 m -131.92 40.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 122.787 1.279 . . . . 0.0 109.452 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.734 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -138.19 -160.71 1.09 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.782 HG12 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.429 ' N ' HG13 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.573 ' CD2' HG13 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.569 HD13 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.489 ' CZ ' HG21 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.593 HD13 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.572 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.572 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.516 HG12 ' HG1' ' A' ' 92' ' ' THR . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.533 HE21 ' HD3' ' A' ' 95' ' ' PRO . 36.8 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.527 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.792 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.504 HD22 ' CA ' ' A' ' 61' ' ' GLN . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.595 ' HE ' ' HH ' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.564 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.504 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' CG2' HD12 ' A' ' 70' ' ' ILE . 18.0 m -160.13 -147.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.644 ' N ' ' CG2' ' A' ' 70' ' ' ILE . 11.0 pt-20 -47.59 163.25 0.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 123.441 1.591 . . . . 0.0 113.988 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.414 ' OG ' HG22 ' A' ' 68' ' ' THR . 20.4 p -101.37 -88.65 0.37 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.821 -2.899 . . . . 0.0 110.12 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -138.33 -18.74 1.12 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.679 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.43 45.49 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.501 ' HG1' ' HB2' ' A' ' 64' ' ' GLU . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.644 ' CG2' ' N ' ' A' ' 64' ' ' GLU . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 55' ' ' TRP . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.524 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.524 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.452 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.561 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.465 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.595 ' HH ' ' HE ' ' A' ' 57' ' ' ARG . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.792 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.533 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.492 HG21 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.559 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.734 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.782 ' CE2' HG12 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG13 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 81' ' ' ILE . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 120.952 0.313 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.476 HG22 ' O ' ' A' ' 15' ' ' THR . 2.7 t -112.39 101.87 10.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.14 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 16' ' ' LEU . 4.2 mp -126.84 100.76 27.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.447 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . 10.3 Cg_endo -76.3 -35.54 2.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.756 2.304 . . . . 0.0 111.552 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -111.88 44.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.732 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.88 52.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.612 ' HB1' ' HE1' ' A' ' 23' ' ' TRP . . . -123.48 -140.48 0.31 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.779 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.505 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -79.61 -173.39 0.4 Allowed Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 3.0 Cg_exo -67.46 34.24 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.794 1.663 . . . . 0.0 112.336 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.612 ' HE1' ' HB1' ' A' ' 20' ' ' ALA . 35.3 p-90 -113.71 152.79 30.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.978 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.11 39.97 0.46 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.4 p -79.87 130.91 65.33 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.078 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -84.6 46.21 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.131 2.554 . . . . 0.0 111.413 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.54 -59.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.66 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 -136.57 -97.22 0.22 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.735 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.689 ' N ' HG13 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.536 ' H ' HD22 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.418 HG11 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.419 ' CB ' ' CD ' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.58 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.462 ' HB3' HG21 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.606 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.462 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.447 ' HE ' ' HA ' ' A' ' 17' ' ' PRO . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HA ' HG23 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.859 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.514 HG22 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.703 ' CE3' HD13 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.654 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.654 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 p -162.06 104.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.62 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 35.6 mt-10 -91.35 -134.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.967 -1.093 . . . . 0.0 112.759 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.435 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 12.6 p 161.2 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 15.9 p30 178.51 -111.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.683 -1.144 . . . . 0.0 107.976 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 56.5 mtt180 -55.78 -25.69 42.31 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.62 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.514 ' HA ' HG22 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.489 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.689 HG21 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.522 HG13 ' HB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.58 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.593 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' HB3' HG22 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.518 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.619 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.477 ' CG2' HD12 ' A' ' 56' ' ' LEU . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.859 ' HG ' ' HG ' ' A' ' 52' ' ' SER . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.424 HG21 HG23 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.802 ' OG1' ' SG ' ' A' ' 90' ' ' CYS . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.706 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.429 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.449 HG13 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.482 0.827 0 N-CA-C 110.938 -0.447 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 73.1 p -122.53 168.66 11.87 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.123 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.46 HD13 ' N ' ' A' ' 16' ' ' LEU . 5.6 mp -128.58 73.48 80.68 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.506 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 12.0 Cg_exo -50.82 -28.78 24.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.478 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.45 ' C ' HH11 ' A' ' 45' ' ' ARG . 8.8 pt-20 -133.69 90.56 2.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.659 ' N ' HH11 ' A' ' 45' ' ' ARG . 1.1 tm0? -105.35 50.59 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.182 0.991 . . . . 0.0 109.485 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' N ' ' NH1' ' A' ' 45' ' ' ARG . . . -160.56 -120.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.066 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 65.6 mt-30 -116.17 162.82 24.14 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -75.67 69.32 6.08 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.005 1.804 . . . . 0.0 111.829 -160.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.665 ' CD1' HG11 ' A' ' 29' ' ' VAL . 1.1 p90 -129.0 58.73 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.209 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.99 87.27 0.54 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.444 HG21 ' HB2' ' A' ' 28' ' ' GLU . 31.6 m -127.77 149.03 69.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.59 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -45.45 -39.11 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.917 2.412 . . . . 0.0 113.696 -154.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.405 ' C ' ' HB2' ' A' ' 102' ' ' TYR . 30.9 m -143.16 35.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.313 1.054 . . . . 0.0 108.914 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.656 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 79.4 mt-10 -151.23 163.29 39.21 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.633 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.717 ' N ' ' O ' ' A' ' 102' ' ' TYR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.745 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.505 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.482 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.418 ' H ' HD13 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.509 HD21 HG23 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.723 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.443 ' HG2' ' HB3' ' A' ' 20' ' ' ALA . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.659 HH11 ' N ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.515 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.674 HH12 ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.618 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.547 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 16.6 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.798 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.576 HD12 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.531 ' CB ' HD23 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.52 ' CB ' ' HD3' ' A' ' 57' ' ' ARG . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.563 ' HB ' HD12 ' A' ' 70' ' ' ILE . 8.2 m -152.63 -153.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.578 ' HA ' ' CG2' ' A' ' 68' ' ' THR . 11.2 pt-20 -42.33 140.35 1.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.835 0.826 . . . . 0.0 111.896 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 23.6 t -139.06 78.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.212 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 65' ' ' SER . 14.1 t-20 80.17 130.22 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' C ' ' O ' ' A' ' 66' ' ' ASN . 27.2 mtm-85 20.76 54.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.578 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.563 HD12 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.46 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.687 HG22 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 HD21 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 80' ' ' SER . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.523 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.562 ' O ' ' N ' ' A' ' 83' ' ' ALA . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.59 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.529 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.798 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' CG2' HD12 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.424 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.558 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.484 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.554 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.504 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.63 ' CA ' HG22 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.745 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.505 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.59 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.466 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.0 p -136.76 149.36 47.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.495 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 35.9 mt -109.52 97.38 27.03 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.007 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.521 ' HG2' ' NH1' ' A' ' 43' ' ' ARG . 2.8 Cg_exo -50.98 -13.92 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 125.09 2.1 . . . . 0.0 113.124 -88.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.67 ' C ' ' NE2' ' A' ' 19' ' ' GLN . 18.5 mp0 -87.3 -140.69 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.882 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.67 ' NE2' ' C ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -151.07 -106.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.018 -178.393 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -150.58 -86.4 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.137 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.622 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 85.9 mt-30 -79.33 -31.51 0.7 Allowed Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.2 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 21' ' ' GLN . 4.8 Cg_exo -70.09 20.48 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.516 1.477 . . . . 0.0 112.014 168.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.504 ' H ' ' C ' ' A' ' 21' ' ' GLN . 48.7 t-105 -143.06 -51.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.829 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.52 ' HA3' HG21 ' A' ' 101' ' ' THR . . . -79.71 142.14 24.31 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 118.763 -1.684 . . . . 0.0 110.228 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 27' ' ' VAL . 5.9 m -107.76 164.75 14.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.922 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.78 7.54 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.551 2.167 . . . . 0.0 111.362 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.502 ' H ' ' C ' ' A' ' 25' ' ' VAL . 57.6 t -114.73 -77.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.11 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.702 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 -156.1 -107.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.727 ' N ' ' O ' ' A' ' 102' ' ' TYR . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.413 ' N ' HG13 ' A' ' 29' ' ' VAL . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.452 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG12 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' C ' HD22 ' A' ' 39' ' ' LEU . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.555 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.581 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.531 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.701 HH22 ' HG1' ' A' ' 92' ' ' THR . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.586 HD22 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.415 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.482 ' O ' ' OG ' ' A' ' 94' ' ' SER . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.45 HE21 ' HG ' ' A' ' 94' ' ' SER . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.49 ' C ' HD13 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.49 HD13 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.45 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.742 ' CD1' HG21 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 HD22 ' N ' ' A' ' 61' ' ' GLN . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.49 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.566 ' N ' HD22 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 ' CG ' ' H ' ' A' ' 63' ' ' VAL . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.535 ' H ' ' CG ' ' A' ' 62' ' ' LEU . 34.8 m -160.28 -140.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.572 ' HA ' ' OG1' ' A' ' 68' ' ' THR . 10.8 pt-20 -43.67 153.05 0.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.65 1.214 . . . . 0.0 113.916 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 p -105.46 -77.25 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 112.276 -2.238 . . . . 0.0 109.597 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.66 -50.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.315 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 -134.28 73.13 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.61 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.519 HG12 ' H ' ' A' ' 64' ' ' GLU . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.742 HG21 ' CD1' ' A' ' 55' ' ' TRP . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.61 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.547 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.529 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.542 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.697 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.581 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 HG22 HD12 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.701 ' HG1' HH22 ' A' ' 45' ' ' ARG . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.88 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.581 ' OG1' ' SG ' ' A' ' 90' ' ' CYS . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.702 ' CE2' HG12 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.452 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.697 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.529 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 111.001 -0.423 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.45 ' OG1' ' HA ' ' A' ' 19' ' ' GLN . 9.7 t -144.35 148.31 34.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 4.7 mp -124.48 149.71 62.44 Favored Pre-proline 0 C--N 1.298 -1.663 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.218 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -21.87 -33.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 1 C-N-CA 126.072 4.515 . . . . 0.0 114.485 -113.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.617 ' C ' ' NE2' ' A' ' 19' ' ' GLN . 70.0 mm-40 -102.73 -113.34 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 117.827 -1.549 . . . . 0.0 109.262 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.617 ' NE2' ' C ' ' A' ' 18' ' ' GLU . 20.0 mp0 -152.68 -96.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.726 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.24 -47.07 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.503 -179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.594 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 9.1 mp0 -122.0 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.118 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 9.6 Cg_endo -60.9 84.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.929 1.753 . . . . 0.0 112.013 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.584 ' CE2' ' HG3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -121.38 -88.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.76 -57.36 0.52 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.6 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 2.6 m -137.5 156.37 74.97 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.829 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -85.49 41.09 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.318 2.678 . . . . 0.0 110.717 148.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.0 t -129.49 -56.4 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.69 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 -152.33 -113.59 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.802 -1.999 . . . . 0.0 105.857 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.785 ' CG2' ' HB ' ' A' ' 101' ' ' THR . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG13 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.483 HD21 ' H ' ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 80' ' ' SER . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.403 ' N ' HD21 ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.523 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.523 ' N ' HD11 ' A' ' 40' ' ' LEU . 3.1 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.557 HD11 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.611 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.616 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.575 ' HB3' HD12 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.487 ' NE2' ' CD ' ' A' ' 95' ' ' PRO . 12.5 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.54 ' HG ' ' HB2' ' A' ' 93' ' ' SER . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.765 ' CZ3' ' HB3' ' A' ' 90' ' ' CYS . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.597 HD12 ' CG2' ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.564 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 3.2 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 HD23 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG11 ' NE2' ' A' ' 61' ' ' GLN . 2.8 p -163.01 94.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 70' ' ' ILE . 23.2 mm-40 -97.08 -145.21 0.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.397 -1.321 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -151.54 -163.27 1.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.4 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 66' ' ' ASN . 2.9 m120 38.53 -115.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -37.12 -37.01 0.15 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.111 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.458 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.633 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.71 HG23 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.458 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.541 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.674 ' HG ' ' H ' ' A' ' 37' ' ' GLY . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.56 ' O ' ' N ' ' A' ' 83' ' ' ALA . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' HB3' HG22 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.456 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.471 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CE1' HG23 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.461 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' HD12 ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 52' ' ' SER . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.578 ' C ' ' H ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.487 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.578 ' H ' ' C ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.517 ' CG ' HE21 ' A' ' 21' ' ' GLN . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.481 ' OG1' HG23 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.69 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.731 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.565 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.808 0 CA-C-O 121.191 0.413 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.507 ' HG1' ' H ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -136.52 168.81 18.76 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.664 HD11 ' N ' ' A' ' 16' ' ' LEU . 4.4 mp -122.57 125.31 26.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.208 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -30.88 -17.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 1 C-N-CA 126.463 4.776 . . . . 0.0 116.747 -111.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 10.6 mp0 -79.41 -126.0 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.568 ' CG ' ' H ' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -160.29 -107.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.378 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.568 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -135.7 -31.0 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.518 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 71.1 mt-30 -113.87 160.53 31.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.507 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 21' ' ' GLN . 20.3 Cg_exo -49.75 142.42 25.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.133 1.889 . . . . 0.0 111.348 -166.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -121.04 -8.62 9.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.496 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.83 -69.58 1.36 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.086 -1.531 . . . . 0.0 110.774 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.439 ' CG2' HG21 ' A' ' 27' ' ' VAL . 16.5 m -141.49 160.73 55.77 Favored Pre-proline 0 N--CA 1.491 1.601 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.819 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -77.95 33.41 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.599 2.2 . . . . 0.0 111.692 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG21 ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -143.35 -67.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.646 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.68 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 81.8 mt-10 -122.1 -104.95 0.38 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.646 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.601 ' N ' HG13 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.584 ' CB ' HD22 ' A' ' 106' ' ' ASN . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.458 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 HD11 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.55 ' N ' HD11 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.66 ' HE ' ' HG1' ' A' ' 101' ' ' THR . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.617 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.617 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG12 ' HG1' ' A' ' 92' ' ' THR . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.516 HE21 ' HD3' ' A' ' 95' ' ' PRO . 31.6 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.537 ' C ' HD13 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.567 HG21 ' SG ' ' A' ' 90' ' ' CYS . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.428 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.76 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.674 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.674 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 70' ' ' ILE . 1.9 p -162.49 98.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.587 ' H ' HG22 ' A' ' 70' ' ' ILE . 34.7 mt-10 -91.69 -111.03 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 7.6 t 167.68 -164.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.043 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' ARG . 11.3 t-20 29.95 -122.14 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.045 0.841 . . . . 0.0 112.579 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ASN . 8.5 mtp85 -31.62 -38.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.472 ' OG1' ' HB2' ' A' ' 64' ' ' GLU . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.612 HD12 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.619 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.658 HG22 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG21 ' HB3' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.547 HH21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.444 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.528 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.499 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.437 ' N ' HD13 ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.536 ' CE1' HG23 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.76 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.519 HG23 HD12 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.516 ' HD3' HE21 ' A' ' 51' ' ' GLN . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.66 ' HG1' ' HE ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.68 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.646 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.536 HG23 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.584 HD22 ' CB ' ' A' ' 33' ' ' LEU . 7.1 p-10 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.482 0.83 0 CA-C-O 121.11 0.379 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.664 ' HG1' ' H ' ' A' ' 16' ' ' LEU . 12.1 t -106.62 -164.77 1.02 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.703 ' HB3' ' CB ' ' A' ' 46' ' ' LEU . 5.2 tt -156.78 115.92 2.05 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.602 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.423 ' CD ' HD21 ' A' ' 16' ' ' LEU . 57.6 Cg_endo -96.11 -19.45 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 124.261 3.307 . . . . 0.0 116.384 -107.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' CB ' ' NE2' ' A' ' 19' ' ' GLN . 2.7 mp0 -78.32 -4.07 46.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.717 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 22.5 mp0 -152.46 90.22 1.48 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' CZ ' ' A' ' 45' ' ' ARG . . . -118.47 -132.8 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.913 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.602 ' C ' ' H ' ' A' ' 23' ' ' TRP . 35.8 mt-30 -79.84 -66.21 0.27 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.094 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.3 Cg_endo -58.31 11.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.046 1.831 . . . . 0.0 112.669 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.607 ' CG ' ' HA ' ' A' ' 19' ' ' GLN . 52.3 t-105 -98.7 -16.21 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.886 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.74 101.84 2.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.554 ' C ' ' H ' ' A' ' 27' ' ' VAL . 6.3 p -79.89 141.05 54.62 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.001 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.49 ' HD2' HG22 ' A' ' 25' ' ' VAL . 3.0 Cg_endo -55.11 -0.97 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.755 2.304 . . . . 0.0 112.154 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 25' ' ' VAL . 59.2 t -103.35 -77.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.65 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 -147.16 -104.89 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.714 HG12 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.532 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' N ' HD21 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.485 HD13 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.537 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.559 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.722 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.492 ' HG2' ' NE2' ' A' ' 19' ' ' GLN . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.727 ' SG ' HG21 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.717 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.703 ' CB ' ' HB3' ' A' ' 16' ' ' LEU . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.635 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.462 HG12 ' HG1' ' A' ' 92' ' ' THR . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.436 HE21 ' HD3' ' A' ' 95' ' ' PRO . 29.2 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.578 HG21 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.444 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.766 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.683 HD12 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.587 ' HG3' ' CZ ' ' A' ' 88' ' ' TYR . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD22 ' A' ' 56' ' ' LEU . 4.7 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.535 HD23 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.528 HG22 ' CG1' ' A' ' 70' ' ' ILE . 1.5 p -162.53 113.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.584 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.4 OUTLIER -96.56 -144.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.633 -178.692 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.443 ' H ' ' HB3' ' A' ' 64' ' ' GLU . 57.9 m -162.08 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.2 -179.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 68' ' ' THR . 3.6 m120 -92.2 145.05 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 52.3 mtt85 76.01 -38.8 0.35 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.584 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.592 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.554 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' O ' HG21 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.704 HG22 ' NE1' ' A' ' 55' ' ' TRP . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.453 HG21 ' O ' ' A' ' 40' ' ' LEU . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.564 ' C ' HG23 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.573 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.546 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.477 ' HB3' HG22 ' A' ' 105' ' ' VAL . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.513 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.587 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.511 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.766 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.683 ' CG2' HD12 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.727 HG21 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.889 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.436 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.889 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.616 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.65 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.714 ' CE2' HG12 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.564 HG23 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 CA-C-O 121.011 0.338 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -112.7 144.83 41.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.592 HD12 ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -107.88 95.68 15.42 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 118.34 -1.344 . . . . 0.0 109.974 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.592 ' HD3' HD12 ' A' ' 16' ' ' LEU . 17.1 Cg_endo -69.71 55.46 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.759 2.973 . . . . 0.0 111.921 -94.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.723 ' CG ' ' HA ' ' A' ' 45' ' ' ARG . 2.7 mm-40 -104.43 -110.78 0.26 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.614 HE21 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -149.32 -91.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.353 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.19 -109.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.648 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.587 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 34.9 tt0 -98.45 -42.25 0.24 Allowed Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.276 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 21' ' ' GLN . 4.2 Cg_endo -76.4 90.06 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.76 1.64 . . . . 0.0 109.761 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.422 ' CE3' ' CA ' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -109.91 -76.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.878 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.79 -70.02 0.57 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 29' ' ' VAL . 22.5 m -132.36 157.92 77.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.535 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.94 10.95 1.54 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.511 2.14 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.06 -87.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.25 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 -80.05 -118.59 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.732 HG12 ' CZ ' ' A' ' 103' ' ' PHE . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.578 ' N ' HG13 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.521 ' HB3' HD22 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.604 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.604 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.534 HD13 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.537 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.723 ' HA ' ' CG ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.58 ' N ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.556 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.463 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.589 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 17.7 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' HD12 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.453 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.812 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.676 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.676 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.607 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.8 p -162.07 95.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.633 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 3.9 tp10 -97.42 -145.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.905 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.539 ' O ' ' C ' ' A' ' 66' ' ' ASN . 8.4 p -164.15 -70.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.232 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.55 ' H ' HD21 ' A' ' 66' ' ' ASN . 1.6 m-80 -4.13 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.519 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -114.79 8.98 16.21 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.661 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.633 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.618 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.573 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.573 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.704 HG22 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.427 HG12 ' HB ' ' A' ' 68' ' ' THR . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.601 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.601 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.549 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.531 ' HB2' ' CG1' ' A' ' 105' ' ' VAL . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.567 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.602 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.812 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.474 HG23 HD12 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.519 HG21 HD11 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.589 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.627 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.732 ' CZ ' HG12 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.524 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 6.6 p-10 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.433 ' O ' ' CG1' ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.71 -0.535 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.559 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -160.23 141.83 12.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 40.0 mt -113.9 112.2 47.77 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-O 122.945 1.355 . . . . 0.0 111.445 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 19' ' ' GLN . 62.5 Cg_endo -104.88 -11.07 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.494 2.796 . . . . 0.0 114.954 -100.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.679 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 12.3 mt-10 -79.55 15.99 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.877 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.679 ' NE2' ' HB2' ' A' ' 18' ' ' GLU . 8.3 mp0 -146.59 67.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.163 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.92 -76.08 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.057 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.651 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 40.3 mt-30 -138.47 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -58.56 71.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.303 2.002 . . . . 0.0 111.16 168.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' CE2' ' O ' ' A' ' 18' ' ' GLU . 29.0 t-105 -160.06 -33.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.338 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.6 121.26 7.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.549 HG21 ' N ' ' A' ' 28' ' ' GLU . 6.7 m -109.85 161.56 23.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.167 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -64.21 -7.09 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.714 2.276 . . . . 0.0 111.049 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.7 t -97.29 -77.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.731 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 -160.36 -108.6 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.107 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.698 HG12 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.545 ' N ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.512 ' CB ' HD22 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.402 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.533 HD11 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.683 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.659 ' SG ' HG21 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.453 ' C ' HD22 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.56 ' HG3' ' N ' ' A' ' 48' ' ' ASP . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.56 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.437 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.409 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.574 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 14.4 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.586 ' C ' HD13 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.659 HG21 ' SG ' ' A' ' 44' ' ' CYS . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.768 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.616 HD12 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.651 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.491 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.523 ' CA ' HD22 ' A' ' 56' ' ' LEU . 2.8 tm0? -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.651 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.606 ' H ' HD12 ' A' ' 62' ' ' LEU . 1.3 p -162.51 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' N ' HG12 ' A' ' 70' ' ' ILE . 36.0 mt-10 -85.43 -139.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.717 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -151.21 -67.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.588 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 2.2 m120 -98.95 159.42 14.97 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.907 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 53.2 mtt-85 71.43 -49.98 0.69 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' HG11 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.611 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.6 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.59 HG22 ' CE2' ' A' ' 55' ' ' TRP . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.502 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.576 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.563 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.491 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.529 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.768 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.623 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.574 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.477 ' HG1' HG23 ' A' ' 91' ' ' VAL . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.567 ' CB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.731 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.698 ' CE2' HG12 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.46 ' HG ' ' HG ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.506 HG11 ' HB2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.512 HD22 ' CB ' ' A' ' 33' ' ' LEU . 8.5 p-10 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.563 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.481 0.739 0 N-CA-C 111.428 -0.258 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.587 HG23 ' HA ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -117.41 143.11 46.34 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.589 ' CB ' ' HB2' ' A' ' 46' ' ' LEU . 6.8 mp -108.12 122.31 41.03 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.736 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.534 ' C ' ' H ' ' A' ' 19' ' ' GLN . 35.2 Cg_endo -92.62 3.32 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 127.258 3.241 . . . . 0.0 114.798 -106.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' C ' ' CD ' ' A' ' 19' ' ' GLN . 31.5 mt-10 -79.21 6.48 9.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.585 ' CB ' ' HB2' ' A' ' 45' ' ' ARG . 20.5 mp0 -150.4 95.32 2.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.587 ' HA ' HG23 ' A' ' 15' ' ' THR . . . -92.85 -77.66 0.44 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 17.1 mm-40 -139.76 -64.81 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.375 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.0 Cg_endo -63.59 30.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.823 1.682 . . . . 0.0 113.231 174.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.554 ' H ' ' C ' ' A' ' 21' ' ' GLN . 25.3 t-105 -108.19 -22.92 12.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 124.2 7.39 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.486 -2.646 . . . . 0.0 106.486 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.524 HG21 ' N ' ' A' ' 28' ' ' GLU . 6.6 m -107.98 163.69 16.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.658 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -63.71 -4.79 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.828 2.352 . . . . 0.0 110.953 166.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.7 t -101.8 -84.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.74 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 -151.01 -105.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.748 HG12 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.526 ' N ' HG13 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.438 ' HB3' HD22 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . 0.414 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.534 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.539 ' C ' HD13 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.769 HD13 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.588 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.735 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.72 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.589 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.673 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.673 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.623 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.496 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.5 ' C ' HD13 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.5 HD13 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.41 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.769 ' CE3' HD13 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.59 HD12 HG23 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.572 ' CB ' HD23 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.511 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 2.0 tm0? -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.572 HD23 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.63 ' CG2' ' CD1' ' A' ' 70' ' ' ILE . 2.5 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -97.12 -137.78 0.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.653 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -164.46 -165.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.079 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.1 m120 42.92 -111.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 4.3 mpt_? -40.68 -36.23 0.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.63 ' CD1' ' CG2' ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.582 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.582 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.657 HG21 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.462 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.534 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.575 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.575 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.639 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.52 ' N ' HD13 ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.488 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.59 HG23 HD12 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.478 HG23 ' SG ' ' A' ' 44' ' ' CYS . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.623 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.496 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.511 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.445 ' OG1' HG21 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.566 HG21 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.74 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.748 ' CE2' HG12 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.488 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.639 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.417 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.462 -0.245 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -140.19 147.09 39.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.072 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 5.6 mp -114.93 121.17 35.81 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.538 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' C ' ' H ' ' A' ' 19' ' ' GLN . 74.2 Cg_endo -105.54 -34.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 127.589 3.415 . . . . 0.0 114.188 -109.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' O ' ' CE2' ' A' ' 23' ' ' TRP . 64.8 mt-10 -78.84 17.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . 0.652 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 15.6 mp0 -158.16 92.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.42 ' H ' ' CB ' ' A' ' 23' ' ' TRP . . . -143.57 -135.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.407 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.611 ' C ' ' H ' ' A' ' 23' ' ' TRP . 5.5 mm100 -79.93 -60.49 0.5 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 9.1 Cg_endo -62.92 25.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.044 1.83 . . . . 0.0 112.407 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . 0.611 ' H ' ' C ' ' A' ' 21' ' ' GLN . 52.0 t-105 -121.79 -14.52 8.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.403 ' HA3' HG23 ' A' ' 101' ' ' THR . . . -107.09 127.79 8.97 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.542 HG21 ' N ' ' A' ' 28' ' ' GLU . 5.9 m -106.24 161.41 22.92 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.734 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -14.09 18.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.638 2.225 . . . . 0.0 110.911 169.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.86 -82.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.685 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 -153.0 -104.34 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.664 HG12 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.565 ' N ' HG13 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.556 HD13 ' N ' ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.447 ' HB ' ' CG ' ' A' ' 79' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.614 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.422 ' O ' ' N ' ' A' ' 79' ' ' ASP . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.484 ' N ' HD22 ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.506 ' CG ' ' HB ' ' A' ' 77' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.547 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.603 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.732 ' SG ' HG21 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.652 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.611 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.601 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG12 ' HG1' ' A' ' 92' ' ' THR . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.732 HG21 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.523 HD12 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.679 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.594 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.627 ' H ' ' CD2' ' A' ' 62' ' ' LEU . 27.2 m -160.42 -140.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.566 ' H ' HG12 ' A' ' 70' ' ' ILE . 15.8 pt-20 -65.75 139.75 58.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.751 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.506 ' HG ' HH21 ' A' ' 57' ' ' ARG . 49.6 m -110.61 -59.57 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.943 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -60.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 -130.34 74.74 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.411 ' OG1' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.594 HG23 ' CA ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.534 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.715 HG22 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.506 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.661 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.614 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.58 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.58 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.613 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.679 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' CYS . . . . . 0.789 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.523 ' CG2' HD12 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.522 ' HG1' HG12 ' A' ' 50' ' ' VAL . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.873 ' HG ' ' HG ' ' A' ' 98' ' ' SER . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.46 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.873 ' HG ' ' HG ' ' A' ' 93' ' ' SER . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . 0.601 ' HB ' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.685 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.617 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . 0.565 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.613 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.694 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.701 ' N ' HG12 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.777 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 47' ' ' ARG . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.673 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.831 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.726 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.606 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.2 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.582 HG23 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 68' ' ' THR . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.74 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.59 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.59 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 70' ' ' ILE . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB2' HG23 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.453 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.831 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.812 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.72 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.634 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.547 ' N ' HD12 ' A' ' 40' ' ' LEU . 14.3 mp0 -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.468 HH11 ' HD2' ' A' ' 43' ' ' ARG . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' HD3' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD21 ' CB ' ' A' ' 73' ' ' GLU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' HB3' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.9 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 92' ' ' THR . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.712 ' NE1' HG23 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.668 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.003 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.5 m . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.572 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 1.003 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.572 HG12 ' HB ' ' A' ' 68' ' ' THR . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.675 ' CD1' HG22 ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.533 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 53' ' ' ILE . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.708 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.778 ' CD1' ' N ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.842 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.675 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 4.0 mt-10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.849 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 80' ' ' SER . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.665 ' C ' HD23 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.863 HD22 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.72 ' CE3' HD12 ' A' ' 42' ' ' LEU . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.819 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.2 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.819 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.774 ' H ' HD13 ' A' ' 62' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.157 0.503 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.863 ' CB ' HD22 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 70' ' ' ILE . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.615 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 87' ' ' LEU . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.679 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG2' HD11 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.849 ' CE2' HG11 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.82 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.591 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' NE ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 13.4 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.713 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp0? -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 70' ' ' ILE . 2.1 p . . . . . 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' ' HG1' ' A' ' 71' ' ' THR . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 HG22 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.519 ' O ' ' OG ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.889 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.721 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . 91.6 mt-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.061 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.782 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.443 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 6.3 m-70 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.45 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HD3' ' OE1' ' A' ' 74' ' ' GLU . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.767 ' H ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 47' ' ' ARG . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.655 ' C ' HD12 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.777 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.626 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.678 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.733 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 70' ' ' ILE . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.546 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.516 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG23 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CE1' HG21 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.777 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.061 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.7 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.633 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 29' ' ' VAL . 9.5 tp10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.839 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.779 ' N ' HG12 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.562 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB2' HG12 ' A' ' 34' ' ' VAL . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.529 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' NH2' ' CB ' ' A' ' 99' ' ' ASP . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.49 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.49 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.2 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.836 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CB ' HD13 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.495 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.0 tpp180 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.452 ' CB ' HG13 ' A' ' 77' ' ' VAL . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.678 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 71' ' ' THR . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.709 HG23 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CG ' HD11 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.836 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.61 HG22 ' SG ' ' A' ' 44' ' ' CYS . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.839 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.71 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.79 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.759 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.736 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.573 ' N ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 50' ' ' VAL . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HA ' HE21 ' A' ' 51' ' ' GLN . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 93' ' ' SER . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.736 ' CE3' HD12 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.693 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.587 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.708 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.2 m . . . . . 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 79' ' ' ASP . 12.7 mtt180 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.522 ' OG1' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.844 HD13 ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.606 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.58 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.891 ' HB ' HG21 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.79 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.489 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.557 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 4.5 p30 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.861 HG12 ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.861 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 45' ' ' ARG . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 73' ' ' GLU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.451 ' OE1' ' HD3' ' A' ' 95' ' ' PRO . 13.4 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.804 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD11 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.638 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.585 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.962 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.7 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.962 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.631 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.744 ' CD1' HG22 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.451 ' HD3' ' OE1' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 92' ' ' THR . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.803 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.687 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.45 HG21 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.723 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 ' N ' ' A' ' 30' ' ' GLU . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.831 ' N ' HG12 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 43' ' ' ARG . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' N ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 46' ' ' LEU . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' O ' ' C ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 53' ' ' ILE . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.752 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.785 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.737 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.9 mtt-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.737 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.602 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.606 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 77' ' ' VAL . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.647 ' C ' HG21 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.645 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 42' ' ' LEU . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.61 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.724 ' CG2' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.723 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.814 ' CE2' HG11 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.647 HG21 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.04 HG11 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' N ' HG12 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.648 ' CD2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' CZ ' HG23 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 91' ' ' VAL . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 70' ' ' ILE . 18.0 m . . . . . 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 77' ' ' VAL . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.927 HD13 ' HB ' ' A' ' 63' ' ' VAL . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 46' ' ' LEU . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 42' ' ' LEU . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.81 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 56' ' ' LEU . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.797 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 1.04 ' CE2' HG11 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 107' ' ' VAL . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.655 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.0 HG21 ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.869 ' N ' HG12 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.427 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.685 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 40' ' ' LEU . 18.7 mp0 -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 45' ' ' ARG . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.52 ' CB ' HG12 ' A' ' 77' ' ' VAL . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HA ' HG21 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG23 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.685 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 100' ' ' THR . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 53' ' ' ILE . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.0 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.73 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.7 ' CE1' HG11 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 29' ' ' VAL . 79.4 mt-10 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 ' HB ' ' A' ' 101' ' ' THR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.772 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.516 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.654 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD23 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 6.4 mp0 -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.771 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 74' ' ' GLU . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HD2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.576 HH21 ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' H ' ' HB2' ' A' ' 94' ' ' SER . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 7.4 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.576 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.1 pp0? -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.765 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.2 m . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HD2' ' NH1' ' A' ' 78' ' ' ARG . 27.2 mtm-85 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 77' ' ' VAL . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.765 HD13 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.666 HG23 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG21 HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD1' HG23 ' A' ' 81' ' ' ILE . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 87' ' ' LEU . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.64 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.536 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.576 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . 1.098 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.772 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.724 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG11 ' CE2' ' A' ' 103' ' ' PHE . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 103' ' ' PHE . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.66 HD22 HE21 ' A' ' 41' ' ' GLN . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.66 HE21 HD22 ' A' ' 39' ' ' LEU . 2.1 mp0 -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.653 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.45 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG12 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.5 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CD1' HG23 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 91' ' ' VAL . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.536 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.576 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 70' ' ' ILE . 34.8 m . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG22 HG22 ' A' ' 70' ' ' ILE . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.718 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.672 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.564 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.72 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.605 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB2' HH12 ' A' ' 45' ' ' ARG . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.732 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.891 ' CE2' HG11 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.72 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 . . . . . 0 C--O 1.214 -0.783 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.867 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.846 ' N ' HG12 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 40' ' ' LEU . 14.5 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.624 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HE ' ' CG2' ' A' ' 101' ' ' THR . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.653 ' HB3' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.2 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.796 ' CG ' HG21 ' A' ' 75' ' ' VAL . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD1' HG23 ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.618 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 1.1 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.559 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.8 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.605 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.634 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.557 ' CE1' HG21 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.628 HG23 ' CD1' ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.708 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.867 ' CE2' HG11 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.8 mt-10 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.699 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.551 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' N ' HD12 ' A' ' 40' ' ' LEU . 8.9 mp0 -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.746 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.577 ' HE ' ' CG2' ' A' ' 101' ' ' THR . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 29.4 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.663 ' C ' HD12 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.772 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 91' ' ' VAL . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 1.3 pp0? -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.744 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.9 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 67' ' ' ARG . 8.5 mtp85 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.744 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.663 HG23 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HB3' HH21 ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.772 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.702 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 3.1 p30 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.673 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.873 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 40' ' ' LEU . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.458 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' N ' HD12 ' A' ' 40' ' ' LEU . 8.6 mp0 -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.789 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HB3' HG21 ' A' ' 92' ' ' THR . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 26.4 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.594 HG23 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.611 HH22 ' HB1' ' A' ' 83' ' ' ALA . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.1 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.691 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.592 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.691 HG22 HG22 ' A' ' 70' ' ' ILE . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 77' ' ' VAL . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.578 ' C ' HG21 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.778 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.789 ' CG2' HD11 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.815 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.673 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.873 ' CE2' HG11 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.638 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG21 ' HB ' ' A' ' 101' ' ' THR . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.401 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' N ' HD12 ' A' ' 40' ' ' LEU . 12.4 mp0 -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.624 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.476 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 7.4 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.824 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.782 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.782 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.8 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.711 0.767 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.61 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.824 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.569 HG22 HD12 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HD3' ' OE1' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.918 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 5.0 p30 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.743 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.87 HG11 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 40' ' ' LEU . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 38' ' ' ASP . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 mp0 -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.484 ' C ' HD23 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 48' ' ' ASP . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.557 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' SER . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.426 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' A' ' 95' ' ' PRO . 6.1 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.73 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.525 ' O ' ' OD1' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.78 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.727 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.874 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' HG12 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 70' ' ' ILE . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 107' ' ' VAL . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.78 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 56' ' ' LEU . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 94' ' ' SER . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.706 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.743 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.87 ' CE2' HG11 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.744 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG11 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.594 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 ' CB ' ' A' ' 73' ' ' GLU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.654 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.63 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.538 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.604 ' C ' HD12 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.474 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG22 HD13 ' A' ' 70' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 4.3 mpt_? . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.672 HD13 HG22 ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.594 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.601 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.601 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 42' ' ' LEU . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.499 ' CB ' HG11 ' A' ' 50' ' ' VAL . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.595 HG22 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.744 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.918 ' CE2' HG11 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' OD1' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.709 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.793 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.479 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.629 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.479 ' OD2' HG12 ' A' ' 34' ' ' VAL . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 HG11 ' A' ' 105' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 10.4 mp0 -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' NH1' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 73' ' ' GLU . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.563 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.504 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . 0.802 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.712 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 61' ' ' GLN . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 70' ' ' ILE . 27.2 m . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.372 0.606 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.692 HD13 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG23 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.661 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.629 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.64 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' CYS . . . . . 0.802 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 ' SG ' ' A' ' 44' ' ' CYS . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.483 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 90' ' ' CYS . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.751 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.709 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.64 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.84 0 CA-C-O 121.39 0.496 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.577 ' HA ' ' CB ' ' A' ' 47' ' ' ARG . 4.8 p -138.08 139.98 39.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.629 -1.229 . . . . 0.0 110.269 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 16' ' ' LEU . 3.7 mp -117.97 86.45 25.53 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' ARG . 7.4 Cg_endo -67.59 -41.89 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.835 2.356 . . . . 0.0 110.913 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.4 62.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.545 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.73 41.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 109.519 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . . . -156.43 -86.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.638 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . 36.5 mm-40 -143.08 157.15 61.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.08 64.66 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.098 1.865 . . . . 0.0 111.282 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.782 ' O ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -126.11 50.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.382 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.18 90.2 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 28' ' ' GLU . 27.5 m -128.3 150.22 73.54 Favored Pre-proline 0 N--CA 1.492 1.662 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 19.8 Cg_exo -42.69 -44.4 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.854 2.369 . . . . 0.0 113.523 -152.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 t -143.11 38.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.541 1.162 . . . . 0.0 108.201 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.694 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 -151.43 167.47 27.87 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.514 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.701 ' N ' HG12 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 0.0 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.777 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.503 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 47' ' ' ARG . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.673 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.445 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.831 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.726 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.606 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.2 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.582 HG23 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p -162.73 92.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.634 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 55.8 mt-10 -97.26 -140.43 0.29 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.904 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 68' ' ' THR . 6.0 p -157.75 -73.98 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.829 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 15.8 t-20 -43.94 117.49 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.198 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER 80.31 -41.3 0.2 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.108 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.74 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.59 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.59 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 70' ' ' ILE . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB2' HG23 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.831 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.474 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.812 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.72 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 109.753 -0.903 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 -158.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.722 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' LEU . 12.7 mt -160.46 -72.42 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' CD ' ' H ' ' A' ' 16' ' ' LEU . 9.7 Cg_endo -65.71 76.87 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.215 2.61 . . . . 0.0 112.067 -113.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -160.9 -84.79 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 22' ' ' PRO . 13.0 tp60 -140.72 134.27 30.07 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 117.496 -1.682 . . . . 0.0 111.892 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.28 -52.2 8.44 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.765 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.4 mm100 -146.7 -64.95 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.286 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 21' ' ' GLN . 17.9 Cg_endo -73.63 131.47 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.015 1.81 . . . . 0.0 111.173 174.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.482 ' HE3' ' C ' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -116.23 -128.56 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.24 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.88 -75.75 1.03 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.43 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 27' ' ' VAL . 19.3 m -86.81 153.27 54.91 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.624 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.81 28.84 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.415 2.743 . . . . 0.0 111.352 164.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' H ' HG23 ' A' ' 25' ' ' VAL . 19.0 t -120.34 -67.86 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.96 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 -136.76 -76.04 0.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.259 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.634 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.547 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.547 ' N ' HD12 ' A' ' 40' ' ' LEU . 14.3 mp0 -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.468 HH11 ' HD2' ' A' ' 43' ' ' ARG . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' HD3' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' LEU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' HB3' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.9 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 92' ' ' THR . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.546 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.712 ' NE1' HG23 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.668 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.003 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.5 m -160.11 -153.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.8 ' N ' HG21 ' A' ' 70' ' ' ILE . 24.8 pt-20 -47.44 158.9 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 123.188 1.471 . . . . 0.0 113.247 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 p -110.76 -80.35 0.58 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 111.306 -2.679 . . . . 0.0 110.741 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.07 -57.61 1.77 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.029 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.96 56.63 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.572 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 1.003 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.572 HG12 ' HB ' ' A' ' 68' ' ' THR . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.675 ' CD1' HG22 ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.533 ' CG2' ' CD1' ' A' ' 56' ' ' LEU . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 53' ' ' ILE . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.708 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.778 ' CD1' ' N ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.842 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.675 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 CA-C-O 120.768 0.237 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -136.74 116.52 13.09 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.611 HD12 ' N ' ' A' ' 16' ' ' LEU . 3.0 mp -121.6 91.23 48.44 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -84.62 87.46 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.165 2.576 . . . . 0.0 111.317 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.504 ' CB ' HE22 ' A' ' 19' ' ' GLN . 1.8 mp0 -92.1 -10.69 38.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.004 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 22.0 mp0 -116.86 138.05 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.975 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.52 -90.61 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.551 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.408 ' N ' ' CA ' ' A' ' 22' ' ' PRO . 80.0 mt-30 -137.95 66.37 47.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.676 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' CA ' ' N ' ' A' ' 21' ' ' GLN . 5.2 Cg_exo -51.9 -162.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.329 -1.53 . . . . 0.0 112.5 -51.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 19' ' ' GLN . 7.1 p-90 -97.43 19.49 13.21 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.57 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.69 -64.97 0.12 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.12 150.79 72.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.429 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -79.02 33.07 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.357 2.038 . . . . 0.0 111.217 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.69 -67.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.136 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 4.0 mt-10 -103.66 -99.91 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.849 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 80' ' ' SER . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.665 ' C ' HD23 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.863 HD22 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.479 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.72 ' CE3' HD12 ' A' ' 42' ' ' LEU . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.819 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.2 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.819 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.774 ' H ' HD13 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -162.28 110.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 45.7 mm-40 -97.18 -136.12 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.362 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t 178.52 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.992 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -43.54 -90.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.23 2.6 43.15 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.192 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.863 ' CB ' HD22 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 70' ' ' ILE . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.615 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.47 HD12 ' N ' ' A' ' 87' ' ' LEU . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.679 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG2' HD11 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.849 ' CE2' HG11 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.826 0 CA-C-O 121.085 0.369 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.5 p -122.14 134.72 54.74 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.0 mp -134.96 111.21 11.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -75.97 -35.64 2.39 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.016 2.477 . . . . 0.0 111.427 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 25.1 pt-20 -135.36 68.31 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.548 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.13 54.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.878 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.73 -83.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 69.9 mt-30 -128.85 65.68 73.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.3 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -51.05 95.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.609 2.206 . . . . 0.0 111.704 -125.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CE2' ' HE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -122.59 63.37 0.97 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.127 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.1 88.8 0.8 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 28.0 m -91.6 158.49 40.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.848 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -77.63 30.22 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.107 2.538 . . . . 0.0 111.207 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' VAL . 47.1 t -128.9 -71.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.0 0.905 . . . . 0.0 108.601 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 -143.87 -98.23 0.11 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.82 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.53 HD12 ' O ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.591 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' NE ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.491 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 13.4 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.713 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.5 pp0? -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 70' ' ' ILE . 2.1 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.3 OUTLIER -97.14 -136.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.447 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 19.4 p -154.78 -174.27 4.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.298 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 67' ' ' ARG . 13.0 t-20 27.68 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.361 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -26.03 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.641 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' ' HG1' ' A' ' 71' ' ' THR . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 HG22 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.519 ' O ' ' OG ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.889 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.721 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 111.447 -0.251 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.524 ' HB ' ' HE ' ' A' ' 47' ' ' ARG . 11.1 p -122.97 146.42 47.63 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.543 HD12 ' N ' ' A' ' 16' ' ' LEU . 2.9 mp -140.11 109.01 6.94 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' C ' ' HG2' ' A' ' 45' ' ' ARG . 9.9 Cg_endo -74.88 2.05 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.594 2.196 . . . . 0.0 110.773 168.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . 7.3 pt-20 -149.63 67.89 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.812 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -80.58 -21.3 41.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -117.84 -71.85 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 3.2 mp0 -119.38 140.65 29.42 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.021 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 19.5 Cg_endo -74.79 67.26 5.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.359 2.039 . . . . 0.0 111.799 -166.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.922 ' O ' HG22 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -131.21 73.71 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.48 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 80.21 0.28 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' GLU . 33.8 m -123.78 145.53 47.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.542 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -46.49 -37.89 20.49 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.89 2.393 . . . . 0.0 113.675 -150.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 30.8 m -145.42 35.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.247 1.022 . . . . 0.0 108.714 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . 91.6 mt-10 -150.96 157.03 42.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.191 -1.822 . . . . 0.0 107.692 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.061 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.782 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.443 ' HA ' ' OD1' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 6.3 m-70 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.45 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' HE ' ' HB1' ' A' ' 20' ' ' ALA . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.767 ' H ' HH11 ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 47' ' ' ARG . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.655 ' C ' HD12 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.777 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.626 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.678 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.7 p -162.55 102.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' HG12 ' A' ' 70' ' ' ILE . 6.9 mm-40 -89.33 -140.98 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.724 -1.191 . . . . 0.0 112.548 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 16.6 p 168.17 28.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.288 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 1.5 m-20 -118.77 -81.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.605 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 -95.86 1.24 52.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.733 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 70' ' ' ILE . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.546 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG23 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CE1' HG21 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.777 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.061 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.7 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.633 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.843 -0.484 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.565 ' C ' HD12 ' A' ' 16' ' ' LEU . 18.0 p -129.74 163.29 26.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 47' ' ' ARG . 5.8 mp -125.85 132.51 24.34 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 117.516 -1.673 . . . . 0.0 112.597 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -42.79 48.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 125.219 3.946 . . . . 0.0 115.179 -112.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.691 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 13.8 mp0 -146.0 -80.15 0.16 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 20' ' ' ALA . 22.9 tp60 -161.14 -118.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.473 -1.691 . . . . 0.0 109.107 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' N ' ' HG3' ' A' ' 19' ' ' GLN . . . -160.56 -78.3 0.05 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.615 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.648 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 3.3 tp60 -109.71 -63.57 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.166 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -65.44 7.77 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.118 1.879 . . . . 0.0 111.889 -155.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' N ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t-105 -93.22 -20.58 20.31 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' CG2' ' A' ' 101' ' ' THR . . . -82.06 96.26 1.8 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -106.14 131.98 21.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.643 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -46.31 -39.78 21.69 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.037 2.491 . . . . 0.0 113.766 -137.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 8.7 p -149.95 35.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.511 1.148 . . . . 0.0 109.037 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 29' ' ' VAL . 9.5 tp10 -158.82 153.82 25.12 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.594 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.839 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.779 ' N ' HG12 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.511 HG12 ' HB2' ' A' ' 38' ' ' ASP . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.562 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB2' HG12 ' A' ' 34' ' ' VAL . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.529 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.691 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HA ' HD13 ' A' ' 16' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.49 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.49 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.2 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.501 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.836 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CB ' HD13 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.6 p -163.24 97.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 2.1 tm-20 -97.0 -141.06 0.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.651 -1.22 . . . . 0.0 111.467 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -167.94 -32.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.744 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 68' ' ' THR . 45.0 t30 -91.88 126.13 36.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.746 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.0 tpp180 77.94 -30.95 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' ASN . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' C ' ' HD3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.678 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 71' ' ' THR . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.709 HG23 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CG ' HD11 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.836 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.61 HG22 ' SG ' ' A' ' 44' ' ' CYS . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.839 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.71 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 111.288 -0.312 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.513 ' C ' HD22 ' A' ' 16' ' ' LEU . 5.6 t -142.21 138.33 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.011 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.555 HD22 ' N ' ' A' ' 16' ' ' LEU . 2.9 mm? -122.46 99.66 42.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.43 -38.81 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.785 2.324 . . . . 0.0 111.85 -165.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -138.0 79.37 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.673 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 15.1 mm-40 -85.29 -3.18 58.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.792 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . . . -124.41 -79.29 0.61 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.982 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 71.6 mt-30 -136.11 152.08 74.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 20.8 Cg_endo -81.08 64.76 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.383 2.056 . . . . 0.0 112.04 -160.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 21' ' ' GLN . 1.1 p90 -121.61 132.4 54.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.554 -1.258 . . . . 0.0 111.847 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.21 49.41 0.38 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 28' ' ' GLU . 32.7 m -96.71 142.05 23.97 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 114.732 -0.734 . . . . 0.0 112.073 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -46.61 -40.59 23.87 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.879 2.386 . . . . 0.0 113.296 -150.391 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.09 37.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.383 1.087 . . . . 0.0 108.962 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.79 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 -151.29 169.12 22.71 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.477 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.759 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.426 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.405 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.573 ' N ' HD23 ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 50' ' ' VAL . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.499 ' HA ' HE21 ' A' ' 51' ' ' GLN . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 93' ' ' SER . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.736 ' CE3' HD12 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.693 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.587 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.708 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.2 m -156.79 -159.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.691 ' H ' HG21 ' A' ' 70' ' ' ILE . 22.5 pt-20 -33.25 132.82 0.16 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.969 0.89 . . . . 0.0 112.487 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 19.6 m -137.03 75.7 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.6 t30 78.3 134.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' C ' ' O ' ' A' ' 66' ' ' ASN . 12.7 mtt180 25.42 53.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.672 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.844 HD13 ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.606 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.58 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.891 ' HB ' HG21 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.79 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.489 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.557 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.418 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 4.5 p30 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.0 -178.02 4.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HB2' ' CB ' ' A' ' 46' ' ' LEU . 6.9 mp -110.14 115.6 54.5 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -83.81 65.3 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.652 2.901 . . . . 0.0 111.237 -110.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.596 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 4.1 mm-40 -115.51 -67.82 0.97 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.349 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 29.4 mp0 -145.01 107.83 4.48 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.496 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 21' ' ' GLN . . . -79.41 -29.64 42.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.182 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.594 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 10.3 mt-30 -160.1 -58.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.313 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 16.8 Cg_endo -74.81 138.95 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.918 1.745 . . . . 0.0 111.949 172.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.718 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -111.77 -149.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.318 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.98 -80.95 0.79 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 m -94.7 149.63 36.74 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.702 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 22.2 Cg_endo -82.63 30.53 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.559 2.172 . . . . 0.0 112.254 -159.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -150.03 -69.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.661 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 -80.47 -102.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.861 HG12 ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.861 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.738 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.451 ' OE1' ' HD3' ' A' ' 95' ' ' PRO . 13.4 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.53 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.804 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD11 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.638 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.962 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.7 m -155.66 -148.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.757 ' N ' HG21 ' A' ' 70' ' ' ILE . 10.8 pt-20 -44.25 156.43 0.07 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.876 1.322 . . . . 0.0 112.88 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.0 t -108.22 -85.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -108.74 -70.27 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 -124.52 71.43 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.962 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.631 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.57 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.744 ' CD1' HG22 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.451 ' HD3' ' OE1' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 92' ' ' THR . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.803 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.687 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.45 HG21 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.893 0 CA-C-O 121.439 0.516 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.76 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -142.53 164.94 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.558 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.503 HD12 ' N ' ' A' ' 16' ' ' LEU . 5.8 mp -121.44 101.84 43.2 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' O ' ' CD ' ' A' ' 45' ' ' ARG . 16.3 Cg_endo -76.9 3.57 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.93 2.42 . . . . 0.0 111.132 -169.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -160.35 59.19 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.011 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.539 HE22 HH22 ' A' ' 43' ' ' ARG . 0.5 OUTLIER -86.67 47.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.739 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.31 -128.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 55.7 mm-40 -115.66 78.01 6.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.13 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.663 2.242 . . . . 0.0 111.73 -113.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 21' ' ' GLN . 0.1 OUTLIER -114.93 74.44 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 45' ' ' ARG . . . -103.36 85.91 0.51 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.587 -1.292 . . . . 0.0 109.99 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 29.3 m -104.37 158.06 32.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.843 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -83.51 21.88 0.99 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.415 2.744 . . . . 0.0 111.363 163.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.3 t -115.83 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.723 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 -148.83 -105.58 0.08 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 ' N ' ' A' ' 30' ' ' GLU . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.831 ' N ' HG12 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.539 HH22 HE22 ' A' ' 19' ' ' GLN . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' CD ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.416 HD12 ' C ' ' A' ' 46' ' ' LEU . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.76 ' HE ' ' CB ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 53' ' ' ILE . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.752 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.785 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.737 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.6 p -162.79 103.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 60.0 mm-40 -97.27 -138.94 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' ASN . 9.1 t -160.07 -168.44 2.21 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.7 m120 27.57 -107.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.1 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ASN . 55.9 mtt-85 -29.9 -41.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.737 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.602 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.606 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 77' ' ' VAL . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.647 ' C ' HG21 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.645 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 42' ' ' LEU . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.61 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.724 ' CG2' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.723 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.814 ' CE2' HG11 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.647 HG21 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.48 0.732 0 CA-C-O 121.113 0.38 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -114.8 128.2 56.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.967 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 46' ' ' LEU . 3.2 mp -130.12 86.9 52.91 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.05 67.96 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.522 2.814 . . . . 0.0 110.212 -162.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.741 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -79.67 -59.62 2.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.768 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 7.6 mp0 -142.62 127.75 18.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.321 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.9 45.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.674 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 mt-30 -160.07 -55.49 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.016 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.674 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 37.9 Cg_endo -88.64 135.44 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.082 1.854 . . . . 0.0 112.629 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.768 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -115.64 -125.96 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.28 45.52 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 105.787 -2.925 . . . . 0.0 105.787 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -154.83 132.34 6.38 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.641 -1.28 . . . . 0.0 108.135 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -39.23 -54.75 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.459 2.106 . . . . 0.0 113.442 -150.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 29.6 m -131.92 40.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 122.787 1.279 . . . . 0.0 109.452 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -138.19 -160.71 1.09 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.04 HG11 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' N ' HG12 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' CD2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' CZ ' HG23 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 91' ' ' VAL . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 70' ' ' ILE . 18.0 m -160.13 -147.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.863 ' N ' HG21 ' A' ' 70' ' ' ILE . 11.0 pt-20 -47.59 163.25 0.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 123.441 1.591 . . . . 0.0 113.988 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 p -101.37 -88.65 0.37 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.821 -2.899 . . . . 0.0 110.12 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -138.33 -18.74 1.12 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.679 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.43 45.49 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 77' ' ' VAL . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.927 HD13 ' HB ' ' A' ' 63' ' ' VAL . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 46' ' ' LEU . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 42' ' ' LEU . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.81 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 56' ' ' LEU . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.797 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 1.04 ' CE2' HG11 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.52 ' O ' HG13 ' A' ' 107' ' ' VAL . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 120.952 0.313 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 15' ' ' THR . 2.7 t -112.39 101.87 10.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.14 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.555 HD12 ' N ' ' A' ' 16' ' ' LEU . 4.2 mp -126.84 100.76 27.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . 10.3 Cg_endo -76.3 -35.54 2.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.756 2.304 . . . . 0.0 111.552 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -111.88 44.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.732 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.88 52.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HB1' ' O ' ' A' ' 43' ' ' ARG . . . -123.48 -140.48 0.31 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.779 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.505 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -79.61 -173.39 0.4 Allowed Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 3.0 Cg_exo -67.46 34.24 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.794 1.663 . . . . 0.0 112.336 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HE1' ' HB1' ' A' ' 20' ' ' ALA . 35.3 p-90 -113.71 152.79 30.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.978 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.11 39.97 0.46 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 25' ' ' VAL . 10.4 p -79.87 130.91 65.33 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.078 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -84.6 46.21 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.131 2.554 . . . . 0.0 111.413 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.54 -59.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.655 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 -136.57 -97.22 0.22 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.0 HG21 ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.869 ' N ' HG12 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.427 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.685 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.455 ' N ' HD12 ' A' ' 40' ' ' LEU . 18.7 mp0 -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.706 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 17' ' ' PRO . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p -162.06 104.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.636 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 35.6 mt-10 -91.35 -134.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.967 -1.093 . . . . 0.0 112.759 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 12.6 p 161.2 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 15.9 p30 178.51 -111.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.683 -1.144 . . . . 0.0 107.976 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 56.5 mtt180 -55.78 -25.69 42.31 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.636 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HA ' HG21 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG23 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.685 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 100' ' ' THR . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 53' ' ' ILE . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.0 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.73 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.7 ' CE1' HG11 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.482 0.827 0 N-CA-C 110.938 -0.447 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 73.1 p -122.53 168.66 11.87 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.123 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.478 HD12 ' N ' ' A' ' 16' ' ' LEU . 5.6 mp -128.58 73.48 80.68 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 12.0 Cg_exo -50.82 -28.78 24.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.478 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' C ' HH11 ' A' ' 45' ' ' ARG . 8.8 pt-20 -133.69 90.56 2.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.681 ' N ' HH11 ' A' ' 45' ' ' ARG . 1.1 tm0? -105.35 50.59 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.182 0.991 . . . . 0.0 109.485 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' N ' ' NH1' ' A' ' 45' ' ' ARG . . . -160.56 -120.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.066 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 65.6 mt-30 -116.17 162.82 24.14 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 21' ' ' GLN . 9.5 Cg_endo -75.67 69.32 6.08 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.005 1.804 . . . . 0.0 111.829 -160.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.805 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.1 p90 -129.0 58.73 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.209 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.99 87.27 0.54 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 28' ' ' GLU . 31.6 m -127.77 149.03 69.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.59 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 14.9 Cg_exo -45.45 -39.11 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.917 2.412 . . . . 0.0 113.696 -154.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' TYR . 30.9 m -143.16 35.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.313 1.054 . . . . 0.0 108.914 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 29' ' ' VAL . 79.4 mt-10 -151.23 163.29 39.21 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.633 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 ' HB ' ' A' ' 101' ' ' THR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.772 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.516 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.654 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD23 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 6.4 mp0 -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.771 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.681 HH11 ' N ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.576 HH21 ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' H ' ' HB2' ' A' ' 94' ' ' SER . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 7.4 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.576 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' HD23 ' A' ' 56' ' ' LEU . 1.1 pp0? -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.765 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.2 m -152.63 -153.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' H ' HG21 ' A' ' 70' ' ' ILE . 11.2 pt-20 -42.33 140.35 1.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.835 0.826 . . . . 0.0 111.896 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 23.6 t -139.06 78.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.212 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 65' ' ' SER . 14.1 t-20 80.17 130.22 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' C ' ' O ' ' A' ' 66' ' ' ASN . 27.2 mtm-85 20.76 54.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.765 HD13 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.666 HG23 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG21 HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD1' HG23 ' A' ' 81' ' ' ILE . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' N ' ' A' ' 87' ' ' LEU . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.64 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.536 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.576 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . 1.098 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.772 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.0 p -136.76 149.36 47.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 35.9 mt -109.52 97.38 27.03 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.007 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HG2' ' NH1' ' A' ' 43' ' ' ARG . 2.8 Cg_exo -50.98 -13.92 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 125.09 2.1 . . . . 0.0 113.124 -88.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 18.5 mp0 -87.3 -140.69 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.882 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.514 ' OE1' ' C ' ' A' ' 18' ' ' GLU . 4.6 pm0 -151.07 -106.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.018 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -150.58 -86.4 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.137 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.622 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 85.9 mt-30 -79.33 -31.51 0.7 Allowed Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.2 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 21' ' ' GLN . 4.8 Cg_exo -70.09 20.48 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.516 1.477 . . . . 0.0 112.014 168.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' C ' ' A' ' 21' ' ' GLN . 48.7 t-105 -143.06 -51.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.829 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' HG22 ' A' ' 101' ' ' THR . . . -79.71 142.14 24.31 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 118.763 -1.684 . . . . 0.0 110.228 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' H ' ' A' ' 28' ' ' GLU . 5.9 m -107.76 164.75 14.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.922 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.78 7.54 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.551 2.167 . . . . 0.0 111.362 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 25' ' ' VAL . 57.6 t -114.73 -77.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.11 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.724 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 -156.1 -107.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG11 ' CE2' ' A' ' 103' ' ' PHE . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 103' ' ' PHE . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.66 HD22 HE21 ' A' ' 41' ' ' GLN . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.66 HE21 HD22 ' A' ' 39' ' ' LEU . 2.1 mp0 -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.45 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG12 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.5 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CD1' HG23 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 91' ' ' VAL . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.576 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 70' ' ' ILE . 34.8 m -160.28 -140.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 70' ' ' ILE . 10.8 pt-20 -43.67 153.05 0.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.65 1.214 . . . . 0.0 113.916 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 p -105.46 -77.25 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 112.276 -2.238 . . . . 0.0 109.597 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.66 -50.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.315 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 -134.28 73.13 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG22 HG22 ' A' ' 70' ' ' ILE . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.718 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.672 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.564 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.72 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.605 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB2' HH12 ' A' ' 45' ' ' ARG . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.732 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.891 ' CE2' HG11 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.72 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 111.001 -0.423 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.7 t -144.35 148.31 34.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.631 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 4.7 mp -124.48 149.71 62.44 Favored Pre-proline 0 C--N 1.298 -1.663 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.218 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -21.87 -33.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 1 C-N-CA 126.072 4.515 . . . . 0.0 114.485 -113.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 70.0 mm-40 -102.73 -113.34 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 117.827 -1.549 . . . . 0.0 109.262 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.62 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 2.4 mp0 -152.68 -96.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.726 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 45' ' ' ARG . . . -160.24 -47.07 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.503 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 2.4 mp0 -122.0 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.118 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 21' ' ' GLN . 9.6 Cg_endo -60.9 84.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.929 1.753 . . . . 0.0 112.013 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -121.38 -88.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.76 -57.36 0.52 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.674 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 2.6 m -137.5 156.37 74.97 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.829 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -85.49 41.09 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.318 2.678 . . . . 0.0 110.717 148.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.0 t -129.49 -56.4 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 -152.33 -113.59 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.802 -1.999 . . . . 0.0 105.857 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.867 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.846 ' N ' HG12 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 40' ' ' LEU . 14.5 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.653 ' HB3' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 5.2 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.796 ' CG ' HG21 ' A' ' 75' ' ' VAL . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD1' HG23 ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.618 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 1.1 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.559 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.8 p -163.01 94.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 70' ' ' ILE . 23.2 mm-40 -97.08 -145.21 0.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.397 -1.321 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -151.54 -163.27 1.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.4 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 38.53 -115.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.635 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -37.12 -37.01 0.15 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.111 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.605 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.634 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.556 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.515 ' O ' ' OG ' ' A' ' 80' ' ' SER . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.557 ' CE1' HG21 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.628 HG23 ' CD1' ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.708 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.867 ' CE2' HG11 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.808 0 CA-C-O 121.191 0.413 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -136.52 168.81 18.76 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 16' ' ' LEU . 4.4 mp -122.57 125.31 26.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.208 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -30.88 -17.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 1 C-N-CA 126.463 4.776 . . . . 0.0 116.747 -111.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 10.6 mp0 -79.41 -126.0 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.516 ' CG ' ' H ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -160.29 -107.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.378 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -135.7 -31.0 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 71.1 mt-30 -113.87 160.53 31.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.507 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 21' ' ' GLN . 20.3 Cg_exo -49.75 142.42 25.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.133 1.889 . . . . 0.0 111.348 -166.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -121.04 -8.62 9.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.496 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.83 -69.58 1.36 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.086 -1.531 . . . . 0.0 110.774 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' A' ' 27' ' ' VAL . 16.5 m -141.49 160.73 55.77 Favored Pre-proline 0 N--CA 1.491 1.601 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.819 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -77.95 33.41 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.599 2.2 . . . . 0.0 111.692 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -143.35 -67.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.646 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.8 mt-10 -122.1 -104.95 0.38 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.699 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.551 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' N ' HD12 ' A' ' 40' ' ' LEU . 8.9 mp0 -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.746 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.656 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 29.4 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.663 ' C ' HD12 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.534 ' N ' ' ND2' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.772 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 91' ' ' VAL . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 1.3 pp0? -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.744 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.9 p -162.49 98.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' O ' HD11 ' A' ' 70' ' ' ILE . 34.7 mt-10 -91.69 -111.03 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 7.6 t 167.68 -164.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.043 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' ARG . 11.3 t-20 29.95 -122.14 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.045 0.841 . . . . 0.0 112.579 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ASN . 8.5 mtp85 -31.62 -38.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 64' ' ' GLU . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.744 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.663 HG23 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.578 ' HB3' HH21 ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 ' N ' ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.772 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.702 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.533 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 3.1 p30 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.5 ' O ' HG13 ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.482 0.83 0 CA-C-O 121.11 0.379 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 16' ' ' LEU . 12.1 t -106.62 -164.77 1.02 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 46' ' ' LEU . 5.2 tt -156.78 115.92 2.05 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.602 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.493 ' CD ' HD23 ' A' ' 16' ' ' LEU . 57.6 Cg_endo -96.11 -19.45 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 124.261 3.307 . . . . 0.0 116.384 -107.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.419 ' C ' ' CD ' ' A' ' 19' ' ' GLN . 2.7 mp0 -78.32 -4.07 46.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.715 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 1.1 mp0 -152.46 90.22 1.48 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' CZ ' ' A' ' 45' ' ' ARG . . . -118.47 -132.8 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.913 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.578 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 24.6 mt-30 -79.84 -66.21 0.27 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.094 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.3 Cg_endo -58.31 11.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.046 1.831 . . . . 0.0 112.669 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 19' ' ' GLN . 52.3 t-105 -98.7 -16.21 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.886 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.74 101.84 2.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 26' ' ' PRO . 6.3 p -79.89 141.05 54.62 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.001 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 25' ' ' VAL . 3.0 Cg_endo -55.11 -0.97 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.755 2.304 . . . . 0.0 112.154 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.591 ' H ' HG22 ' A' ' 25' ' ' VAL . 59.2 t -103.35 -77.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.673 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 -147.16 -104.89 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.873 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 40' ' ' LEU . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.458 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' N ' HD12 ' A' ' 40' ' ' LEU . 8.6 mp0 -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.789 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.501 ' O ' ' HG2' ' A' ' 19' ' ' GLN . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 26.4 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.594 HG23 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.466 ' ND2' ' N ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.611 HH22 ' HB1' ' A' ' 83' ' ' ALA . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.1 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.5 p -162.53 113.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.594 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.4 OUTLIER -96.56 -144.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.633 -178.692 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -162.08 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.2 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 46.8 m-20 -92.2 145.05 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 52.3 mtt85 76.01 -38.8 0.35 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.594 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.691 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.592 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.691 HG22 HG22 ' A' ' 70' ' ' ILE . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 77' ' ' VAL . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.578 ' C ' HG21 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.778 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.789 ' CG2' HD11 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.815 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.673 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.873 ' CE2' HG11 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 CA-C-O 121.011 0.338 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -112.7 144.83 41.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.682 HD13 ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -107.88 95.68 15.42 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 118.34 -1.344 . . . . 0.0 109.974 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.682 ' HD3' HD13 ' A' ' 16' ' ' LEU . 17.1 Cg_endo -69.71 55.46 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.759 2.973 . . . . 0.0 111.921 -94.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.738 ' CG ' ' HA ' ' A' ' 45' ' ' ARG . 2.7 mm-40 -104.43 -110.78 0.26 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.32 -91.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.353 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.19 -109.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.648 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 34.9 tt0 -98.45 -42.25 0.24 Allowed Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.276 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 21' ' ' GLN . 4.2 Cg_endo -76.4 90.06 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.76 1.64 . . . . 0.0 109.761 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.465 ' HA ' ' HE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -109.91 -76.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.878 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.79 -70.02 0.57 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 29' ' ' VAL . 22.5 m -132.36 157.92 77.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.535 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.94 10.95 1.54 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.511 2.14 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.06 -87.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.25 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.638 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 -80.05 -118.59 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG21 ' HB ' ' A' ' 101' ' ' THR . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.401 ' O ' ' ND2' ' A' ' 106' ' ' ASN . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.454 ' N ' HD23 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' N ' HD12 ' A' ' 40' ' ' LEU . 12.4 mp0 -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.738 ' HA ' ' CG ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.624 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.476 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 7.4 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.824 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.782 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.782 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.8 p -162.07 95.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 3.9 tp10 -97.42 -145.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.905 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.539 ' O ' ' C ' ' A' ' 66' ' ' ASN . 8.4 p -164.15 -70.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.232 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.539 ' C ' ' O ' ' A' ' 65' ' ' SER . 3.1 m120 -4.13 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.519 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -114.79 8.98 16.21 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.661 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.65 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.61 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.824 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.569 HG22 HD12 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HD3' ' OE1' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.918 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 5.0 p30 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.71 -0.535 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -160.23 141.83 12.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 40.0 mt -113.9 112.2 47.77 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-O 122.945 1.355 . . . . 0.0 111.445 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -104.88 -11.07 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.494 2.796 . . . . 0.0 114.954 -100.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.694 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 12.3 mt-10 -79.55 15.99 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.877 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.694 ' NE2' ' HB2' ' A' ' 18' ' ' GLU . 8.3 mp0 -146.59 67.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.163 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.92 -76.08 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.057 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.651 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 40.3 mt-30 -138.47 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -58.56 71.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.303 2.002 . . . . 0.0 111.16 168.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' CE2' ' O ' ' A' ' 18' ' ' GLU . 29.0 t-105 -160.06 -33.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.338 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.6 121.26 7.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 28' ' ' GLU . 6.7 m -109.85 161.56 23.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.167 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -64.21 -7.09 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.714 2.276 . . . . 0.0 111.049 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 28' ' ' GLU . 4.7 t -97.29 -77.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.743 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 -160.36 -108.6 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.107 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.87 HG11 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 40' ' ' LEU . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.599 ' ND1' ' N ' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 38' ' ' ASP . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.4 mp0 -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.484 ' C ' HD23 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.534 ' N ' HD23 ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 15' ' ' THR . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.557 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' SER . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.426 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.433 ' OE1' ' HD3' ' A' ' 95' ' ' PRO . 6.1 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.73 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.525 ' O ' ' OD1' ' A' ' 54' ' ' ASN . 0.1 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.78 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.727 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.874 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p -162.51 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 70' ' ' ILE . 36.0 mt-10 -85.43 -139.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.717 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -151.21 -67.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.588 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 2.2 m120 -98.95 159.42 14.97 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.907 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 53.2 mtt-85 71.43 -49.98 0.69 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' HG12 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 70' ' ' ILE . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 107' ' ' VAL . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.78 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 56' ' ' LEU . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' CD ' ' CB ' ' A' ' 94' ' ' SER . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.706 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.743 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.87 ' CE2' HG11 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.481 0.739 0 N-CA-C 111.428 -0.258 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -117.41 143.11 46.34 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.625 ' CB ' ' HB2' ' A' ' 46' ' ' LEU . 6.8 mp -108.12 122.31 41.03 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.736 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 19' ' ' GLN . 35.2 Cg_endo -92.62 3.32 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 127.258 3.241 . . . . 0.0 114.798 -106.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' C ' ' CD ' ' A' ' 19' ' ' GLN . 31.5 mt-10 -79.21 6.48 9.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 45' ' ' ARG . 20.5 mp0 -150.4 95.32 2.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HA ' HG21 ' A' ' 15' ' ' THR . . . -92.85 -77.66 0.44 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 10.2 mm100 -139.76 -64.81 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.375 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.0 Cg_endo -63.59 30.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.823 1.682 . . . . 0.0 113.231 174.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CD1' ' HG3' ' A' ' 19' ' ' GLN . 25.3 t-105 -108.19 -22.92 12.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 124.2 7.39 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.486 -2.646 . . . . 0.0 106.486 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 28' ' ' GLU . 6.6 m -107.98 163.69 16.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.658 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -63.71 -4.79 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.828 2.352 . . . . 0.0 110.953 166.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' C ' ' HG3' ' A' ' 28' ' ' GLU . 60.7 t -101.8 -84.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.744 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 -151.01 -105.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG11 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.594 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.654 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.63 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.538 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.604 ' C ' HD12 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.474 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG22 HD13 ' A' ' 70' ' ' ILE . 2.5 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -97.12 -137.78 0.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.653 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -164.46 -165.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.079 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 42.92 -111.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 4.3 mpt_? -40.68 -36.23 0.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.672 HD13 HG22 ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.594 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.601 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.601 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.585 HD12 ' N ' ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 42' ' ' LEU . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.499 ' CB ' HG11 ' A' ' 50' ' ' VAL . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.595 HG22 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.744 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.918 ' CE2' HG11 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' OD1' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.462 -0.245 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -140.19 147.09 39.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.072 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 5.6 mp -114.93 121.17 35.81 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.538 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.635 ' C ' ' H ' ' A' ' 19' ' ' GLN . 74.2 Cg_endo -105.54 -34.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 127.589 3.415 . . . . 0.0 114.188 -109.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' O ' ' CE2' ' A' ' 23' ' ' TRP . 64.8 mt-10 -78.84 17.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -158.16 92.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' H ' ' CB ' ' A' ' 23' ' ' TRP . . . -143.57 -135.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.407 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.598 ' C ' ' H ' ' A' ' 23' ' ' TRP . 5.5 mm100 -79.93 -60.49 0.5 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 9.1 Cg_endo -62.92 25.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.044 1.83 . . . . 0.0 112.407 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 21' ' ' GLN . 52.0 t-105 -121.79 -14.52 8.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' HG22 ' A' ' 101' ' ' THR . . . -107.09 127.79 8.97 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 28' ' ' GLU . 5.9 m -106.24 161.41 22.92 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.734 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -14.09 18.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.638 2.225 . . . . 0.0 110.911 169.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.86 -82.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.709 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 -153.0 -104.34 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.793 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.591 HD12 ' N ' ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.479 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.629 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.479 ' OD2' HG12 ' A' ' 34' ' ' VAL . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 HG11 ' A' ' 105' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.44 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 10.4 mp0 -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.563 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.504 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . 0.802 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.712 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 61' ' ' GLN . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 70' ' ' ILE . 27.2 m -160.42 -140.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.659 ' N ' HG21 ' A' ' 70' ' ' ILE . 15.8 pt-20 -65.75 139.75 58.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.751 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -110.61 -59.57 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.943 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -123.22 -60.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 -130.34 74.74 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.692 HD13 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG23 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.661 ' N ' ' CD ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.629 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.64 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' CYS . . . . . 0.802 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 ' SG ' ' A' ' 44' ' ' CYS . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.483 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 90' ' ' CYS . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.751 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.709 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.64 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.694 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 . . . . . 0 N--CA 1.477 0.876 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.701 ' N ' HG12 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 0.2 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.638 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.449 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.777 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.426 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 47' ' ' ARG . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.497 HE21 ' HB2' ' A' ' 94' ' ' SER . 18.9 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.673 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.831 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.726 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.606 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.0 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.582 HG23 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p . . . . . 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HA ' ' CZ ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.419 0.152 . . . . 0.0 111.108 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.524 ' O ' HG23 ' A' ' 68' ' ' THR . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.74 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.59 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.59 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 70' ' ' ILE . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB2' HG23 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.453 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.831 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.497 ' HB2' HE21 ' A' ' 51' ' ' GLN . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.812 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.72 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 . . . . . 0 N--CA 1.487 1.414 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.842 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.558 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.634 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.468 HH11 ' HD2' ' A' ' 43' ' ' ARG . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.556 ' HD3' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.537 HD21 ' CB ' ' A' ' 73' ' ' GLU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' HB3' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 14.3 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 92' ' ' THR . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.691 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.712 ' NE1' HG23 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.668 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.003 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.5 m . . . . . 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.572 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 1.003 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.452 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.572 HG12 ' HB ' ' A' ' 68' ' ' THR . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.516 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.675 ' CD1' HG22 ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 53' ' ' ILE . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' NE2' ' A' ' 51' ' ' GLN . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.708 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.778 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.842 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.675 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 4.0 mt-10 . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.849 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 80' ' ' SER . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.665 ' C ' HD23 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.863 HD22 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.531 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.72 ' CE3' HD12 ' A' ' 42' ' ' LEU . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.819 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 4.3 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.819 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.774 ' H ' HD13 ' A' ' 62' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 121.157 0.503 . . . . 0.0 112.192 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.863 ' CB ' HD22 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 70' ' ' ILE . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.615 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.615 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 87' ' ' LEU . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.679 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG2' HD11 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.849 ' CE2' HG11 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 . . . . . 0 N--CA 1.48 1.073 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.82 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.591 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.602 ' NE ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.632 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.59 HE21 ' HD3' ' A' ' 95' ' ' PRO . 19.9 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.542 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.713 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 70' ' ' ILE . 2.1 p . . . . . 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.562 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' ' HG1' ' A' ' 71' ' ' THR . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 HG22 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.59 ' HD3' HE21 ' A' ' 51' ' ' GLN . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.889 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.721 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . 91.6 mt-10 . . . . . 0 N--CA 1.48 1.056 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.061 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.782 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.593 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 37.3 m170 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.527 ' HD3' ' OE1' ' A' ' 74' ' ' GLU . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.767 HH11 ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 47' ' ' ARG . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.655 ' C ' HD12 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.777 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.626 ' CA ' HD23 ' A' ' 56' ' ' LEU . 3.1 tm0? -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.678 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.7 p . . . . . 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.733 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.527 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 70' ' ' ILE . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.516 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG23 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CE1' HG21 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.777 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.061 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.7 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.633 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 29' ' ' VAL . 9.5 tp10 . . . . . 0 N--CA 1.481 1.087 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.839 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.779 ' N ' HG12 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.562 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB2' HG12 ' A' ' 34' ' ' VAL . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 2.9 pm0 -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.661 ' NH2' ' CB ' ' A' ' 99' ' ' ASP . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.519 HD12 ' N ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.519 ' N ' HD12 ' A' ' 46' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.49 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.543 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 12.4 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.481 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.836 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CB ' HD13 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.495 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.452 ' HD3' ' HA ' ' A' ' 67' ' ' ARG . 3.0 tpp180 . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.452 ' CB ' HG13 ' A' ' 77' ' ' VAL . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.678 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 71' ' ' THR . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.709 HG23 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CG ' HD11 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.836 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.61 HG22 ' SG ' ' A' ' 44' ' ' CYS . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.839 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.71 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.79 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 . . . . . 0 N--CA 1.477 0.881 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.759 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.604 ' CB ' HD21 ' A' ' 106' ' ' ASN . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.736 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 50' ' ' VAL . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 93' ' ' SER . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.736 ' CE3' HD12 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.693 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.587 ' HA ' HD23 ' A' ' 56' ' ' LEU . 3.0 tm0? -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.708 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.2 m . . . . . 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.46 ' HD3' ' OD1' ' A' ' 79' ' ' ASP . 12.7 mtt180 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.522 ' OG1' ' CG1' ' A' ' 77' ' ' VAL . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.844 HD13 ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.606 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.58 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.891 ' HB ' HG21 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.79 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.489 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.557 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.604 HD21 ' CB ' ' A' ' 33' ' ' LEU . 7.0 p-10 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 . . . . . 0 N--CA 1.479 1.025 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.861 HG12 ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.861 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.486 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' O ' ' HG2' ' A' ' 45' ' ' ARG . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.456 HD11 ' HB3' ' A' ' 73' ' ' GLU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.43 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.605 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 26.8 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.55 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.804 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.694 HD11 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.638 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.585 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.962 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.7 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.962 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.631 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.744 ' CD1' HG22 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 92' ' ' THR . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.803 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.687 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.45 HG21 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.723 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 . . . . . 0 N--CA 1.477 0.907 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 ' N ' ' A' ' 30' ' ' GLU . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.831 ' N ' HG12 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 43' ' ' ARG . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.443 ' N ' ' SG ' ' A' ' 44' ' ' CYS . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 46' ' ' LEU . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.613 ' O ' ' C ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 53' ' ' ILE . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.752 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.785 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.737 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.6 p . . . . . 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 55.9 mtt-85 . . . . . 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.737 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.602 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.606 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.647 ' C ' HG21 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.645 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 42' ' ' LEU . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.61 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.724 ' CG2' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.723 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.814 ' CE2' HG11 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.647 HG21 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.797 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.04 HG11 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.54 ' N ' HG12 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.648 ' CD2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.57 ' CZ ' HG23 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.595 HE21 ' HD3' ' A' ' 95' ' ' PRO . 36.8 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 91' ' ' VAL . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 70' ' ' ILE . 18.0 m . . . . . 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 77' ' ' VAL . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.927 HD13 ' HB ' ' A' ' 63' ' ' VAL . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 46' ' ' LEU . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 42' ' ' LEU . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.81 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 56' ' ' LEU . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.797 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 1.04 ' CE2' HG11 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.655 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.0 HG21 ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.869 ' N ' HG12 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.427 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.685 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.425 ' H ' ' HG2' ' A' ' 45' ' ' ARG . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p . . . . . 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 . . . . . 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.52 ' CB ' HG12 ' A' ' 77' ' ' VAL . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HA ' HG21 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.714 HG23 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.685 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 100' ' ' THR . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 53' ' ' ILE . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.0 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.73 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.7 ' CE1' HG11 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 29' ' ' VAL . 79.4 mt-10 . . . . . 0 N--CA 1.477 0.888 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 ' HB ' ' A' ' 101' ' ' THR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.772 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.516 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.654 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.642 HD23 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.771 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.415 ' HG3' ' HB2' ' A' ' 74' ' ' GLU . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HD2' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.576 HH21 ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.64 ' H ' ' HB2' ' A' ' 94' ' ' SER . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 16.6 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.576 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.765 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.2 m . . . . . 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.472 ' HD2' ' NH1' ' A' ' 78' ' ' ARG . 27.2 mtm-85 . . . . . 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.536 HG23 ' HA ' ' A' ' 77' ' ' VAL . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.765 HD13 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.666 HG23 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.642 HG21 HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD1' HG23 ' A' ' 81' ' ' ILE . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 87' ' ' LEU . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.64 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.536 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.576 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 1.098 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.772 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.724 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.891 HG11 ' CE2' ' A' ' 103' ' ' PHE . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 103' ' ' PHE . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 39' ' ' LEU . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.595 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.653 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.45 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.6 HG12 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.5 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CD1' HG23 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 91' ' ' VAL . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.536 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.576 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 70' ' ' ILE . 34.8 m . . . . . 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.877 HG22 HG22 ' A' ' 70' ' ' ILE . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.718 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.672 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.564 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.536 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.72 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.605 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB2' HH12 ' A' ' 45' ' ' ARG . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.732 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.891 ' CE2' HG11 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.72 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 . . . . . 0 C--O 1.214 -0.783 0 N-CA-C 105.857 -1.905 . . . . 0.0 105.857 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.867 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.846 ' N ' HG12 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.1 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.624 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.505 ' HE ' ' CG2' ' A' ' 101' ' ' THR . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.653 ' HB3' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 12.5 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.492 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.796 ' CG ' HG21 ' A' ' 75' ' ' VAL . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD1' HG23 ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.618 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 3.2 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.618 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.559 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.8 p . . . . . 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.605 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.634 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.605 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.557 ' CE1' HG21 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.628 HG23 ' CD1' ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.487 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.708 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.867 ' CE2' HG11 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.8 mt-10 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.968 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.699 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.622 ' CB ' HD21 ' A' ' 106' ' ' ASN . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.551 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.582 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.746 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.577 ' HE ' ' CG2' ' A' ' 101' ' ' THR . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.488 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.578 HE21 ' HD3' ' A' ' 95' ' ' PRO . 31.6 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.663 ' C ' HD12 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.479 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.772 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 91' ' ' VAL . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.744 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.9 p . . . . . 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.416 ' HD2' HH11 ' A' ' 67' ' ' ARG . 8.5 mtp85 . . . . . 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 77' ' ' VAL . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.744 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.663 HG23 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.578 HH21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.772 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.578 ' HD3' HE21 ' A' ' 51' ' ' GLN . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.702 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 33' ' ' LEU . 7.1 p-10 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.673 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.873 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 40' ' ' LEU . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.566 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.789 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.49 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.422 ' HB3' HG21 ' A' ' 92' ' ' THR . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.544 ' O ' ' HG2' ' A' ' 47' ' ' ARG . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.497 HE21 ' HD3' ' A' ' 95' ' ' PRO . 29.2 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.594 HG23 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.452 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.789 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.611 HH22 ' HB1' ' A' ' 83' ' ' ALA . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 4.7 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.5 p . . . . . 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 52.3 mtt85 . . . . . 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.691 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.592 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' NE1' ' A' ' 55' ' ' TRP . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.52 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.578 ' C ' HG21 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.501 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.778 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.789 ' CG2' HD11 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.497 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.815 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.673 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.873 ' CE2' HG11 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.638 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG21 ' HB ' ' A' ' 101' ' ' THR . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.7 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB3' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.574 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.511 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.606 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.476 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.602 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 17.7 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.824 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.782 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.782 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.8 p . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 . . . . . 0 N--CA 1.494 1.734 0 CA-C-O 121.711 0.767 . . . . 0.0 110.661 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.61 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.824 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.569 HG22 HD12 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.602 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.918 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 6.6 p-10 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.743 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 . . . . . 0 N--CA 1.478 0.957 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.87 HG11 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.628 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 40' ' ' LEU . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.552 ' CB ' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 38' ' ' ASP . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.572 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.484 ' C ' HD23 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.557 ' HG3' ' N ' ' A' ' 48' ' ' ASP . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.557 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' SER . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.426 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.579 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 14.4 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.73 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.78 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.727 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD23 ' A' ' 56' ' ' LEU . 2.8 tm0? -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.874 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p . . . . . 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 . . . . . 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' HG12 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 70' ' ' ILE . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 107' ' ' VAL . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.78 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 56' ' ' LEU . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.579 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.706 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.743 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.87 ' CE2' HG11 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.552 HD21 ' CB ' ' A' ' 33' ' ' LEU . 8.5 p-10 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.744 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.918 HG11 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.594 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.441 HD11 ' CB ' ' A' ' 73' ' ' GLU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.654 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.654 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.63 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.538 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.604 ' C ' HD12 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.474 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 2.0 tm0? -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.672 HG22 HD13 ' A' ' 70' ' ' ILE . 2.5 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 67' ' ' ARG . 4.3 mpt_? . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.672 HD13 HG22 ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.594 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.601 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.601 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 42' ' ' LEU . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.499 ' CB ' HG11 ' A' ' 50' ' ' VAL . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.595 HG22 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.744 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.918 ' CE2' HG11 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.506 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' OD1' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.709 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.793 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.479 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.629 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.479 ' OD2' HG12 ' A' ' 34' ' ' VAL . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 HG11 ' A' ' 105' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.44 ' NH1' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.4 HD21 ' HB2' ' A' ' 73' ' ' GLU . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.563 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.504 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . 0.802 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.712 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 61' ' ' GLN . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 70' ' ' ILE . 27.2 m . . . . . 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.372 0.606 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.426 ' OG1' HG23 ' A' ' 70' ' ' ILE . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.692 HD13 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.718 HG23 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.521 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.661 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.629 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.64 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' CYS . . . . . 0.802 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 ' SG ' ' A' ' 44' ' ' CYS . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.483 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 90' ' ' CYS . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.751 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.709 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.64 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo . . . . . 0 N--CA 1.482 0.84 0 CA-C-O 121.39 0.496 . . . . 0.0 111.699 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.577 ' HA ' ' CB ' ' A' ' 47' ' ' ARG . 4.8 p -138.08 139.98 39.78 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 118.629 -1.229 . . . . 0.0 110.269 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.586 ' N ' HD12 ' A' ' 16' ' ' LEU . 3.7 mp -117.97 86.45 25.53 Favored Pre-proline 0 N--CA 1.487 1.425 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.449 ' O ' ' HB3' ' A' ' 45' ' ' ARG . 7.4 Cg_endo -67.59 -41.89 7.84 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.835 2.356 . . . . 0.0 110.913 -176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -116.4 62.9 0.71 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.545 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -89.73 41.24 1.03 Allowed 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 122.188 0.994 . . . . 0.0 109.519 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.503 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . . . -156.43 -86.27 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 114.76 -1.109 . . . . 0.0 108.638 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.461 ' HB2' ' CD2' ' A' ' 23' ' ' TRP . 36.5 mm-40 -143.08 157.15 61.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 N-CA-C 108.22 -1.029 . . . . 0.0 108.22 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -72.08 64.66 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.098 1.865 . . . . 0.0 111.282 178.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.782 ' O ' HG22 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -126.11 50.68 1.85 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 118.84 -1.144 . . . . 0.0 112.382 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -98.18 90.2 1.03 Allowed Glycine 0 N--CA 1.492 2.405 0 N-CA-C 108.909 -1.676 . . . . 0.0 108.909 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.482 HG23 ' HB2' ' A' ' 28' ' ' GLU . 27.5 m -128.3 150.22 73.54 Favored Pre-proline 0 N--CA 1.492 1.662 0 C-N-CA 119.764 -0.774 . . . . 0.0 111.121 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 19.8 Cg_exo -42.69 -44.4 8.72 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.854 2.369 . . . . 0.0 113.523 -152.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.5 t -143.11 38.44 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.541 1.162 . . . . 0.0 108.201 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.694 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 39.3 mt-10 -151.43 167.47 27.87 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 112.806 -1.997 . . . . 0.0 107.514 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.812 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.5 t -161.72 -66.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.819 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.215 177.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.701 ' N ' HG12 ' A' ' 29' ' ' VAL . 78.2 tt0 -136.26 96.71 3.43 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 113.948 -1.478 . . . . 0.0 113.406 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 44.0 p -92.76 100.64 13.09 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.341 -0.944 . . . . 0.0 108.843 178.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -129.91 146.43 51.62 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 115.154 -0.93 . . . . 0.0 113.419 -179.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 pp -106.58 135.71 47.62 Favored 'General case' 0 N--CA 1.49 1.532 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.023 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.638 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -121.9 142.06 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.599 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 108' ' ' SER . 0.2 OUTLIER -79.75 169.82 18.5 Favored Pre-proline 0 N--CA 1.492 1.656 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.881 -179.488 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.414 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 6.5 Cg_endo -75.19 82.44 2.04 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 121.839 1.693 . . . . 0.0 111.823 -167.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.4 43.3 0.27 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.326 -1.416 . . . . 0.0 110.031 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 79' ' ' ASP . 34.6 m-20 -138.62 -178.51 5.34 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 122.333 1.063 . . . . 0.0 112.429 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.551 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.99 123.42 36.23 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 113.432 -1.713 . . . . 0.0 113.108 -179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.638 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.2 OUTLIER -126.4 140.12 52.73 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 113.133 -1.849 . . . . 0.0 107.638 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.449 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.2 pt20 -140.59 151.88 45.03 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.052 -1.459 . . . . 0.0 114.527 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.777 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -132.2 113.57 13.43 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-N 113.449 -1.705 . . . . 0.0 106.661 179.159 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.503 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 28.4 ttt85 -107.74 124.25 49.75 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.78 -1.168 . . . . 0.0 111.204 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -88.29 -152.49 0.22 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 113.1 -1.863 . . . . 0.0 111.468 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.604 ' CZ ' ' CG2' ' A' ' 101' ' ' THR . 0.0 OUTLIER -124.32 175.5 7.04 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.265 -1.334 . . . . 0.0 109.308 179.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -160.59 142.49 12.51 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.22 -1.392 . . . . 0.0 112.749 -179.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.6 176.62 11.36 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.391 -1.324 . . . . 0.0 111.229 178.561 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -70.06 25.85 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 119.206 -0.998 . . . . 0.0 109.854 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.637 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.8 m-20 -117.86 -70.77 0.77 Allowed 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.413 HG22 ' HG2' ' A' ' 47' ' ' ARG . 20.5 m -72.86 144.04 13.31 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.223 0 C-N-CA 119.357 -0.937 . . . . 0.0 108.94 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.497 HE21 ' HB2' ' A' ' 94' ' ' SER . 18.9 mt-30 -129.73 -24.86 2.66 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 113.947 -1.479 . . . . 0.0 109.418 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.673 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.0 t -119.46 128.78 54.32 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.673 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -113.55 112.3 39.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -100.76 132.21 46.27 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.831 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -103.01 106.12 16.58 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.606 HD23 ' HA ' ' A' ' 61' ' ' GLN . 2.0 mt -78.75 107.71 11.66 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.896 -1.522 . . . . 0.0 107.306 -177.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.726 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.15 144.44 34.49 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.384 -0.926 . . . . 0.0 108.943 -178.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 9.5 t70 66.06 -75.85 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.39 14.53 0.15 Allowed Glycine 0 N--CA 1.49 2.258 0 O-C-N 124.695 1.247 . . . . 0.0 110.631 178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.8 t -144.24 150.56 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.998 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.606 ' HA ' HD23 ' A' ' 56' ' ' LEU . 5.0 tm0? -36.44 133.63 0.51 Allowed 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.726 HD22 ' CB ' ' A' ' 57' ' ' ARG . 7.1 tp -157.32 142.63 17.17 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 123.126 1.441 . . . . 0.0 113.326 178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.582 HG23 ' CG1' ' A' ' 70' ' ' ILE . 2.4 p -162.73 92.49 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 111.641 -2.527 . . . . 0.0 107.569 177.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.634 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 55.8 mt-10 -97.26 -140.43 0.29 Allowed 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.715 -1.194 . . . . 0.0 112.904 -178.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' O ' ' O ' ' A' ' 68' ' ' THR . 6.0 p -157.75 -73.98 0.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.829 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 15.8 t-20 -43.94 117.49 1.21 Allowed 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.198 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.522 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 0.9 OUTLIER 80.31 -41.3 0.2 Allowed 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.108 179.769 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.634 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 10.3 t -109.99 120.79 43.57 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 119.478 -0.889 . . . . 0.0 111.388 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 69' ' ' ARG . 7.3 ttm105 -99.15 97.85 8.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 102.714 -3.069 . . . . 0.0 102.714 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.74 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -90.86 109.65 21.25 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.651 -1.219 . . . . 0.0 111.281 -178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.59 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.2 p -104.82 146.5 28.9 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 116.38 -2.128 . . . . 0.0 108.968 179.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.485 ' O ' HD13 ' A' ' 53' ' ' ILE . . . -50.57 7.04 0.01 OUTLIER Glycine 0 N--CA 1.492 2.369 0 CA-C-N 115.043 -0.98 . . . . 0.0 113.779 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.59 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.7 pt-20 -131.19 -33.44 1.51 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.041 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.426 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 54.4 tt0 -152.41 150.89 30.15 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.596 -1.242 . . . . 0.0 108.343 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.74 HG22 HG22 ' A' ' 70' ' ' ILE . 25.6 t -113.11 122.71 67.76 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.843 0 C-N-CA 118.549 -1.26 . . . . 0.0 108.386 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -118.43 119.31 34.19 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.336 -1.346 . . . . 0.0 111.422 179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -109.63 120.3 60.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 104.178 -2.527 . . . . 0.0 104.178 179.067 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.643 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -104.55 47.5 0.87 Allowed 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 118.129 -1.428 . . . . 0.0 111.263 -177.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 38' ' ' ASP . 33.8 t0 -160.02 -30.95 0.06 Allowed 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.886 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 10.5 p 40.78 80.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.154 -179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.589 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -104.02 -177.71 0.55 Allowed Pre-proline 0 N--CA 1.492 1.626 0 N-CA-C 104.517 -2.401 . . . . 0.0 104.517 178.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.589 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.5 Cg_exo -29.46 -31.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 121.23 1.287 . . . . 0.0 112.165 163.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.554 ' HB3' HG13 ' A' ' 81' ' ' ILE . . . -54.02 -33.63 57.76 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.519 ' HB2' HG23 ' A' ' 105' ' ' VAL . 3.6 p-10 -97.19 33.22 1.99 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.896 -1.122 . . . . 0.0 111.615 -179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.5 t -98.82 73.43 2.0 Allowed 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.532 177.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.453 ' HA3' ' NH1' ' A' ' 57' ' ' ARG . . . 168.13 -163.37 37.1 Favored Glycine 0 N--CA 1.495 2.583 0 C-N-CA 118.459 -1.829 . . . . 0.0 111.368 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' O ' ' N ' ' A' ' 58' ' ' ASP . 58.1 mt -100.94 131.14 46.95 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 117.264 -1.774 . . . . 0.0 110.903 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 57' ' ' ARG . 20.6 m-85 -108.32 88.91 2.84 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 104.414 -2.439 . . . . 0.0 104.414 178.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.467 ' O ' ' HG ' ' A' ' 56' ' ' LEU . . . -89.01 130.4 35.49 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 105.1 -2.185 . . . . 0.0 105.1 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.831 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 52.1 t -99.4 128.4 45.52 Favored 'General case' 0 C--N 1.296 -1.736 0 C-N-CA 118.044 -1.462 . . . . 0.0 109.951 -178.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.567 HG21 HD11 ' A' ' 56' ' ' LEU . 24.8 t -116.46 113.74 43.94 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.438 0 O-C-N 125.008 1.442 . . . . 0.0 107.569 178.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.624 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 p -98.89 128.34 45.05 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 103.47 -2.789 . . . . 0.0 103.47 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -143.08 162.36 35.72 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 117.663 -1.615 . . . . 0.0 114.945 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.497 ' HB2' HE21 ' A' ' 51' ' ' GLN . 1.5 p -139.4 162.67 50.34 Favored Pre-proline 0 N--CA 1.487 1.382 0 CA-C-N 111.049 -2.796 . . . . 0.0 105.95 178.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -47.18 -13.62 0.14 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 122.263 1.975 . . . . 0.0 113.697 -174.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.474 ' N ' ' O ' ' A' ' 94' ' ' SER . 43.7 m -148.62 26.72 0.92 Allowed 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 118.36 -1.336 . . . . 0.0 112.652 -179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.28 150.01 19.8 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.004 -1.57 . . . . 0.0 111.318 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 48.0 m -144.53 135.38 24.93 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.989 -0.684 . . . . 0.0 111.999 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -131.1 138.46 49.54 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.1 m -130.87 148.73 52.67 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 117.81 -1.556 . . . . 0.0 115.177 -178.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.812 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 140.22 51.79 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 112.657 -2.065 . . . . 0.0 108.192 179.232 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.72 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 22.3 m-85 -111.47 101.71 10.12 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 116.359 1.985 . . . . 0.0 116.359 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.711 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 19.1 m-85 -92.02 108.66 20.09 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.805 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.422 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 0.1 OUTLIER -82.39 116.13 21.73 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 104.766 -2.309 . . . . 0.0 104.766 178.03 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -118.58 122.52 69.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.514 -1.674 . . . . 0.0 106.526 179.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.2 p-10 -128.15 132.6 48.9 Favored 'General case' 0 C--N 1.295 -1.764 0 C-N-CA 118.376 -1.33 . . . . 0.0 113.375 -178.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.7 p -79.57 139.95 17.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-N 114.263 -1.335 . . . . 0.0 108.314 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 35' ' ' HIS . 33.0 t . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 122.23 1.014 . . . . 0.0 112.682 -178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.482 0.832 0 N-CA-C 109.753 -0.903 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -133.87 -158.82 0.91 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.868 -0.733 . . . . 0.0 111.722 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.642 ' N ' ' O ' ' A' ' 46' ' ' LEU . 12.7 mt -160.46 -72.42 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' CD ' ' H ' ' A' ' 16' ' ' LEU . 9.7 Cg_endo -65.71 76.87 0.28 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.215 2.61 . . . . 0.0 112.067 -113.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.521 ' OE1' ' HB2' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -160.9 -84.79 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.305 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 22' ' ' PRO . 3.2 tp-100 -140.72 134.27 30.07 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 117.496 -1.682 . . . . 0.0 111.892 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.28 -52.2 8.44 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 113.149 -1.841 . . . . 0.0 107.765 178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 8.4 mm100 -146.7 -64.95 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.686 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.286 178.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 21' ' ' GLN . 17.9 Cg_endo -73.63 131.47 16.07 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.015 1.81 . . . . 0.0 111.173 174.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.482 ' C ' ' HE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -116.23 -128.56 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.41 -0.916 . . . . 0.0 111.24 -179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.88 -75.75 1.03 Allowed Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.564 -1.303 . . . . 0.0 112.43 -178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 27' ' ' VAL . 19.3 m -86.81 153.27 54.91 Favored Pre-proline 0 N--CA 1.494 1.768 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.624 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -80.81 28.84 0.53 Allowed 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 123.415 2.743 . . . . 0.0 111.352 164.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' H ' HG23 ' A' ' 25' ' ' VAL . 19.0 t -120.34 -67.86 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 119.425 -0.91 . . . . 0.0 108.96 -179.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.597 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 59.6 mt-10 -136.76 -76.04 0.42 Allowed 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.726 -1.124 . . . . 0.0 108.259 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.842 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.6 t -160.95 -68.9 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 114.397 -1.274 . . . . 0.0 108.118 176.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.558 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.2 tp10 -146.54 111.67 5.41 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.972 -1.467 . . . . 0.0 113.639 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.6 m -96.81 110.84 23.24 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.749 178.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.4 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 58.2 tp -136.61 149.73 48.17 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-O 122.611 1.196 . . . . 0.0 113.758 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.535 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -104.13 146.87 28.12 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.563 178.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -137.8 169.33 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 119.421 -0.912 . . . . 0.0 112.014 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -109.0 162.67 19.17 Favored Pre-proline 0 N--CA 1.491 1.606 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.014 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -57.11 101.83 0.1 Allowed 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.506 2.137 . . . . 0.0 111.38 172.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 98.88 49.38 1.63 Allowed Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.827 -1.177 . . . . 0.0 111.894 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.634 ' H ' ' HB2' ' A' ' 80' ' ' SER . 21.3 t70 -131.09 178.9 6.34 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.295 -0.962 . . . . 0.0 112.686 179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 18.5 mt -106.0 123.55 48.17 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.28 -1.327 . . . . 0.0 110.162 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -129.55 133.32 47.15 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.605 -1.179 . . . . 0.0 110.081 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -129.83 141.1 50.89 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.691 -1.204 . . . . 0.0 112.973 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.643 ' CD1' ' HB ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -125.34 109.59 12.96 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 178.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.468 HH11 ' HD2' ' A' ' 43' ' ' ARG . 16.8 ttt85 -106.41 117.3 33.68 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.335 1.064 . . . . 0.0 113.671 -178.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.587 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 5.6 t -91.41 -171.4 2.92 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 112.933 -1.94 . . . . 0.0 108.933 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.556 ' HD3' HG21 ' A' ' 92' ' ' THR . 0.0 OUTLIER -111.02 164.62 12.63 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 118.876 -1.13 . . . . 0.0 112.47 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.642 ' O ' ' N ' ' A' ' 16' ' ' LEU . 21.6 mt -129.12 90.58 3.05 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 103.794 -2.669 . . . . 0.0 103.794 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -79.4 -162.35 0.4 Allowed 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.584 -0.846 . . . . 0.0 113.002 -176.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.29 15.38 23.02 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.103 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' C ' ' HB3' ' A' ' 94' ' ' SER . 24.9 m-20 -132.16 -55.42 0.98 Allowed 'General case' 0 N--CA 1.487 1.416 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.343 -179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 33.1 m -67.85 144.59 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 122.337 1.065 . . . . 0.0 111.816 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.498 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 14.3 mt-30 -136.92 -21.66 1.23 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 112.915 -1.948 . . . . 0.0 109.895 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.0 m -115.58 124.91 52.17 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 -179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.676 HD12 HG22 ' A' ' 92' ' ' THR . 24.9 mm -113.13 113.25 43.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.691 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -99.19 138.43 36.3 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.868 -1.515 . . . . 0.0 107.561 179.79 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.712 ' NE1' HG23 ' A' ' 75' ' ' VAL . 95.7 m95 -106.16 108.81 20.51 Favored 'General case' 0 C--N 1.302 -1.496 0 C-N-CA 117.564 -1.654 . . . . 0.0 107.22 179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.573 HD23 ' HA ' ' A' ' 61' ' ' GLN . 24.1 mt -78.96 101.84 7.98 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.668 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -79.27 142.06 36.51 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.07 -1.452 . . . . 0.0 108.09 -179.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 34.5 t70 62.98 -74.76 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 124.488 1.117 . . . . 0.0 109.403 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -164.11 19.38 0.13 Allowed Glycine 0 N--CA 1.49 2.283 0 O-C-N 124.581 1.176 . . . . 0.0 110.514 178.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 13.5 p -143.3 159.3 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.565 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.573 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -52.66 134.48 35.93 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 122.057 0.932 . . . . 0.0 112.836 -179.326 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.668 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.2 OUTLIER -161.32 -174.47 4.32 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 123.732 1.73 . . . . 0.0 112.78 179.57 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.003 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.5 m -160.11 -153.78 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 CA-C-N 109.632 -3.44 . . . . 0.0 108.772 178.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.8 ' N ' HG21 ' A' ' 70' ' ' ILE . 24.8 pt-20 -47.44 158.9 0.16 Allowed 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 123.188 1.471 . . . . 0.0 113.247 -178.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.3 p -110.76 -80.35 0.58 Allowed 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 111.306 -2.679 . . . . 0.0 110.741 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -122.07 -57.61 1.77 Allowed 'General case' 0 N--CA 1.493 1.689 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.029 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -123.96 56.63 1.23 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.118 0.961 . . . . 0.0 110.147 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.572 ' HB ' HG12 ' A' ' 77' ' ' VAL . 74.7 p -131.82 143.9 50.53 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.096 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 20.8 ttt-85 -105.55 108.09 19.42 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 1.003 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.8 pt -91.09 113.79 27.37 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 114.503 -1.226 . . . . 0.0 111.017 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.63 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.3 p -106.73 141.58 37.76 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 116.444 -2.102 . . . . 0.0 106.457 177.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.598 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.19 11.29 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 CA-C-N 115.119 -0.946 . . . . 0.0 113.659 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.63 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.4 pt-20 -133.96 -32.65 1.08 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.665 178.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.452 ' OE1' ' HD2' ' A' ' 43' ' ' ARG . 39.5 tt0 -150.89 151.05 31.64 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 119.071 -1.051 . . . . 0.0 108.407 -178.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' NE1' ' A' ' 55' ' ' TRP . 16.3 t -112.71 125.96 70.04 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 C-N-CA 118.548 -1.261 . . . . 0.0 108.623 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -118.34 114.03 22.32 Favored 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.324 -1.35 . . . . 0.0 110.683 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.572 HG12 ' HB ' ' A' ' 68' ' ' THR . 6.8 m -100.91 123.99 54.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 104.495 -2.409 . . . . 0.0 104.495 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.516 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -108.03 51.57 0.74 Allowed 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 118.428 -1.309 . . . . 0.0 108.637 -177.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' SER . 44.1 t0 -161.37 -31.0 0.05 Allowed 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 118.31 -1.356 . . . . 0.0 111.109 -178.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.634 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 65.5 m 49.48 92.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 -178.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.556 ' O ' ' N ' ' A' ' 83' ' ' ALA . 3.2 pt -132.13 161.83 60.45 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 -178.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.5 Cg_exo -35.02 -31.1 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.906 1.738 . . . . 0.0 111.796 -175.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -39.32 19.05 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.278 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 8.0 m-20 -84.18 32.93 0.49 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 123.833 0.708 . . . . 0.0 111.926 -178.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.9 t -98.55 74.52 2.13 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.301 176.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 165.94 -158.18 30.97 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 118.689 -1.719 . . . . 0.0 111.715 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 89.0 mt -100.43 131.11 46.53 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 117.387 -1.725 . . . . 0.0 110.367 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.675 ' CD1' HG22 ' A' ' 105' ' ' VAL . 34.1 m-85 -109.8 95.06 5.36 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.071 -2.196 . . . . 0.0 105.071 178.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.42 140.37 31.96 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 117.802 -1.559 . . . . 0.0 107.072 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.684 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 2.9 p -104.31 119.7 39.55 Favored 'General case' 0 C--N 1.295 -1.762 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.691 ' HB ' ' ND2' ' A' ' 54' ' ' ASN . 1.9 t -104.48 118.2 51.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 125.332 1.645 . . . . 0.0 108.555 -179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.676 HG22 HD12 ' A' ' 53' ' ' ILE . 81.7 p -99.93 119.41 38.19 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 104.662 -2.347 . . . . 0.0 104.662 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 m -123.85 146.2 48.55 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 118.868 -1.133 . . . . 0.0 112.474 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 96' ' ' SER . 56.9 p -136.01 152.59 75.86 Favored Pre-proline 0 C--N 1.305 -1.352 0 CA-C-N 112.126 -2.306 . . . . 0.0 106.231 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.465 ' HD2' ' NE2' ' A' ' 51' ' ' GLN . 2.9 Cg_exo -53.1 2.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.406 2.071 . . . . 0.0 111.847 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.577 ' H ' ' C ' ' A' ' 94' ' ' SER . 0.0 OUTLIER -115.82 -42.37 3.1 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.28 179.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.39 -169.38 23.6 Favored Glycine 0 N--CA 1.495 2.627 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.177 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 38.7 m -145.26 146.67 31.77 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 119.685 -0.806 . . . . 0.0 111.294 179.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' HB3' ' NH1' ' A' ' 45' ' ' ARG . 0.7 OUTLIER -128.39 142.61 51.06 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 179.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 77.1 m -128.51 136.9 51.42 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 117.253 -1.779 . . . . 0.0 113.435 -179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.708 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.81 143.21 50.46 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 104.991 -2.226 . . . . 0.0 104.991 179.725 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.778 ' N ' ' CD1' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -136.66 138.14 40.78 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 115.445 -2.502 . . . . 0.0 116.897 -178.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.842 ' CE2' HG11 ' A' ' 29' ' ' VAL . 1.4 m-85 -104.57 117.14 33.4 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-N 112.841 -1.982 . . . . 0.0 108.942 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.76 119.58 22.86 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 103.609 -2.737 . . . . 0.0 103.609 177.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.675 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.11 121.86 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 117.548 -1.661 . . . . 0.0 108.575 -178.339 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -130.46 107.35 9.16 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.44 -1.255 . . . . 0.0 112.846 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.504 HG11 ' O ' ' A' ' 81' ' ' ILE . 8.7 p -102.68 128.88 55.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 118.06 -1.456 . . . . 0.0 109.796 178.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 39.1 t . . . . . 0 N--CA 1.489 1.477 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.565 179.818 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.482 0.833 0 CA-C-O 120.768 0.237 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 94.3 m -136.74 116.52 13.09 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.698 -0.801 . . . . 0.0 111.243 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 16' ' ' LEU . 3.0 mp -121.6 91.23 48.44 Favored Pre-proline 0 N--CA 1.487 1.407 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -84.62 87.46 1.08 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 123.165 2.576 . . . . 0.0 111.317 176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.504 ' CB ' HE22 ' A' ' 19' ' ' GLN . 1.8 mp0 -92.1 -10.69 38.06 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.207 -0.997 . . . . 0.0 109.004 179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.531 ' N ' ' CD ' ' A' ' 19' ' ' GLN . 22.0 mp0 -116.86 138.05 51.78 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.975 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.52 -90.61 0.39 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.551 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.408 ' N ' ' CA ' ' A' ' 22' ' ' PRO . 80.0 mt-30 -137.95 66.37 47.09 Favored Pre-proline 0 N--CA 1.491 1.6 0 C-N-CA 119.667 -0.813 . . . . 0.0 110.676 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' CA ' ' N ' ' A' ' 21' ' ' GLN . 5.2 Cg_exo -51.9 -162.55 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.329 -1.53 . . . . 0.0 112.5 -51.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.509 ' CD1' ' HA ' ' A' ' 19' ' ' GLN . 7.1 p-90 -97.43 19.49 13.21 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.744 -0.782 . . . . 0.0 111.57 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -128.69 -64.97 0.12 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.9 m -136.12 150.79 72.17 Favored Pre-proline 0 N--CA 1.492 1.663 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.429 179.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -79.02 33.07 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.357 2.038 . . . . 0.0 111.217 175.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 36.5 t -139.69 -67.49 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.431 -0.908 . . . . 0.0 110.136 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 4.0 mt-10 -103.66 -99.91 0.3 Allowed 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.849 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.0 t -162.52 -71.61 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 CA-C-N 113.641 -1.618 . . . . 0.0 108.794 177.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.7 tt0 -137.63 118.18 13.89 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 112.171 -2.286 . . . . 0.0 112.56 -178.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 57.2 p -101.24 105.28 16.37 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.306 -1.315 . . . . 0.0 108.836 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.504 HD23 HD13 ' A' ' 40' ' ' LEU . 14.9 tp -119.09 132.02 55.97 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.904 -1.044 . . . . 0.0 112.936 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.539 ' CD2' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -104.29 124.12 48.59 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 178.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -130.66 172.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 119.56 -0.856 . . . . 0.0 112.989 -178.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' PRO . 6.2 p80 -135.17 159.96 69.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 C-N-CA 119.686 -0.805 . . . . 0.0 111.803 -179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HA ' ' O ' ' A' ' 80' ' ' SER . 16.1 Cg_exo -46.22 106.04 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.989 2.46 . . . . 0.0 112.161 176.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.82 37.07 1.6 Allowed Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.944 -1.262 . . . . 0.0 109.944 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.41 ' H ' ' HB3' ' A' ' 80' ' ' SER . 4.9 t70 -136.83 169.12 18.27 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 118.427 -1.309 . . . . 0.0 114.092 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.571 ' HB3' ' NH1' ' A' ' 78' ' ' ARG . 4.3 mt -110.42 123.05 49.16 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 113.039 -1.891 . . . . 0.0 108.823 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -126.57 133.39 51.09 Favored 'General case' 0 N--CA 1.494 1.75 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.147 -179.405 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -133.44 147.67 51.72 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 118.89 -1.124 . . . . 0.0 113.3 -179.796 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.14 121.17 27.18 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 179.192 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.436 ' O ' ' NE2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -108.6 124.06 49.9 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.228 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.694 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 4.8 t -98.34 -164.62 1.15 Allowed 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 114.265 -1.334 . . . . 0.0 110.352 179.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.665 ' C ' HD23 ' A' ' 46' ' ' LEU . 44.9 mtm-85 -93.04 135.48 34.16 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.487 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.863 HD22 ' CB ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -122.83 115.71 22.45 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.665 -1.214 . . . . 0.0 108.833 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.538 ' O ' ' N ' ' A' ' 49' ' ' ASP . 41.1 mtt180 -151.98 147.66 26.81 Favored 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 117.64 -1.624 . . . . 0.0 110.94 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -44.63 -13.76 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.299 -0.961 . . . . 0.0 109.475 177.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 47' ' ' ARG . 37.5 m-20 -85.99 -68.74 0.71 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 106.997 -1.482 . . . . 0.0 106.997 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.492 ' HB ' ' HB ' ' A' ' 92' ' ' THR . 18.4 m -80.19 118.01 27.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.0 mt-30 -121.76 -23.81 5.42 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 114.686 -1.143 . . . . 0.0 109.496 -178.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 54.5 m -103.46 88.73 3.17 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.577 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 22.2 mm -95.09 110.04 23.34 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 114.696 -1.138 . . . . 0.0 107.999 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.531 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.83 138.05 40.23 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.473 -1.694 . . . . 0.0 108.303 -179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.72 ' CE3' HD12 ' A' ' 42' ' ' LEU . 96.3 m95 -106.49 108.43 19.93 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.781 -1.562 . . . . 0.0 106.781 179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.778 HD11 ' CG2' ' A' ' 91' ' ' VAL . 4.1 mt -78.64 110.35 13.68 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 -177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.819 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.3 ttp180 -79.83 140.73 36.71 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 -179.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 38.1 t70 63.27 -76.12 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.27 14.2 0.21 Allowed Glycine 0 N--CA 1.49 2.27 0 O-C-N 124.259 0.974 . . . . 0.0 111.375 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 61' ' ' GLN . 11.5 p -143.56 147.23 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.781 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 4.3 tm0? -29.68 131.67 0.07 Allowed 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 115.069 -0.969 . . . . 0.0 112.64 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.819 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.11 143.22 13.74 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 123.097 1.427 . . . . 0.0 113.287 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.774 ' H ' HD13 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -162.28 110.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 CA-C-N 111.435 -2.621 . . . . 0.0 107.48 177.419 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.567 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 45.7 mm-40 -97.18 -136.12 0.25 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.74 -1.184 . . . . 0.0 112.362 -178.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.4 t 178.52 -43.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.325 -0.852 . . . . 0.0 110.992 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -43.54 -90.59 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -85.23 2.6 43.15 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 119.319 -0.952 . . . . 0.0 112.192 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 5.2 t -132.19 149.27 52.43 Favored 'General case' 0 C--N 1.304 -1.395 0 C-N-CA 118.026 -1.47 . . . . 0.0 111.773 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.518 ' HG3' HH21 ' A' ' 69' ' ' ARG . 0.1 OUTLIER -102.89 89.14 3.37 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 104.296 -2.483 . . . . 0.0 104.296 178.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.808 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -86.16 98.66 7.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.046 -1.462 . . . . 0.0 109.118 179.725 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.62 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.5 p -97.94 148.83 23.06 Favored 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 116.142 -2.223 . . . . 0.0 108.72 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.577 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.34 11.95 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 CA-C-N 114.978 -1.01 . . . . 0.0 113.322 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.863 ' CB ' HD22 ' A' ' 46' ' ' LEU . 4.6 pt-20 -139.09 -30.02 0.75 Allowed 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 119.371 -0.932 . . . . 0.0 110.762 178.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -149.01 144.92 27.05 Favored 'General case' 0 C--N 1.303 -1.42 0 C-N-CA 118.467 -1.293 . . . . 0.0 108.41 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.808 HG22 HG22 ' A' ' 70' ' ' ILE . 20.1 t -111.84 118.53 57.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 C-N-CA 118.484 -1.287 . . . . 0.0 108.373 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -114.57 112.01 22.26 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 118.421 -1.312 . . . . 0.0 111.151 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.615 ' C ' ' HD2' ' A' ' 78' ' ' ARG . 6.1 m -103.3 122.31 55.66 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 N-CA-C 103.689 -2.708 . . . . 0.0 103.689 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.615 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 2.8 mpt_? -111.16 59.98 0.61 Allowed 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 117.854 -1.538 . . . . 0.0 111.345 -177.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -161.93 -33.42 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 118.631 -1.228 . . . . 0.0 110.518 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 28.1 t 54.37 92.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.5 OUTLIER -145.57 166.78 16.24 Favored Pre-proline 0 N--CA 1.491 1.613 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 -178.919 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.8 Cg_exo -32.76 -33.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.275 1.983 . . . . 0.0 113.089 -174.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -47.97 -35.92 11.66 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 119.769 -0.772 . . . . 0.0 112.42 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.466 ' HB3' HG23 ' A' ' 105' ' ' VAL . 4.9 m-20 -87.23 30.3 0.79 Allowed 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.3 p -98.72 73.13 2.01 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.955 177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.91 -162.99 36.78 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.733 -1.699 . . . . 0.0 111.011 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.47 ' N ' HD12 ' A' ' 87' ' ' LEU . 9.2 mp -101.49 132.31 47.17 Favored 'General case' 0 C--N 1.304 -1.401 0 C-N-CA 117.247 -1.781 . . . . 0.0 110.711 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.588 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 28.8 m-85 -108.75 86.51 2.3 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.716 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -87.4 133.62 33.7 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.679 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.2 p -100.45 119.98 39.3 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -177.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.778 ' CG2' HD11 ' A' ' 56' ' ' LEU . 12.8 t -105.73 120.29 56.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 125.519 1.762 . . . . 0.0 107.743 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.694 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.1 p -100.27 128.03 46.43 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 105.024 -2.213 . . . . 0.0 105.024 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -128.12 134.47 49.12 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.409 -1.317 . . . . 0.0 112.136 -178.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.555 ' C ' ' H ' ' A' ' 96' ' ' SER . 59.1 p -130.96 150.83 77.69 Favored Pre-proline 0 N--CA 1.485 1.324 0 CA-C-N 113.913 -1.494 . . . . 0.0 107.079 178.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -50.77 1.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.477 2.118 . . . . 0.0 112.913 -178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.555 ' H ' ' C ' ' A' ' 94' ' ' SER . 69.0 p -113.92 -43.2 3.29 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.947 179.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.43 -177.05 33.19 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.599 -179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.5 t -134.0 146.44 50.41 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 120.166 -0.614 . . . . 0.0 110.509 179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -135.96 148.48 48.5 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 98.3 m -131.49 140.23 49.51 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.901 -1.52 . . . . 0.0 113.822 -179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.728 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.29 137.82 54.52 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 112.836 -1.984 . . . . 0.0 105.75 179.313 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.678 ' O ' ' N ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -113.76 119.58 37.85 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -177.124 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.849 ' CE2' HG11 ' A' ' 29' ' ' VAL . 6.1 m-85 -101.87 104.45 15.18 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.231 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 1.4 p -78.89 122.55 26.25 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 116.286 -2.166 . . . . 0.0 106.348 178.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.539 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -125.51 127.69 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.001 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.539 HD21 ' CD2' ' A' ' 33' ' ' LEU . 7.3 p-10 -130.21 126.31 37.08 Favored 'General case' 0 C--N 1.298 -1.658 0 CA-C-N 114.625 -1.17 . . . . 0.0 112.79 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.492 HG11 ' O ' ' A' ' 81' ' ' ILE . 9.7 p -106.07 127.15 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.697 -1.201 . . . . 0.0 110.504 178.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.493 1.687 0 C-N-CA 119.518 -0.873 . . . . 0.0 110.347 179.492 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo . . . . . 0 N--CA 1.482 0.826 0 CA-C-O 121.085 0.369 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 10.5 p -122.14 134.72 54.74 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.56 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.541 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 5.0 mp -134.96 111.21 11.07 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -75.97 -35.64 2.39 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 123.016 2.477 . . . . 0.0 111.427 -172.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.499 ' HB2' ' HA ' ' A' ' 22' ' ' PRO . 25.1 pt-20 -135.36 68.31 1.46 Allowed 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.835 -1.146 . . . . 0.0 111.548 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.13 54.36 0.84 Allowed 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.878 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -148.73 -83.84 0.1 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.131 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 69.9 mt-30 -128.85 65.68 73.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.3 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 6.3 Cg_exo -51.05 95.29 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.609 2.206 . . . . 0.0 111.704 -125.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.444 ' CE2' ' HE2' ' A' ' 103' ' ' PHE . 0.1 OUTLIER -122.59 63.37 0.97 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.25 -0.98 . . . . 0.0 112.127 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.1 88.8 0.8 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 28.0 m -91.6 158.49 40.36 Favored Pre-proline 0 N--CA 1.492 1.626 0 C-N-CA 119.82 -0.752 . . . . 0.0 111.848 -179.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -77.63 30.22 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.107 2.538 . . . . 0.0 111.207 165.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.4 ' H ' ' C ' ' A' ' 25' ' ' VAL . 47.1 t -128.9 -71.64 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 122.0 0.905 . . . . 0.0 108.601 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 2.3 mt-10 -143.87 -98.23 0.11 Allowed 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.889 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.3 t -163.41 -71.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-N 114.104 -1.407 . . . . 0.0 110.538 176.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.82 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.9 tp10 -147.87 107.99 4.06 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.091 -1.868 . . . . 0.0 112.548 -178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m -95.73 106.46 18.58 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.333 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 50.4 tp -136.44 151.12 49.15 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' O ' HD12 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.64 137.34 45.83 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.538 178.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.619 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -118.76 147.38 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.098 -179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.423 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 57.0 m170 -99.37 155.89 36.02 Favored Pre-proline 0 N--CA 1.492 1.669 0 C-N-CA 118.947 -1.101 . . . . 0.0 111.924 -178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.423 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 6.1 Cg_exo -62.76 131.73 34.47 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.525 2.15 . . . . 0.0 111.604 -156.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.458 ' CA ' ' O ' ' A' ' 79' ' ' ASP . . . 77.29 33.64 43.61 Favored Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.759 -1.21 . . . . 0.0 110.752 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.597 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 29.6 t70 -120.45 -174.08 2.72 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.893 0.854 . . . . 0.0 112.676 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.604 HD12 ' N ' ' A' ' 39' ' ' LEU . 5.2 mp -104.11 122.39 45.21 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 114.414 -1.266 . . . . 0.0 111.137 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.619 ' HB2' HG21 ' A' ' 34' ' ' VAL . 1.4 tp -120.11 133.93 55.38 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.25 -1.341 . . . . 0.0 108.692 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.532 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.8 pt20 -137.8 150.43 47.21 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 118.172 -1.411 . . . . 0.0 114.217 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.884 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -134.33 115.38 14.01 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.775 -1.557 . . . . 0.0 106.934 179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 27.3 ttt180 -106.61 127.2 53.15 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 119.001 -1.08 . . . . 0.0 110.087 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.591 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 0.9 OUTLIER -80.06 -162.71 0.46 Allowed 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 113.084 -1.871 . . . . 0.0 113.661 -178.429 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.602 ' NE ' HG21 ' A' ' 101' ' ' THR . 0.0 OUTLIER -136.39 -151.74 0.42 Allowed 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 112.808 -1.996 . . . . 0.0 109.113 -179.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 ' HA ' HG21 ' A' ' 50' ' ' VAL . 2.3 pp -158.65 154.2 26.07 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 117.449 -1.7 . . . . 0.0 112.6 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.632 ' CD ' ' HB2' ' A' ' 99' ' ' ASP . 1.6 mtp85 -121.37 -169.83 1.92 Allowed 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 118.485 -1.286 . . . . 0.0 109.941 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.577 ' C ' ' O ' ' A' ' 47' ' ' ARG . 0.3 OUTLIER -16.86 -59.51 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 123.936 0.773 . . . . 0.0 111.76 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.491 ' O ' ' CG ' ' A' ' 51' ' ' GLN . 12.4 m-20 -155.92 24.5 0.38 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.782 -1.167 . . . . 0.0 112.507 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 46' ' ' LEU . 13.7 m -37.94 142.12 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.811 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.59 HE21 ' HD3' ' A' ' 95' ' ' PRO . 19.9 mt-30 -137.83 -18.74 1.2 Allowed 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.683 -1.599 . . . . 0.0 109.992 -179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 55.7 m -119.49 105.37 11.18 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.636 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 3.0 mt -101.62 117.21 46.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 C-N-CA 118.599 -1.24 . . . . 0.0 108.803 179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.542 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.84 139.12 38.83 Favored 'General case' 0 C--N 1.299 -1.6 0 CA-C-N 113.379 -1.737 . . . . 0.0 107.53 -179.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.884 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.3 m95 -106.36 107.45 18.47 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 179.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.623 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.6 mt -79.09 108.6 12.7 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 117.968 -1.493 . . . . 0.0 108.198 -177.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.713 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.3 143.88 34.79 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.641 -179.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 12.1 t70 64.33 -77.69 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.858 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.507 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.01 18.41 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.4 m -143.35 153.86 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.819 -179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.551 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.3 130.7 13.29 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 113.518 0.932 . . . . 0.0 113.518 -179.275 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.713 HD22 ' CB ' ' A' ' 57' ' ' ARG . 10.0 tp -144.65 138.64 27.48 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 122.784 1.278 . . . . 0.0 111.642 178.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.719 ' CG2' HD13 ' A' ' 70' ' ' ILE . 2.1 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 CA-C-N 112.537 -2.12 . . . . 0.0 107.471 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.641 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.3 OUTLIER -97.14 -136.43 0.26 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 -177.353 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.447 ' H ' ' CD ' ' A' ' 64' ' ' GLU . 19.4 p -154.78 -174.27 4.91 Favored 'General case' 0 N--CA 1.495 1.776 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.298 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.52 ' O ' ' C ' ' A' ' 67' ' ' ARG . 52.2 t30 27.68 -107.33 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.361 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.52 ' C ' ' O ' ' A' ' 66' ' ' ASN . 0.0 OUTLIER -26.03 -44.8 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.944 0 CA-C-O 121.973 0.892 . . . . 0.0 111.01 179.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.641 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -116.67 112.26 20.99 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.4 ttp85 -87.39 89.6 8.05 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 105.57 -2.011 . . . . 0.0 105.57 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.719 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.2 pt -80.27 106.07 10.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 114.112 -1.404 . . . . 0.0 110.73 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.591 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.9 p -105.7 142.51 35.31 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 116.297 -2.161 . . . . 0.0 106.82 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -46.63 2.95 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.875 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.591 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.2 pt-20 -131.42 -29.35 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.48 179.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.4 ' H ' ' HG1' ' A' ' 71' ' ' THR . 68.8 tt0 -148.32 145.67 28.23 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 118.312 -1.355 . . . . 0.0 108.769 -178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.706 HG22 HG22 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -107.65 120.9 59.78 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 178.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -115.67 110.96 19.9 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.555 -1.258 . . . . 0.0 111.949 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -100.63 118.45 47.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 104.997 -2.223 . . . . 0.0 104.997 179.767 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -103.02 58.36 0.76 Allowed 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 118.54 -1.264 . . . . 0.0 111.542 -177.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.458 ' O ' ' CA ' ' A' ' 37' ' ' GLY . 51.8 t0 -161.54 -35.5 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 118.443 -1.303 . . . . 0.0 110.701 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.519 ' OG ' ' O ' ' A' ' 80' ' ' SER . 7.0 p 52.78 93.82 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 -177.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.533 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.0 pt -139.32 170.76 9.28 Favored Pre-proline 0 N--CA 1.49 1.573 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.275 -178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.7 Cg_exo -31.95 -36.11 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.111 1.874 . . . . 0.0 112.767 171.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -49.76 -32.84 14.7 Favored 'General case' 0 N--CA 1.493 1.68 0 C-N-CA 119.934 -0.706 . . . . 0.0 112.869 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.441 ' HB3' HG23 ' A' ' 105' ' ' VAL . 3.4 m-20 -94.75 35.58 1.23 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.981 -0.687 . . . . 0.0 112.094 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 74.2 p -98.8 72.56 1.96 Allowed 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.887 177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.08 -165.13 38.48 Favored Glycine 0 N--CA 1.494 2.552 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.72 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.479 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.6 mp -99.19 127.93 45.24 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 117.661 -1.616 . . . . 0.0 111.077 -179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.621 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 30.3 m-85 -106.25 81.68 1.65 Allowed 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.042 -2.207 . . . . 0.0 105.042 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -83.71 138.76 33.14 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -178.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.754 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 42.6 t -101.57 135.49 43.01 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 116.153 -2.219 . . . . 0.0 110.23 -178.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.623 ' CG2' HD11 ' A' ' 56' ' ' LEU . 14.1 t -117.37 114.27 45.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 124.572 1.17 . . . . 0.0 108.309 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.509 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 78.4 p -96.37 120.92 37.56 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.611 -2.366 . . . . 0.0 104.611 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.76 141.31 52.2 Favored 'General case' 0 C--N 1.305 -1.361 0 C-N-CA 119.492 -0.883 . . . . 0.0 112.547 -178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.503 ' O ' ' N ' ' A' ' 96' ' ' SER . 0.1 OUTLIER -138.87 157.63 71.33 Favored Pre-proline 0 N--CA 1.488 1.469 0 CA-C-N 113.041 -1.89 . . . . 0.0 106.711 177.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.59 ' HD3' HE21 ' A' ' 51' ' ' GLN . 13.2 Cg_exo -44.02 -16.74 0.1 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.565 2.177 . . . . 0.0 113.564 -175.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 94' ' ' SER . 53.7 m -145.9 25.89 1.27 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 118.241 -1.384 . . . . 0.0 112.941 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.38 150.54 20.69 Favored Glycine 0 N--CA 1.493 2.484 0 C-N-CA 118.927 -1.606 . . . . 0.0 111.67 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 58.7 p -146.95 123.54 11.11 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 120.296 -0.562 . . . . 0.0 110.396 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.632 ' HB2' ' CD ' ' A' ' 47' ' ' ARG . 11.0 t70 -131.27 139.58 49.65 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.827 -0.749 . . . . 0.0 109.577 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 94.2 m -128.9 143.67 50.96 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 118.336 -1.346 . . . . 0.0 113.899 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.889 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -120.97 168.01 11.96 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 112.855 -1.975 . . . . 0.0 109.283 179.366 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.721 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 40.0 m-85 -131.38 96.88 4.1 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 117.741 -1.584 . . . . 0.0 115.143 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.751 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 87.9 m-85 -88.33 100.87 13.34 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.65 113.82 17.03 Favored 'General case' 0 C--N 1.297 -1.697 0 C-N-CA 116.561 -2.056 . . . . 0.0 105.736 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.541 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -119.28 125.61 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 118.586 -1.245 . . . . 0.0 108.303 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.75 125.65 38.33 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.183 -1.371 . . . . 0.0 112.146 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.438 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.0 p -80.59 136.09 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 C-N-CA 118.009 -1.476 . . . . 0.0 107.891 177.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.556 0 C-N-CA 119.071 -1.052 . . . . 0.0 110.94 -178.811 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo . . . . . 0 N--CA 1.482 0.802 0 N-CA-C 111.447 -0.251 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.524 ' HB ' ' HE ' ' A' ' 47' ' ' ARG . 11.1 p -122.97 146.42 47.63 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.119 -1.033 . . . . 0.0 110.945 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.543 ' N ' HD12 ' A' ' 16' ' ' LEU . 2.9 mp -140.11 109.01 6.94 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' C ' ' HG2' ' A' ' 45' ' ' ARG . 9.9 Cg_endo -74.88 2.05 6.98 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.594 2.196 . . . . 0.0 110.773 168.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.402 ' CB ' ' HA ' ' A' ' 22' ' ' PRO . 7.3 pt-20 -149.63 67.89 1.01 Allowed 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.812 179.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -80.58 -21.3 41.79 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.47 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.562 ' HB1' ' HE ' ' A' ' 43' ' ' ARG . . . -117.84 -71.85 0.72 Allowed 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.478 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.464 ' HB2' ' CZ2' ' A' ' 23' ' ' TRP . 3.2 mp0 -119.38 140.65 29.42 Favored Pre-proline 0 N--CA 1.489 1.486 0 C-N-CA 119.73 -0.788 . . . . 0.0 109.021 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 19.5 Cg_endo -74.79 67.26 5.76 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.359 2.039 . . . . 0.0 111.799 -166.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.922 ' O ' HG22 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -131.21 73.71 1.56 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 118.913 -1.115 . . . . 0.0 112.48 179.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.86 80.21 0.28 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 28' ' ' GLU . 33.8 m -123.78 145.53 47.83 Favored Pre-proline 0 N--CA 1.491 1.583 0 C-N-CA 119.557 -0.857 . . . . 0.0 111.542 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_exo -46.49 -37.89 20.49 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.89 2.393 . . . . 0.0 113.675 -150.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 30.8 m -145.42 35.22 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 CA-C-O 122.247 1.022 . . . . 0.0 108.714 -179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.851 ' O ' HG23 ' A' ' 29' ' ' VAL . 91.6 mt-10 -150.96 157.03 42.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 113.191 -1.822 . . . . 0.0 107.692 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.061 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.7 t -161.64 -77.8 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 114.296 -1.32 . . . . 0.0 112.845 176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.782 ' N ' HG12 ' A' ' 29' ' ' VAL . 14.3 tp10 -131.46 106.58 8.32 Favored 'General case' 0 N--CA 1.491 1.595 0 C-N-CA 118.465 -1.294 . . . . 0.0 113.488 -178.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 104' ' ' SER . 33.9 m -100.77 112.73 25.19 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.584 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.4 tp -130.78 142.58 50.41 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.693 -1.14 . . . . 0.0 112.959 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.593 ' HA ' ' ND2' ' A' ' 106' ' ' ASN . 2.3 pp -110.01 132.84 53.8 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 114.458 -1.247 . . . . 0.0 109.607 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -125.53 166.74 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 114.745 -1.116 . . . . 0.0 109.687 -179.738 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.431 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 37.3 m170 -118.47 158.24 47.46 Favored Pre-proline 0 N--CA 1.492 1.671 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.107 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 4.0 Cg_exo -64.21 89.34 0.16 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.56 2.173 . . . . 0.0 112.294 -157.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.6 36.13 0.54 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 14.1 t70 -123.26 -173.92 2.83 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 122.603 1.192 . . . . 0.0 114.0 -179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.655 HD12 ' N ' ' A' ' 39' ' ' LEU . 8.1 mp -102.47 121.92 43.3 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 113.221 -1.808 . . . . 0.0 109.927 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 34' ' ' VAL . 0.9 OUTLIER -126.3 134.81 51.04 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.2 179.847 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.47 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -137.95 146.6 43.4 Favored 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 118.253 -1.379 . . . . 0.0 113.747 -179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.15 120.24 28.37 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 178.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.562 ' HE ' ' HB1' ' A' ' 20' ' ' ALA . 10.8 ttp180 -111.6 121.29 44.75 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 122.147 0.975 . . . . 0.0 112.413 -178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.51 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 0.5 OUTLIER -87.29 -163.0 0.86 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.24 -1.8 . . . . 0.0 110.17 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.767 HH11 ' H ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -134.85 -144.67 0.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 114.021 -1.445 . . . . 0.0 109.138 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.1 pp -160.31 156.62 26.64 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 118.163 -1.415 . . . . 0.0 112.183 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.59 ' H ' HG13 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -120.57 -169.56 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.602 -1.239 . . . . 0.0 109.278 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.571 ' C ' ' O ' ' A' ' 47' ' ' ARG . 8.5 p-10 -24.42 -52.29 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.945 0.778 . . . . 0.0 110.531 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 50' ' ' VAL . 5.2 t70 -160.5 46.73 0.23 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.999 -1.08 . . . . 0.0 112.157 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.59 HG13 ' H ' ' A' ' 47' ' ' ARG . 5.6 m -42.79 137.27 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.624 -1.231 . . . . 0.0 109.469 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.435 ' CG ' ' O ' ' A' ' 49' ' ' ASP . 7.7 mt-30 -125.31 -25.59 3.76 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 113.959 -1.473 . . . . 0.0 107.94 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.655 ' C ' HD12 ' A' ' 53' ' ' ILE . 6.3 t -123.62 128.94 50.41 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 118.32 -1.352 . . . . 0.0 109.299 178.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.655 HD12 ' C ' ' A' ' 52' ' ' SER . 1.8 mp -119.98 99.91 8.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 N-CA-C 105.289 -2.115 . . . . 0.0 105.289 178.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -88.39 124.34 33.84 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 113.85 -1.523 . . . . 0.0 108.724 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.771 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 97.3 m95 -101.51 100.82 11.31 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 178.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.777 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.77 107.45 11.49 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 117.981 -1.488 . . . . 0.0 107.32 -177.672 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -79.26 143.75 34.97 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 59.4 t0 64.0 -77.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.713 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.85 16.09 0.21 Allowed Glycine 0 N--CA 1.491 2.346 0 O-C-N 124.423 1.077 . . . . 0.0 110.541 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 62.0 t -140.24 147.45 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 C-N-CA 119.862 -0.735 . . . . 0.0 111.043 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.626 ' CA ' HD23 ' A' ' 56' ' ' LEU . 3.1 tm0? -42.97 132.2 4.02 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.539 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.579 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.3 tp -150.62 142.31 23.66 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 122.829 1.3 . . . . 0.0 113.039 179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.678 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.7 p -162.55 102.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 CA-C-N 111.573 -2.558 . . . . 0.0 106.446 177.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.522 ' N ' HG12 ' A' ' 70' ' ' ILE . 6.9 mm-40 -89.33 -140.98 0.14 Allowed 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 118.724 -1.191 . . . . 0.0 112.548 -178.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 16.6 p 168.17 28.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.288 -178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.468 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 1.5 m-20 -118.77 -81.49 0.63 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.605 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 49.4 mmt-85 -95.86 1.24 52.93 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.518 ' HB ' HG13 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -127.97 139.35 52.63 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.06 -179.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 58.5 mmt-85 -101.4 92.82 5.1 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 104.11 -2.552 . . . . 0.0 104.11 178.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.733 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -88.14 92.23 3.82 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 118.303 -1.359 . . . . 0.0 109.464 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.626 ' C ' ' H ' ' A' ' 73' ' ' GLU . 6.6 p -89.9 148.51 23.11 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 115.839 -2.344 . . . . 0.0 108.794 -179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.79 13.62 0.01 OUTLIER Glycine 0 N--CA 1.493 2.46 0 CA-C-N 114.88 -1.054 . . . . 0.0 113.777 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.626 ' H ' ' C ' ' A' ' 71' ' ' THR . 5.5 pt-20 -146.59 -25.9 0.42 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.618 -0.833 . . . . 0.0 111.096 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.527 ' OE1' ' HD3' ' A' ' 43' ' ' ARG . 13.0 mt-10 -147.03 140.82 25.79 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 118.47 -1.292 . . . . 0.0 108.532 -178.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.733 HG22 HG22 ' A' ' 70' ' ' ILE . 24.2 t -111.37 118.46 57.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 118.329 -1.348 . . . . 0.0 108.243 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -114.24 115.06 26.83 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 124.733 1.271 . . . . 0.0 111.512 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -103.38 119.89 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 179.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -105.86 51.51 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.765 -1.174 . . . . 0.0 111.365 -177.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -162.27 -33.11 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.517 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.1 p 55.59 91.68 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.516 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 3.2 pt -128.44 164.52 37.35 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 38.9 Cg_exo -33.3 -34.49 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.174 1.916 . . . . 0.0 111.641 178.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.1 -43.01 14.43 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 119.768 -0.773 . . . . 0.0 112.127 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.515 ' HB3' HG23 ' A' ' 105' ' ' VAL . 8.3 m-20 -84.16 35.76 0.55 Allowed 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 121.7 0.762 . . . . 0.0 112.481 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.6 p -98.23 72.08 2.12 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.625 -1.17 . . . . 0.0 110.497 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 165.94 -161.74 35.29 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 117.946 -2.073 . . . . 0.0 112.181 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.475 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.7 mp -98.36 130.57 45.02 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 117.736 -1.586 . . . . 0.0 110.867 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.633 ' CE1' HG21 ' A' ' 105' ' ' VAL . 9.0 m-85 -103.01 95.17 5.96 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.623 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -94.53 126.2 39.67 Favored 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.771 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 49.9 t -96.06 121.74 38.15 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.858 -178.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.777 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.6 t -102.24 108.35 23.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 125.123 1.514 . . . . 0.0 108.163 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.78 120.75 35.5 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 104.535 -2.394 . . . . 0.0 104.535 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 m -131.79 136.07 47.26 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 118.726 -1.189 . . . . 0.0 112.801 -178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.547 ' O ' ' N ' ' A' ' 96' ' ' SER . 53.3 p -130.96 153.55 81.78 Favored Pre-proline 0 C--N 1.305 -1.345 0 CA-C-N 113.245 -1.798 . . . . 0.0 106.889 178.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -52.39 1.21 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.475 2.117 . . . . 0.0 112.672 -176.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.547 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.5 t -114.07 -41.99 3.44 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.187 -1.005 . . . . 0.0 110.141 179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -179.09 34.83 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.508 -1.806 . . . . 0.0 111.726 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 66.0 m -135.94 153.22 51.49 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 120.022 -0.671 . . . . 0.0 111.449 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.502 ' HB2' ' HD2' ' A' ' 47' ' ' ARG . 55.8 t0 -144.17 139.44 28.78 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.934 -1.03 . . . . 0.0 108.356 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 5.0 m -128.48 140.01 52.03 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.321 -1.352 . . . . 0.0 112.488 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.061 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -121.74 144.83 48.56 Favored 'General case' 0 N--CA 1.499 2.021 0 CA-C-N 113.627 -1.624 . . . . 0.0 109.773 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.7 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 15.4 m-85 -113.44 113.7 25.54 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -178.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.803 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 1.6 m-85 -101.17 109.62 21.52 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.42 178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.2 m -79.83 122.28 26.44 Favored 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 115.975 -2.29 . . . . 0.0 105.375 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.633 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.86 125.2 69.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 117.329 -1.748 . . . . 0.0 108.216 -179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.593 ' ND2' ' HA ' ' A' ' 33' ' ' LEU . 0.1 OUTLIER -130.29 119.48 22.9 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 113.955 -1.475 . . . . 0.0 112.121 -179.526 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.59 ' O ' HG22 ' A' ' 107' ' ' VAL . 7.1 p -82.54 62.51 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 CA-C-N 114.796 -1.093 . . . . 0.0 111.685 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.401 ' N ' ' O ' ' A' ' 34' ' ' VAL . 35.5 t . . . . . 0 N--CA 1.486 1.33 0 C-N-CA 118.406 -1.317 . . . . 0.0 111.466 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.48 0.705 0 N-CA-C 110.843 -0.484 . . . . 0.0 110.843 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.565 ' C ' HD12 ' A' ' 16' ' ' LEU . 18.0 p -129.74 163.29 26.49 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 47' ' ' ARG . 5.8 mp -125.85 132.51 24.34 Favored Pre-proline 0 C--N 1.304 -1.388 0 C-N-CA 117.516 -1.673 . . . . 0.0 112.597 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -42.79 48.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 125.219 3.946 . . . . 0.0 115.179 -112.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.691 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 13.8 mp0 -146.0 -80.15 0.16 Allowed 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.452 ' HG3' ' N ' ' A' ' 20' ' ' ALA . 2.0 tp-100 -161.14 -118.35 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 117.473 -1.691 . . . . 0.0 109.107 178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.452 ' N ' ' HG3' ' A' ' 19' ' ' GLN . . . -160.56 -78.3 0.05 Allowed 'General case' 0 C--N 1.297 -1.682 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.615 -178.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.648 ' HA ' ' NH1' ' A' ' 45' ' ' ARG . 3.3 tp60 -109.71 -63.57 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.748 -0.781 . . . . 0.0 111.166 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' CD ' ' H ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -65.44 7.77 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.118 1.879 . . . . 0.0 111.889 -155.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' N ' ' O ' ' A' ' 21' ' ' GLN . 37.2 t-105 -93.22 -20.58 20.31 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.103 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA2' ' CG2' ' A' ' 101' ' ' THR . . . -82.06 96.26 1.8 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -106.14 131.98 21.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 C-N-CA 119.629 -0.828 . . . . 0.0 111.643 -179.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -46.31 -39.78 21.69 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.037 2.491 . . . . 0.0 113.766 -137.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.541 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 8.7 p -149.95 35.84 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 CA-C-O 122.511 1.148 . . . . 0.0 109.037 -179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.725 ' O ' HG23 ' A' ' 29' ' ' VAL . 9.5 tp10 -158.82 153.82 25.12 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 113.546 -1.661 . . . . 0.0 107.594 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.839 HG21 ' CB ' ' A' ' 101' ' ' THR . 2.1 t -161.69 -76.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 CA-C-N 114.862 -1.063 . . . . 0.0 111.525 176.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.779 ' N ' HG12 ' A' ' 29' ' ' VAL . 2.9 tp10 -128.87 102.28 6.47 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 118.873 -1.131 . . . . 0.0 111.902 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.3 m -103.99 112.16 25.03 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.831 -1.077 . . . . 0.0 110.444 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.437 ' HG ' ' N ' ' A' ' 33' ' ' LEU . 53.3 tp -143.32 152.22 41.39 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.481 ' C ' HD12 ' A' ' 33' ' ' LEU . 3.0 pp -109.99 144.45 38.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 114.866 -1.061 . . . . 0.0 108.419 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.511 ' HB ' ' HB2' ' A' ' 80' ' ' SER . 0.2 OUTLIER -128.89 154.57 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.393 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.562 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 52.1 m170 -103.37 159.49 29.13 Favored Pre-proline 0 N--CA 1.495 1.824 0 C-N-CA 119.396 -0.921 . . . . 0.0 112.886 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.562 ' CD ' ' HB3' ' A' ' 35' ' ' HIS . 2.0 Cg_endo -68.53 87.95 0.42 Allowed 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 123.017 2.478 . . . . 0.0 112.274 -147.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 124.37 36.27 0.61 Allowed Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.511 ' HB2' HG12 ' A' ' 34' ' ' VAL . 89.1 m-20 -120.42 170.42 9.39 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 48.9 tp -90.98 122.3 33.53 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.338 -2.21 . . . . 0.0 111.653 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.592 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.27 139.7 49.67 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.043 -1.435 . . . . 0.0 108.818 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.642 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 2.9 pm0 -137.36 151.5 48.66 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.232 -1.387 . . . . 0.0 113.919 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -127.69 121.38 30.21 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.249 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.541 ' HG3' ' HG2' ' A' ' 18' ' ' GLU . 1.8 tpp180 -107.1 120.79 43.06 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.06 -179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.61 ' SG ' HG22 ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.35 -143.82 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 114.678 -1.146 . . . . 0.0 110.821 -179.218 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.691 ' HA ' ' CB ' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -153.54 97.31 2.11 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.292 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.524 ' HG ' ' CB ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -112.08 160.42 17.53 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 116.602 -2.039 . . . . 0.0 109.927 -179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.614 ' HA ' HD13 ' A' ' 16' ' ' LEU . 4.9 ttt180 -153.19 -155.01 0.56 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.17 -1.012 . . . . 0.0 110.094 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -86.13 33.86 0.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 179.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 47' ' ' ARG . 3.9 m-20 -129.67 -73.47 0.56 Allowed 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.575 -1.193 . . . . 0.0 108.82 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.49 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 27.7 m -75.01 146.94 8.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.923 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.543 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 12.4 mt-30 -134.24 -17.81 2.05 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.384 -179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 48.5 t -115.17 95.64 5.29 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 119.344 -0.942 . . . . 0.0 108.945 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.6 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 20.9 mm -95.68 113.42 30.03 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.481 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.49 138.49 42.56 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 113.765 -1.562 . . . . 0.0 108.855 -179.432 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.836 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.6 m95 -106.96 106.7 17.35 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 117.902 -1.519 . . . . 0.0 107.824 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 4.4 mt -79.66 109.51 14.13 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 117.882 -1.527 . . . . 0.0 107.789 -178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.647 ' CB ' HD13 ' A' ' 62' ' ' LEU . 4.7 tmm_? -79.46 145.1 33.47 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 119.165 -1.014 . . . . 0.0 108.689 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.495 ' CB ' ' HD2' ' A' ' 57' ' ' ARG . 32.3 t70 63.29 -75.86 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.225 0.953 . . . . 0.0 109.161 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.87 19.64 0.16 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 178.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 p -147.02 154.12 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 C-N-CA 120.236 -0.585 . . . . 0.0 111.031 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 65.2 tp60 -38.03 135.27 0.7 Allowed 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.647 HD13 ' CB ' ' A' ' 57' ' ' ARG . 1.7 tt -158.66 138.21 11.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 123.262 1.506 . . . . 0.0 114.351 178.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.6 p -163.24 97.69 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 111.089 -2.778 . . . . 0.0 107.193 177.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 2.1 tm-20 -97.0 -141.06 0.29 Allowed 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 118.651 -1.22 . . . . 0.0 111.467 -178.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.7 t -167.94 -32.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.744 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.516 ' C ' ' H ' ' A' ' 68' ' ' THR . 45.0 t30 -91.88 126.13 36.85 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.557 -0.857 . . . . 0.0 109.746 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.472 ' CB ' ' O ' ' A' ' 66' ' ' ASN . 3.0 tpp180 77.94 -30.95 0.16 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 -179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.516 ' H ' ' C ' ' A' ' 66' ' ' ASN . 9.8 t -124.18 134.18 53.37 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.431 179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.421 ' HD3' ' C ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -109.43 101.75 10.69 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 103.901 -2.629 . . . . 0.0 103.901 179.133 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.678 ' O ' HD12 ' A' ' 70' ' ' ILE . 1.1 pp -93.19 113.34 27.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 C-N-CA 118.711 -1.196 . . . . 0.0 111.304 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.2 p -103.13 143.73 32.22 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 117.025 -1.87 . . . . 0.0 108.479 179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.6 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.25 7.41 0.01 OUTLIER Glycine 0 N--CA 1.492 2.384 0 CA-C-N 114.892 -1.049 . . . . 0.0 114.36 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.583 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -143.25 -24.71 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.245 -0.982 . . . . 0.0 110.964 178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.404 ' O ' HG23 ' A' ' 71' ' ' THR . 82.3 tt0 -148.7 148.11 29.66 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.709 HG23 ' NE1' ' A' ' 55' ' ' TRP . 38.0 t -119.97 127.77 75.9 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.75 0 C-N-CA 117.71 -1.596 . . . . 0.0 109.716 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' CG ' HD11 ' A' ' 39' ' ' LEU . 36.7 tt0 -114.49 119.51 37.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 124.807 1.317 . . . . 0.0 110.641 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG23 ' HG ' ' A' ' 40' ' ' LEU . 0.0 OUTLIER -110.52 124.64 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 101.875 -3.38 . . . . 0.0 101.875 178.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.637 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -116.1 58.09 0.75 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 116.924 -1.91 . . . . 0.0 113.829 -176.697 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' OG ' ' A' ' 80' ' ' SER . 22.3 t70 -160.91 -28.7 0.06 Allowed 'General case' 0 C--N 1.302 -1.475 0 C-N-CA 118.117 -1.433 . . . . 0.0 112.143 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.511 ' HB2' ' HB ' ' A' ' 34' ' ' VAL . 70.8 p 49.23 84.74 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 122.267 1.032 . . . . 0.0 109.789 -178.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.567 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.0 OUTLIER -132.01 172.89 6.58 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 -179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.0 Cg_exo -32.58 -34.14 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.897 1.731 . . . . 0.0 113.192 174.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -53.2 -31.67 44.17 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.813 -0.755 . . . . 0.0 112.786 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.494 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 2.6 m-20 -97.88 32.39 2.38 Favored 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.768 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.7 t -99.09 72.71 1.89 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 120.083 -0.647 . . . . 0.0 109.757 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 171.52 -166.61 39.64 Favored Glycine 0 N--CA 1.494 2.517 0 C-N-CA 118.363 -1.875 . . . . 0.0 111.469 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.427 ' O ' ' N ' ' A' ' 58' ' ' ASP . 60.4 mt -98.02 130.83 44.83 Favored 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 117.494 -1.682 . . . . 0.0 110.206 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD2' ' HB ' ' A' ' 105' ' ' VAL . 13.4 m-85 -105.57 95.12 5.6 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 104.594 -2.373 . . . . 0.0 104.594 178.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -97.13 123.39 40.87 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.836 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 38.9 t -95.64 128.37 42.45 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 117.772 -1.571 . . . . 0.0 108.323 -178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 56' ' ' LEU . 59.5 t -114.95 119.49 61.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 125.552 1.782 . . . . 0.0 107.838 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.61 HG22 ' SG ' ' A' ' 44' ' ' CYS . 32.8 p -99.83 132.56 45.1 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -129.92 139.72 51.07 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 118.43 -1.308 . . . . 0.0 112.772 -177.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.595 ' O ' ' N ' ' A' ' 96' ' ' SER . 54.2 p -127.16 154.24 76.79 Favored Pre-proline 0 N--CA 1.485 1.302 0 N-CA-C 105.839 -1.912 . . . . 0.0 105.839 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.543 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.4 Cg_exo -50.04 -1.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.73 2.286 . . . . 0.0 112.862 -172.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.8 t -115.3 -44.13 3.02 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 119.159 -1.016 . . . . 0.0 110.688 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.67 -175.12 31.34 Favored Glycine 0 N--CA 1.494 2.548 0 C-N-CA 118.737 -1.697 . . . . 0.0 110.887 -178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 74.5 m -135.75 161.38 35.74 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.656 -0.818 . . . . 0.0 111.203 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.661 ' CB ' ' NH2' ' A' ' 45' ' ' ARG . 2.4 t0 -133.73 153.29 51.81 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.7 m -133.77 146.37 50.66 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 117.603 -1.639 . . . . 0.0 115.036 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.839 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.7 OUTLIER -122.02 131.96 54.27 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 112.351 -2.204 . . . . 0.0 107.989 179.314 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.71 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 19.0 m-85 -108.38 110.33 21.85 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 116.554 2.057 . . . . 0.0 116.554 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.754 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 3.3 m-85 -100.49 111.19 23.42 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.837 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 13.5 m -81.27 121.67 26.46 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 115.0 -2.68 . . . . 0.0 104.935 178.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.45 ' O ' ' O ' ' A' ' 84' ' ' ASP . 8.2 t -116.47 119.47 62.04 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 C-N-CA 117.853 -1.539 . . . . 0.0 106.96 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -129.25 122.42 29.62 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 118.343 -1.343 . . . . 0.0 113.621 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.36 137.93 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 118.552 -1.259 . . . . 0.0 108.186 177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.491 1.625 0 C-N-CA 118.821 -1.152 . . . . 0.0 111.106 -178.918 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo . . . . . 0 N--CA 1.481 0.756 0 N-CA-C 111.288 -0.312 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.513 ' C ' HD22 ' A' ' 16' ' ' LEU . 5.6 t -142.21 138.33 31.41 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.401 -0.92 . . . . 0.0 111.011 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.555 ' N ' HD22 ' A' ' 16' ' ' LEU . 2.9 mm? -122.46 99.66 42.41 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 179.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -83.43 -38.81 0.14 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.785 2.324 . . . . 0.0 111.85 -165.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -138.0 79.37 1.74 Allowed 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.604 -0.839 . . . . 0.0 111.673 -179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.5 mm100 -85.29 -3.18 58.74 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.792 179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB2' ' HG2' ' A' ' 43' ' ' ARG . . . -124.41 -79.29 0.61 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.982 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.619 ' HB2' ' CH2' ' A' ' 23' ' ' TRP . 71.6 mt-30 -136.11 152.08 74.76 Favored Pre-proline 0 N--CA 1.49 1.559 0 C-N-CA 119.606 -0.837 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 21' ' ' GLN . 20.8 Cg_endo -81.08 64.76 8.9 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 C-N-CA 122.383 2.056 . . . . 0.0 112.04 -160.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.619 ' CH2' ' HB2' ' A' ' 21' ' ' GLN . 1.1 p90 -121.61 132.4 54.65 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 118.554 -1.258 . . . . 0.0 111.847 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.21 49.41 0.38 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 107.422 -2.271 . . . . 0.0 107.422 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.43 HG23 ' C ' ' A' ' 28' ' ' GLU . 32.7 m -96.71 142.05 23.97 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 114.732 -0.734 . . . . 0.0 112.073 -178.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -46.61 -40.59 23.87 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.879 2.386 . . . . 0.0 113.296 -150.391 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.09 37.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 122.383 1.087 . . . . 0.0 108.962 -179.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.79 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 3.1 mm-40 -151.29 169.12 22.71 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 112.928 -1.942 . . . . 0.0 107.477 179.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG21 ' HB ' ' A' ' 101' ' ' THR . 1.8 t -162.24 -68.63 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 CA-C-N 113.031 -1.895 . . . . 0.0 110.37 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.759 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.2 tt0 -144.45 109.08 4.9 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.849 -1.523 . . . . 0.0 113.556 -178.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.489 ' HA ' ' HB2' ' A' ' 104' ' ' SER . 63.0 p -92.84 117.3 29.88 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.122 -1.399 . . . . 0.0 110.377 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -134.96 141.16 46.19 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.176 0.988 . . . . 0.0 112.843 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.604 ' CB ' HD21 ' A' ' 106' ' ' ASN . 0.3 OUTLIER -108.43 131.88 54.34 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 114.396 -1.275 . . . . 0.0 109.7 179.311 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.6 169.84 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 119.613 -0.835 . . . . 0.0 112.066 -179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.57 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.82 168.98 15.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.546 -0.862 . . . . 0.0 109.991 179.48 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 80' ' ' SER . 10.1 Cg_exo -54.25 109.74 0.42 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.574 2.182 . . . . 0.0 111.982 -171.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 112.28 36.2 1.66 Allowed Glycine 0 N--CA 1.489 2.189 0 C-N-CA 119.962 -1.114 . . . . 0.0 110.61 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.418 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 82.6 m-20 -130.5 164.41 24.88 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.81 1.411 . . . . 0.0 114.81 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 3.3 mp -106.15 117.42 33.99 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 112.941 -1.936 . . . . 0.0 109.126 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -126.48 141.59 51.83 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 114.297 -1.32 . . . . 0.0 109.777 -179.179 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.488 ' NE2' ' O ' ' A' ' 41' ' ' GLN . 1.0 OUTLIER -135.53 153.91 51.56 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 118.067 -1.453 . . . . 0.0 114.347 -179.843 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.736 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -133.89 113.5 12.29 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 106.003 -1.851 . . . . 0.0 106.003 178.676 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.4 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -111.28 121.92 46.5 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.021 -1.072 . . . . 0.0 111.758 -179.02 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -88.33 -154.12 0.27 Allowed 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 113.734 -1.575 . . . . 0.0 111.025 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.33 -172.44 2.85 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 114.498 -1.228 . . . . 0.0 109.273 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 46' ' ' LEU . 1.6 pt? -148.33 147.45 29.29 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 118.172 -1.411 . . . . 0.0 111.243 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 94' ' ' SER . 0.0 OUTLIER -92.67 -92.45 0.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 117.366 -1.733 . . . . 0.0 109.347 -179.522 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 57.0 t0 -97.88 -48.26 5.24 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.6 ' O ' ' C ' ' A' ' 50' ' ' VAL . 31.1 t70 -160.67 58.7 0.32 Allowed 'General case' 0 N--CA 1.487 1.419 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.552 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.607 ' HB ' HD11 ' A' ' 53' ' ' ILE . 15.9 m -16.36 125.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-O 121.921 0.867 . . . . 0.0 112.581 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.499 HE21 ' HA ' ' A' ' 51' ' ' GLN . 0.0 OUTLIER -111.02 -33.85 6.37 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.062 -1.426 . . . . 0.0 107.674 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 93' ' ' SER . 11.2 t -128.98 101.33 6.01 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.447 -1.301 . . . . 0.0 112.506 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.766 ' N ' HD12 ' A' ' 53' ' ' ILE . 3.8 mp -114.0 89.19 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.328 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.446 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -88.96 140.87 28.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.736 ' CE3' HD12 ' A' ' 42' ' ' LEU . 91.6 m95 -108.37 106.73 16.99 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.587 HD23 ' HA ' ' A' ' 61' ' ' GLN . 8.1 mt -78.86 110.76 14.34 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 -178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.693 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 0.3 OUTLIER -82.5 141.25 32.81 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 179.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.568 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 35.8 t70 60.44 -77.27 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.955 0.784 . . . . 0.0 109.743 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.74 18.45 0.24 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.033 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 61' ' ' GLN . 10.4 p -144.75 147.54 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 119.415 -0.914 . . . . 0.0 111.859 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.587 ' HA ' HD23 ' A' ' 56' ' ' LEU . 3.0 tm0? -37.93 135.36 0.67 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.684 0.754 . . . . 0.0 112.031 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.708 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.14 174.91 13.57 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.73 -1.577 . . . . 0.0 110.472 179.911 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.844 ' HB ' HD13 ' A' ' 70' ' ' ILE . 4.2 m -156.79 -159.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-N 110.886 -2.87 . . . . 0.0 109.462 178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.691 ' H ' HG21 ' A' ' 70' ' ' ILE . 22.5 pt-20 -33.25 132.82 0.16 Allowed 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.969 0.89 . . . . 0.0 112.487 -179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.49 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 19.6 m -137.03 75.7 1.55 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 106.496 -1.668 . . . . 0.0 106.496 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.51 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.6 t30 78.3 134.79 0.06 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 -178.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' C ' ' O ' ' A' ' 66' ' ' ASN . 12.7 mtt180 25.42 53.59 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.672 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 5.7 m -124.72 143.02 50.99 Favored 'General case' 0 C--N 1.305 -1.332 0 C-N-CA 117.88 -1.528 . . . . 0.0 108.464 178.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.2 ttt85 -115.86 90.57 3.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 106.017 -1.845 . . . . 0.0 106.017 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.844 HD13 ' HB ' ' A' ' 63' ' ' VAL . 14.3 pt -81.26 128.16 38.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.12 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.507 ' C ' ' H ' ' A' ' 73' ' ' GLU . 3.8 p -121.01 141.03 51.12 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.471 ' O ' ' CD1' ' A' ' 53' ' ' ILE . . . -66.04 42.96 0.16 Allowed Glycine 0 N--CA 1.495 2.618 0 O-C-N 123.854 0.721 . . . . 0.0 112.577 179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' H ' ' C ' ' A' ' 71' ' ' THR . 20.8 pt-20 -160.71 -35.31 0.05 Allowed 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HG2' ' N ' ' A' ' 75' ' ' VAL . 0.1 OUTLIER -153.5 158.95 42.08 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -179.264 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.689 ' CG2' ' CD1' ' A' ' 55' ' ' TRP . 2.3 t -126.5 127.99 70.88 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 117.808 -1.557 . . . . 0.0 109.421 179.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -108.75 116.87 32.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 118.379 -1.328 . . . . 0.0 109.007 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.522 ' CG1' ' OG1' ' A' ' 68' ' ' THR . 0.0 OUTLIER -106.27 109.24 27.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 N-CA-C 102.576 -3.12 . . . . 0.0 102.576 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.652 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -106.95 64.28 0.64 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -176.777 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' OD1' ' HD3' ' A' ' 67' ' ' ARG . 0.7 OUTLIER -161.61 -37.17 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 118.338 -1.345 . . . . 0.0 110.714 -179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 36' ' ' PRO . 68.1 m 51.31 79.84 0.09 Allowed 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 104.484 -2.413 . . . . 0.0 104.484 -176.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.638 ' O ' ' N ' ' A' ' 83' ' ' ALA . 2.2 pp -138.87 159.49 66.86 Favored Pre-proline 0 N--CA 1.488 1.435 0 N-CA-C 106.041 -1.837 . . . . 0.0 106.041 -177.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.55 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 29.8 Cg_exo -40.18 -27.71 0.25 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.117 1.878 . . . . 0.0 111.197 -157.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.638 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.92 -43.75 19.24 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.423 -0.911 . . . . 0.0 112.202 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.606 ' HA ' ' CE1' ' A' ' 88' ' ' TYR . 6.7 m-20 -76.08 31.32 0.12 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.601 1.334 . . . . 0.0 114.601 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.4 p -97.53 73.45 2.39 Favored 'General case' 0 N--CA 1.494 1.745 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.904 176.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.525 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 167.05 -164.12 37.63 Favored Glycine 0 N--CA 1.495 2.579 0 C-N-CA 118.559 -1.782 . . . . 0.0 111.882 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.658 ' N ' HD22 ' A' ' 87' ' ' LEU . 2.4 mm? -92.37 129.16 38.38 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 117.645 -1.622 . . . . 0.0 110.085 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.606 ' CE1' ' HA ' ' A' ' 84' ' ' ASP . 20.9 m-85 -106.87 89.32 2.97 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HB2' ' CD2' ' A' ' 102' ' ' TYR . . . -105.78 136.2 45.83 Favored 'General case' 0 C--N 1.295 -1.762 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.444 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.678 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -97.45 135.4 39.38 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 117.166 -1.814 . . . . 0.0 109.924 -179.555 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.58 ' CG2' HD11 ' A' ' 56' ' ' LEU . 1.4 t -106.77 102.7 14.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 104.871 -2.27 . . . . 0.0 104.871 178.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.25 140.61 29.55 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 114.079 -1.419 . . . . 0.0 108.815 -178.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 52' ' ' SER . 2.1 t -138.31 124.15 19.95 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.514 ' HB3' ' CB ' ' A' ' 47' ' ' ARG . 40.9 t -139.93 129.33 13.67 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.11 -1.97 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.478 2.119 . . . . 0.0 113.294 -109.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.483 ' N ' ' O ' ' A' ' 94' ' ' SER . 74.8 p -115.03 -19.84 10.74 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 119.698 -0.801 . . . . 0.0 112.698 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -141.89 165.0 26.67 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 119.602 -1.285 . . . . 0.0 110.895 -179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 77.5 p -134.18 166.52 22.59 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.59 -0.844 . . . . 0.0 110.893 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -160.03 151.88 20.21 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.895 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 32.8 m -129.19 145.18 51.38 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.706 -178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.891 ' HB ' HG21 ' A' ' 29' ' ' VAL . 32.6 p -117.23 149.06 41.04 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 113.171 -1.831 . . . . 0.0 108.26 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.79 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 27.1 m-85 -124.69 99.52 6.2 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 115.786 1.773 . . . . 0.0 115.786 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.786 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 16.9 m-85 -93.02 112.76 24.83 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.489 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 67.2 m -79.75 116.12 19.74 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 179.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.557 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 21.9 t -119.59 121.53 66.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 C-N-CA 117.801 -1.56 . . . . 0.0 108.438 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.604 HD21 ' CB ' ' A' ' 33' ' ' LEU . 7.0 p-10 -125.68 120.54 30.99 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.251 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.558 HG11 ' O ' ' A' ' 81' ' ' ILE . 6.4 p -109.3 121.07 61.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.448 179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 46.6 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.473 178.81 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo . . . . . 0 N--CA 1.482 0.799 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.582 HG23 ' N ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -125.0 -178.02 4.04 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 179.489 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.738 ' HB2' ' CB ' ' A' ' 46' ' ' LEU . 6.9 mp -110.14 115.6 54.5 Favored Pre-proline 0 C--N 1.302 -1.468 0 C-N-CA 119.241 -0.984 . . . . 0.0 109.754 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -83.81 65.3 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 123.652 2.901 . . . . 0.0 111.237 -110.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.696 ' CB ' ' NE2' ' A' ' 19' ' ' GLN . 4.1 mm-40 -115.51 -67.82 0.97 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.349 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.718 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -145.01 107.83 4.48 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 118.902 -1.119 . . . . 0.0 112.496 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' HG3' ' A' ' 21' ' ' GLN . . . -79.41 -29.64 42.05 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.982 -1.087 . . . . 0.0 108.182 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.594 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 4.0 mt-30 -160.1 -58.12 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.583 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.313 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.594 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 16.8 Cg_endo -74.81 138.95 24.23 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 121.918 1.745 . . . . 0.0 111.949 172.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.718 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.1 OUTLIER -111.77 -149.14 0.44 Allowed 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.223 -0.899 . . . . 0.0 109.318 179.181 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.98 -80.95 0.79 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.139 -1.584 . . . . 0.0 109.139 179.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.411 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 m -94.7 149.63 36.74 Favored Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.702 179.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 25' ' ' VAL . 22.2 Cg_endo -82.63 30.53 0.53 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.559 2.172 . . . . 0.0 112.254 -159.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.3 t -150.03 -69.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 119.468 -0.893 . . . . 0.0 109.661 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.633 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 6.0 mt-10 -80.47 -102.43 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 106.43 -1.693 . . . . 0.0 106.43 179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.861 HG12 ' N ' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -163.09 -71.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 114.237 -1.347 . . . . 0.0 108.513 176.861 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.861 ' N ' HG12 ' A' ' 29' ' ' VAL . 46.6 tt0 -142.45 104.79 4.46 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 112.114 -2.312 . . . . 0.0 109.275 -179.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.509 ' CB ' ' HB2' ' A' ' 104' ' ' SER . 17.7 m -104.26 107.99 19.17 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.107 -1.037 . . . . 0.0 109.758 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 93.0 mt -129.68 155.45 45.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.736 1.255 . . . . 0.0 113.58 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.574 ' N ' HD12 ' A' ' 33' ' ' LEU . 2.8 mp -117.03 133.31 56.17 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.168 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.486 ' CG1' ' HB2' ' A' ' 38' ' ' ASP . 4.5 t -127.95 164.6 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.668 -179.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.535 ' CG ' ' HD2' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -100.43 156.56 35.09 Favored Pre-proline 0 N--CA 1.491 1.601 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.855 -179.253 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD2' ' CG ' ' A' ' 35' ' ' HIS . 9.9 Cg_endo -71.35 87.16 0.77 Allowed 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.331 2.02 . . . . 0.0 111.765 -162.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 133.03 31.11 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 C-N-CA 119.953 -1.117 . . . . 0.0 111.501 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.486 ' HB2' ' CG1' ' A' ' 34' ' ' VAL . 26.5 m-20 -122.06 -160.5 0.88 Allowed 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.991 -1.083 . . . . 0.0 112.259 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -110.06 121.87 46.28 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 114.376 -1.284 . . . . 0.0 110.514 -179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.631 ' HB3' ' CG2' ' A' ' 77' ' ' VAL . 1.1 tp -116.94 138.37 51.59 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 113.905 -1.498 . . . . 0.0 108.627 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.7 pt20 -138.08 144.15 40.79 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 118.18 -1.408 . . . . 0.0 114.407 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.708 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -127.33 115.39 18.91 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 178.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.458 ' N ' ' CE2' ' A' ' 103' ' ' PHE . 14.6 mtm105 -107.7 113.83 27.38 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.07 0.938 . . . . 0.0 113.497 -178.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 5.6 t -85.22 -154.16 0.18 Allowed 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 113.932 -1.485 . . . . 0.0 108.022 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.596 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 5.1 ptt85 -131.16 154.41 48.39 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 118.854 -1.138 . . . . 0.0 112.194 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.738 ' CB ' ' HB2' ' A' ' 16' ' ' LEU . 35.9 mt -112.9 127.65 56.26 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 177.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.43 ' H ' ' CG2' ' A' ' 50' ' ' VAL . 2.3 ttt180 -122.86 -179.02 4.1 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.692 -1.203 . . . . 0.0 111.889 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -92.44 18.14 8.92 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.653 -1.239 . . . . 0.0 107.653 179.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 94' ' ' SER . 18.1 m-20 -126.8 -58.86 1.3 Allowed 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 114.314 -1.312 . . . . 0.0 107.969 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' HA ' ' OG ' ' A' ' 94' ' ' SER . 13.1 m -66.85 139.79 20.51 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.291 179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.605 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 26.8 mt-30 -129.21 -23.29 3.01 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 113.795 -1.548 . . . . 0.0 109.077 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.411 ' O ' HD13 ' A' ' 53' ' ' ILE . 59.3 m -121.73 126.94 50.08 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.642 HG23 ' SG ' ' A' ' 90' ' ' CYS . 35.7 mm -115.18 112.12 38.6 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.55 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -98.22 142.87 29.34 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -179.468 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.804 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.8 m95 -108.45 111.59 23.56 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.179 -1.409 . . . . 0.0 108.179 179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.694 HD11 ' CG2' ' A' ' 91' ' ' VAL . 14.7 mt -78.27 105.59 9.61 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 105.777 -1.934 . . . . 0.0 105.777 -178.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.638 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 7.4 ttp180 -79.73 128.53 33.53 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 51.2 t0 69.45 -65.86 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 124.6 1.188 . . . . 0.0 109.631 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.69 9.29 0.08 OUTLIER Glycine 0 N--CA 1.49 2.286 0 O-C-N 124.317 1.011 . . . . 0.0 112.097 178.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 61' ' ' GLN . 8.7 p -144.28 149.13 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 C-N-CA 118.997 -1.081 . . . . 0.0 112.209 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -37.7 130.75 1.03 Allowed 'General case' 0 N--CA 1.497 1.895 0 CA-C-O 121.685 0.755 . . . . 0.0 112.245 -179.614 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.759 ' CD1' ' H ' ' A' ' 63' ' ' VAL . 0.2 OUTLIER -160.66 -172.41 3.51 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.842 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.962 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.7 m -155.66 -148.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 110.255 -3.157 . . . . 0.0 108.757 178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.757 ' N ' HG21 ' A' ' 70' ' ' ILE . 10.8 pt-20 -44.25 156.43 0.07 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 122.876 1.322 . . . . 0.0 112.88 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 29.0 t -108.22 -85.27 0.52 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 111.924 -2.398 . . . . 0.0 110.519 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -108.74 -70.27 0.81 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 9.3 mtp-105 -124.52 71.43 1.15 Allowed 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.544 ' CB ' ' HA ' ' A' ' 77' ' ' VAL . 33.7 p -130.97 154.01 48.6 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 117.909 -1.516 . . . . 0.0 108.194 -179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 17.4 ttt-85 -109.67 106.62 16.35 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.962 HD13 ' HB ' ' A' ' 63' ' ' VAL . 3.2 pt -88.57 117.76 32.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-N 114.426 -1.261 . . . . 0.0 110.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -109.63 139.65 44.41 Favored 'General case' 0 C--N 1.3 -1.558 0 C-N-CA 117.323 -1.751 . . . . 0.0 107.079 177.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.627 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -47.15 7.22 0.01 OUTLIER Glycine 0 N--CA 1.491 2.363 0 CA-C-N 114.907 -1.042 . . . . 0.0 114.198 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.618 ' H ' ' C ' ' A' ' 71' ' ' THR . 12.1 pt-20 -138.41 -28.77 0.83 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 117.916 0.858 . . . . 0.0 110.316 178.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 tt0 -145.38 150.35 36.42 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.696 ' HB ' ' CD1' ' A' ' 42' ' ' LEU . 24.1 t -115.85 122.06 68.72 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.741 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 74.6 mt-10 -117.24 114.34 23.5 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.778 -1.169 . . . . 0.0 110.003 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.631 ' CG2' ' HB3' ' A' ' 40' ' ' LEU . 4.1 m -102.5 125.37 56.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.421 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -102.11 58.44 0.82 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -177.691 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 79' ' ' ASP . 2.9 p30 -161.29 -40.88 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 114.26 -1.337 . . . . 0.0 111.278 -178.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.0 OUTLIER 55.41 83.4 0.09 Allowed 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 103.804 -2.665 . . . . 0.0 103.804 -177.05 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.437 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.0 171.49 4.36 Favored Pre-proline 0 N--CA 1.488 1.437 0 CA-C-N 114.142 -1.39 . . . . 0.0 110.334 -177.431 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.437 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 23.9 Cg_exo -39.54 -35.03 0.79 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.228 1.952 . . . . 0.0 110.336 166.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -51.05 -44.74 61.17 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.155 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.473 ' HB3' HG23 ' A' ' 105' ' ' VAL . 14.2 m-20 -81.0 34.06 0.34 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.292 -179.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 89.1 p -98.76 68.88 1.8 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 177.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.27 -156.31 25.15 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 118.109 -1.996 . . . . 0.0 112.22 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 62.7 mt -102.49 128.35 49.15 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 117.609 -1.637 . . . . 0.0 111.46 -179.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.744 ' CD1' HG22 ' A' ' 105' ' ' VAL . 29.8 m-85 -109.69 96.54 6.33 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.51 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -101.7 135.07 43.86 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.804 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.6 t -96.57 142.97 28.0 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 115.831 -2.347 . . . . 0.0 109.441 -179.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HD11 ' A' ' 56' ' ' LEU . 58.2 t -118.62 107.98 23.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 124.943 1.402 . . . . 0.0 107.252 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' SG ' ' A' ' 44' ' ' CYS . 53.1 p -90.23 127.62 36.18 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 m -129.89 143.44 50.8 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 118.584 -1.247 . . . . 0.0 112.489 -178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 96' ' ' SER . 1.0 OUTLIER -131.53 166.37 28.6 Favored Pre-proline 0 N--CA 1.487 1.407 0 CA-C-N 111.486 -2.597 . . . . 0.0 105.257 178.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.605 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 13.1 Cg_exo -48.88 -22.29 4.62 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.391 2.06 . . . . 0.0 113.112 -151.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.515 ' N ' ' O ' ' A' ' 94' ' ' SER . 36.8 m -152.92 31.16 0.49 Allowed 'General case' 0 N--CA 1.498 1.926 0 C-N-CA 119.162 -1.015 . . . . 0.0 111.926 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.14 154.66 25.71 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.723 -1.227 . . . . 0.0 110.14 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -141.58 153.99 45.15 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.772 -1.171 . . . . 0.0 112.407 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB3' ' OG1' ' A' ' 92' ' ' THR . 8.7 t70 -130.57 132.42 45.53 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 90' ' ' CYS . 37.5 m -121.82 145.81 47.69 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 117.435 -1.706 . . . . 0.0 113.754 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.803 ' CB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -121.47 159.41 26.32 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.097 -2.32 . . . . 0.0 108.908 -179.854 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.687 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 1.5 m-85 -129.38 103.59 7.01 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 117.497 -1.681 . . . . 0.0 113.973 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.707 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 47.4 m-85 -93.6 106.75 18.69 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.509 ' HB2' ' CB ' ' A' ' 31' ' ' SER . 19.6 m -78.53 122.51 25.97 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 115.024 -2.67 . . . . 0.0 105.111 178.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 88' ' ' TYR . 0.8 OUTLIER -126.28 118.72 52.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 118.047 -1.461 . . . . 0.0 107.737 -179.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -126.59 122.46 35.12 Favored 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 118.413 -1.315 . . . . 0.0 111.785 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.45 HG21 ' CA ' ' A' ' 80' ' ' SER . 19.1 t -106.54 120.57 57.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.563 178.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 62.4 m . . . . . 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.222 . . . . 0.0 112.344 -179.087 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 N--CA 1.483 0.893 0 CA-C-O 121.439 0.516 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.76 ' CB ' ' HE ' ' A' ' 47' ' ' ARG . 0.9 OUTLIER -142.53 164.94 28.76 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 118.287 -1.365 . . . . 0.0 111.558 -179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.503 ' N ' HD12 ' A' ' 16' ' ' LEU . 5.8 mp -121.44 101.84 43.2 Favored Pre-proline 0 N--CA 1.486 1.374 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' O ' ' CD ' ' A' ' 45' ' ' ARG . 16.3 Cg_endo -76.9 3.57 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.93 2.42 . . . . 0.0 111.132 -169.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -160.35 59.19 0.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.903 -0.719 . . . . 0.0 110.011 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.539 HE22 HH22 ' A' ' 43' ' ' ARG . 0.5 OUTLIER -86.67 47.14 1.44 Allowed 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.266 -0.974 . . . . 0.0 109.739 -179.814 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.31 -128.89 0.17 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.671 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 4.7 mm100 -115.66 78.01 6.57 Favored Pre-proline 0 N--CA 1.491 1.587 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.393 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -53.13 102.57 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.663 2.242 . . . . 0.0 111.73 -113.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 21' ' ' GLN . 0.1 OUTLIER -114.93 74.44 0.88 Allowed 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.722 -0.791 . . . . 0.0 110.576 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.44 ' HA2' ' CZ ' ' A' ' 45' ' ' ARG . . . -103.36 85.91 0.51 Allowed Glycine 0 N--CA 1.49 2.28 0 C-N-CA 119.587 -1.292 . . . . 0.0 109.99 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.437 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 29.3 m -104.37 158.06 32.76 Favored Pre-proline 0 N--CA 1.491 1.615 0 C-N-CA 119.616 -0.833 . . . . 0.0 110.843 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -83.51 21.88 0.99 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 123.415 2.744 . . . . 0.0 111.363 163.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.3 t -115.83 -72.86 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.723 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 78.8 mt-10 -148.83 -105.58 0.08 Allowed 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.831 HG12 ' N ' ' A' ' 30' ' ' GLU . 2.0 t -162.97 -73.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 CA-C-N 113.886 -1.506 . . . . 0.0 111.337 176.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.831 ' N ' HG12 ' A' ' 29' ' ' VAL . 13.6 tp10 -147.24 112.85 5.65 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 113.382 -1.736 . . . . 0.0 113.347 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 104' ' ' SER . 4.6 p -94.52 109.93 21.78 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 113.467 -1.697 . . . . 0.0 109.295 177.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.473 ' HG ' ' HG3' ' A' ' 30' ' ' GLU . 62.8 mt -126.88 143.83 51.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 115.23 -0.895 . . . . 0.0 113.335 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.485 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -107.91 128.43 54.62 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 114.357 -1.292 . . . . 0.0 109.124 179.585 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.42 169.21 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 119.203 -0.999 . . . . 0.0 113.44 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 66.7 m170 -121.68 166.65 15.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.393 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 80' ' ' SER . 14.1 Cg_exo -49.38 103.15 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.552 2.168 . . . . 0.0 112.018 166.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 124.07 29.16 1.15 Allowed Glycine 0 N--CA 1.489 2.174 0 C-N-CA 119.99 -1.1 . . . . 0.0 112.162 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.471 ' HB2' ' CB ' ' A' ' 80' ' ' SER . 73.6 m-20 -129.34 167.79 17.22 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 17.4 mt -110.84 117.46 33.48 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 112.408 -2.178 . . . . 0.0 106.888 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.51 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -120.09 128.67 53.68 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.644 -179.08 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -124.07 139.12 54.25 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.029 -1.069 . . . . 0.0 112.484 -179.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.752 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -126.36 104.31 8.11 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 178.487 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.539 HH22 HE22 ' A' ' 19' ' ' GLN . 10.2 ttt180 -101.08 122.38 43.47 Favored 'General case' 0 N--CA 1.489 1.525 0 C-N-CA 119.439 -0.904 . . . . 0.0 109.421 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.773 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 12.8 t -83.74 -169.03 2.36 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 113.737 -1.574 . . . . 0.0 112.228 -178.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.468 ' CD ' ' O ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -106.74 168.58 9.09 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 112.907 -1.951 . . . . 0.0 106.588 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.416 ' C ' HD12 ' A' ' 46' ' ' LEU . 3.7 pp -160.85 168.39 24.79 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 116.772 -1.971 . . . . 0.0 114.361 -178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.76 ' HE ' ' CB ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -115.05 169.37 9.15 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.246 -1.391 . . . . 0.0 107.246 178.695 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.613 ' C ' ' O ' ' A' ' 47' ' ' ARG . 11.0 t70 -16.85 -51.6 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.707 0.629 . . . . 0.0 110.908 178.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.597 ' N ' ' O ' ' A' ' 47' ' ' ARG . 10.9 t70 -154.96 74.45 0.92 Allowed 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 119.456 -0.898 . . . . 0.0 110.231 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG21 ' CD1' ' A' ' 53' ' ' ILE . 12.4 p -37.38 147.87 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 118.658 -1.217 . . . . 0.0 108.716 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -94.94 -34.84 12.24 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.431 ' HB3' ' HB2' ' A' ' 93' ' ' SER . 14.4 t -151.71 119.91 6.32 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 117.341 -1.743 . . . . 0.0 114.515 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.606 HG13 ' O ' ' A' ' 72' ' ' GLY . 15.2 mm -111.56 97.95 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 105.207 -2.145 . . . . 0.0 105.207 176.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.464 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -92.22 141.87 28.1 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -179.322 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.752 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.1 m95 -109.03 103.92 13.04 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.614 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.7 mt -79.05 114.5 18.04 Favored 'General case' 0 C--N 1.307 -1.274 0 C-N-CA 118.316 -1.353 . . . . 0.0 109.361 -177.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.785 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 27.1 ttt-85 -82.0 141.29 33.38 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 57.1 t0 62.31 -78.37 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.92 17.77 0.23 Allowed Glycine 0 N--CA 1.492 2.385 0 O-C-N 124.375 1.047 . . . . 0.0 110.831 178.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.401 ' O ' ' C ' ' A' ' 61' ' ' GLN . 27.7 m -141.68 145.64 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 C-N-CA 120.065 -0.654 . . . . 0.0 111.783 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -34.98 129.68 0.45 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.464 -0.789 . . . . 0.0 113.026 -179.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.785 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -149.27 142.7 25.27 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 122.61 1.195 . . . . 0.0 111.412 179.364 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.737 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.6 p -162.79 103.36 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 CA-C-N 112.531 -2.122 . . . . 0.0 107.638 178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.608 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 60.0 mm-40 -97.27 -138.94 0.28 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -177.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' ASN . 9.1 t -160.07 -168.44 2.21 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.935 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.469 ' O ' ' C ' ' A' ' 67' ' ' ARG . 1.7 m120 27.57 -107.75 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 115.474 -0.785 . . . . 0.0 113.1 -179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.469 ' C ' ' O ' ' A' ' 66' ' ' ASN . 55.9 mtt-85 -29.9 -41.23 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.573 0.702 . . . . 0.0 111.998 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.608 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -121.61 118.92 30.41 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 106.318 -1.734 . . . . 0.0 106.318 179.537 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 18.8 ttt85 -89.89 95.11 10.08 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.737 HD13 ' CG2' ' A' ' 63' ' ' VAL . 1.4 pt -80.02 108.47 13.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-N 113.855 -1.52 . . . . 0.0 110.951 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.602 ' C ' ' H ' ' A' ' 73' ' ' GLU . 1.6 p -104.52 141.7 35.92 Favored 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 116.358 -2.137 . . . . 0.0 106.518 177.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.606 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -46.42 8.45 0.01 OUTLIER Glycine 0 N--CA 1.49 2.289 0 CA-C-N 114.711 -1.131 . . . . 0.0 114.826 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.602 ' H ' ' C ' ' A' ' 71' ' ' THR . 13.0 pt-20 -144.19 -23.26 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 118.204 1.002 . . . . 0.0 110.998 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HA ' ' CZ2' ' A' ' 55' ' ' TRP . 32.0 tt0 -147.67 145.73 29.02 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 119.123 -1.031 . . . . 0.0 108.52 -179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.707 HG23 ' CD1' ' A' ' 55' ' ' TRP . 1.3 t -112.2 125.45 69.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.149 -1.421 . . . . 0.0 108.291 179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -117.12 112.22 20.58 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 118.324 -1.351 . . . . 0.0 111.828 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 77' ' ' VAL . 6.1 m -101.73 120.52 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 104.9 -2.259 . . . . 0.0 104.9 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 1.2 mmm180 -104.53 55.07 0.72 Allowed 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.808 -177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.42 ' O ' ' O ' ' A' ' 80' ' ' SER . 28.8 t0 -161.53 -36.42 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 118.075 -1.45 . . . . 0.0 110.929 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.647 ' C ' HG21 ' A' ' 107' ' ' VAL . 68.4 m 51.3 88.55 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.047 -1.835 . . . . 0.0 106.047 -177.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.645 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 8.8 pt -142.86 164.4 32.46 Favored Pre-proline 0 N--CA 1.49 1.534 0 N-CA-C 105.961 -1.866 . . . . 0.0 105.961 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.645 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 47.2 Cg_exo -32.07 -40.06 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 121.421 1.414 . . . . 0.0 112.172 -169.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.518 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -41.78 -34.8 0.69 Allowed 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.454 ' HB3' ' CG2' ' A' ' 105' ' ' VAL . 1.2 m-20 -94.48 38.26 1.1 Allowed 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -178.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 30.6 m -98.13 77.73 2.45 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 119.52 -0.872 . . . . 0.0 109.766 176.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.81 -166.77 39.96 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 118.613 -1.756 . . . . 0.0 111.368 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 4.3 mp -96.12 127.36 42.07 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 117.279 -1.768 . . . . 0.0 109.712 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 42' ' ' LEU . 37.3 m-85 -107.1 82.02 1.62 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.625 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -85.43 143.37 28.62 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 113.45 -1.704 . . . . 0.0 107.735 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.61 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -101.42 126.45 48.2 Favored 'General case' 0 C--N 1.299 -1.597 0 C-N-CA 117.968 -1.493 . . . . 0.0 109.551 -178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.614 ' CG2' HD11 ' A' ' 56' ' ' LEU . 36.7 t -109.87 114.83 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 C-N-CA 119.046 -1.061 . . . . 0.0 108.518 178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.773 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 80.2 p -97.96 146.28 25.64 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 33.8 m -135.03 120.02 18.62 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 118.798 -1.161 . . . . 0.0 108.527 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.453 ' OG ' ' HD2' ' A' ' 47' ' ' ARG . 2.9 p -135.92 122.34 14.14 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 124.887 1.367 . . . . 0.0 108.799 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -62.93 -2.8 3.93 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 C-N-CA 122.568 2.179 . . . . 0.0 112.846 -102.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 94' ' ' SER . 32.9 t -110.64 -26.04 9.64 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.749 -0.78 . . . . 0.0 111.813 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -134.64 156.15 22.31 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.521 -1.323 . . . . 0.0 111.112 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.8 m -129.78 160.96 31.82 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.42 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -145.98 150.21 35.6 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.335 -0.848 . . . . 0.0 108.856 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 86.3 m -127.28 139.77 52.67 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.241 -1.383 . . . . 0.0 114.006 -179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.724 ' CG2' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -113.43 169.29 9.06 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 112.717 -2.038 . . . . 0.0 107.476 179.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.723 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 36.9 m-85 -138.19 102.71 4.74 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.814 ' CE2' HG11 ' A' ' 29' ' ' VAL . 92.0 m-85 -89.13 103.15 15.79 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.69 110.61 13.99 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.575 HG22 ' CD2' ' A' ' 88' ' ' TYR . 0.9 OUTLIER -121.41 123.42 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 C-N-CA 118.058 -1.457 . . . . 0.0 107.811 -178.782 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -129.84 116.22 18.37 Favored 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 118.371 -1.332 . . . . 0.0 110.649 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.647 HG21 ' C ' ' A' ' 80' ' ' SER . 11.7 p -118.85 135.08 60.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 117.324 -1.75 . . . . 0.0 111.61 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.49 1.54 0 CA-C-N 114.014 -1.448 . . . . 0.0 110.107 179.467 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo . . . . . 0 N--CA 1.48 0.732 0 CA-C-O 121.113 0.38 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 t -114.8 128.2 56.16 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.967 179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.542 HD13 ' HB2' ' A' ' 46' ' ' LEU . 3.2 mp -130.12 86.9 52.91 Favored Pre-proline 0 N--CA 1.486 1.357 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -77.05 67.96 7.45 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.522 2.814 . . . . 0.0 110.212 -162.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.741 ' HB3' ' NE2' ' A' ' 19' ' ' GLN . 1.0 OUTLIER -79.67 -59.62 2.67 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.009 -1.478 . . . . 0.0 107.009 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.768 ' HG2' ' CG ' ' A' ' 23' ' ' TRP . 7.6 mp0 -142.62 127.75 18.58 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.321 178.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.03 -32.9 45.14 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.674 ' CB ' ' HD3' ' A' ' 22' ' ' PRO . 2.5 mt-30 -160.07 -55.49 0.01 OUTLIER Pre-proline 0 N--CA 1.489 1.523 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.016 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.674 ' HD3' ' CB ' ' A' ' 21' ' ' GLN . 37.9 Cg_endo -88.64 135.44 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.082 1.854 . . . . 0.0 112.629 174.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.768 ' CG ' ' HG2' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -115.64 -125.96 0.29 Allowed 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 105.989 -1.856 . . . . 0.0 105.989 178.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.5 -30.28 45.52 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 105.787 -2.925 . . . . 0.0 105.787 178.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' A' ' 28' ' ' GLU . 0.2 OUTLIER -154.83 132.34 6.38 Favored Pre-proline 0 N--CA 1.49 1.565 0 CA-C-N 113.641 -1.28 . . . . 0.0 108.135 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -39.23 -54.75 1.69 Allowed 'Trans proline' 0 C--N 1.305 -1.744 0 C-N-CA 122.459 2.106 . . . . 0.0 113.442 -150.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' CD1' ' A' ' 102' ' ' TYR . 29.6 m -131.92 40.54 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-O 122.787 1.279 . . . . 0.0 109.452 -179.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.797 ' C ' ' H ' ' A' ' 102' ' ' TYR . 0.9 OUTLIER -138.19 -160.71 1.09 Allowed 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 100.692 -3.818 . . . . 0.0 100.692 177.57 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.04 HG11 ' CE2' ' A' ' 103' ' ' PHE . 93.3 t -159.51 -86.0 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 115.18 1.548 . . . . 0.0 115.18 177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.54 ' N ' HG12 ' A' ' 29' ' ' VAL . 86.4 tt0 -142.58 124.86 15.5 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 117.36 -1.736 . . . . 0.0 115.241 -176.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m -95.0 110.07 22.03 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.071 -1.877 . . . . 0.0 106.587 177.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 53.6 tp -125.28 137.09 54.08 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 122.414 1.102 . . . . 0.0 113.94 -178.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -101.55 134.49 44.59 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.242 178.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -134.88 164.44 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 C-N-CA 119.62 -0.832 . . . . 0.0 111.292 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.576 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -124.84 175.54 2.94 Favored Pre-proline 0 N--CA 1.492 1.634 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 179.807 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.537 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.1 Cg_endo -70.93 91.85 0.63 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 121.976 1.784 . . . . 0.0 112.628 -158.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.55 40.02 0.37 Allowed Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.905 -1.141 . . . . 0.0 111.527 179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -118.62 171.46 8.17 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-O 122.637 1.208 . . . . 0.0 114.179 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.0 mt -111.13 122.43 47.85 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-N 113.012 -1.904 . . . . 0.0 108.04 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.648 ' CD2' HG11 ' A' ' 105' ' ' VAL . 0.1 OUTLIER -131.7 135.41 46.84 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 114.659 -1.155 . . . . 0.0 110.497 -179.023 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.638 ' N ' ' CD ' ' A' ' 41' ' ' GLN . 2.7 pm0 -131.92 142.19 49.57 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.659 -1.217 . . . . 0.0 112.38 179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.773 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -119.78 110.66 17.04 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 179.137 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -106.75 121.76 45.02 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 119.229 -0.988 . . . . 0.0 111.256 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.544 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -79.57 -141.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.037 -179.287 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.57 ' CZ ' HG23 ' A' ' 101' ' ' THR . 4.9 ptp180 -140.65 142.66 34.95 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.928 -0.768 . . . . 0.0 108.928 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.71 HD11 ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -140.46 135.61 32.16 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 116.979 -1.888 . . . . 0.0 112.663 -179.434 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.541 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.1 OUTLIER -137.15 -164.62 1.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.555 179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.3 26.87 0.27 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.541 ' H ' ' C ' ' A' ' 47' ' ' ARG . 40.0 m-20 -126.34 -71.81 0.68 Allowed 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.023 179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.0 m -63.57 134.25 28.72 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 C-N-CA 118.762 -1.175 . . . . 0.0 109.674 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.595 HE21 ' HD3' ' A' ' 95' ' ' PRO . 36.8 mt-30 -124.49 -24.19 4.28 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 113.38 -1.736 . . . . 0.0 108.525 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 10.2 p -118.46 130.59 56.04 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.603 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 49.3 mm -120.51 104.91 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 179.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.537 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -94.04 141.6 28.35 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 -179.111 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.0 m95 -106.07 111.66 24.37 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 118.109 -1.437 . . . . 0.0 109.432 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.581 HD11 ' CG2' ' A' ' 91' ' ' VAL . 38.0 mt -77.78 96.63 4.97 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 106.304 -1.739 . . . . 0.0 106.304 -179.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.574 ' CZ ' ' HB2' ' A' ' 58' ' ' ASP . 0.8 OUTLIER -79.61 145.98 32.78 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 -179.627 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.574 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 36.1 t70 62.56 -76.36 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 123.964 0.79 . . . . 0.0 109.242 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -165.03 20.13 0.12 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 28.1 m -146.89 161.35 9.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 120.207 -0.597 . . . . 0.0 110.306 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.542 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -55.37 130.55 42.94 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.312 -0.955 . . . . 0.0 111.979 -179.357 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HG ' ' H ' ' A' ' 63' ' ' VAL . 2.6 tp -161.16 -161.74 0.84 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 113.638 -1.619 . . . . 0.0 111.722 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.927 ' HB ' HD13 ' A' ' 70' ' ' ILE . 18.0 m -160.13 -147.07 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-N 110.062 -3.245 . . . . 0.0 109.435 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.863 ' N ' HG21 ' A' ' 70' ' ' ILE . 11.0 pt-20 -47.59 163.25 0.05 Allowed 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 123.441 1.591 . . . . 0.0 113.988 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 p -101.37 -88.65 0.37 Allowed 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 110.821 -2.899 . . . . 0.0 110.12 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -138.33 -18.74 1.12 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 114.819 -1.082 . . . . 0.0 108.679 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -143.43 45.49 1.52 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.16 0.981 . . . . 0.0 110.821 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 77' ' ' VAL . 53.0 p -136.81 149.41 47.74 Favored 'General case' 0 C--N 1.305 -1.349 0 C-N-CA 118.101 -1.439 . . . . 0.0 107.558 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.0 ttm180 -105.68 111.71 24.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.927 HD13 ' HB ' ' A' ' 63' ' ' VAL . 2.3 pt -92.82 119.03 39.78 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.438 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.638 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.6 OUTLIER -110.59 141.37 43.88 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 177.552 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.603 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.08 9.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.416 0 CA-C-N 115.119 -0.946 . . . . 0.0 114.04 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.71 ' HB2' HD11 ' A' ' 46' ' ' LEU . 7.6 pt-20 -142.09 -28.07 0.62 Allowed 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.704 -0.798 . . . . 0.0 110.705 177.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.52 144.78 38.05 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 118.835 -1.146 . . . . 0.0 110.63 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.773 HG11 HD11 ' A' ' 42' ' ' LEU . 2.1 t -106.24 114.33 45.24 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 178.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' HB3' ' CZ ' ' A' ' 78' ' ' ARG . 2.8 mt-10 -110.52 109.75 20.21 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 117.734 -1.587 . . . . 0.0 111.358 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.57 HG21 HD23 ' A' ' 40' ' ' LEU . 2.9 m -100.26 124.41 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 103.584 -2.747 . . . . 0.0 103.584 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' HD2' ' C ' ' A' ' 77' ' ' VAL . 3.1 mpt_? -115.03 49.93 1.02 Allowed 'General case' 0 N--CA 1.496 1.85 0 C-N-CA 117.69 -1.604 . . . . 0.0 112.08 -176.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.598 ' O ' ' OG ' ' A' ' 80' ' ' SER . 10.2 t0 -162.61 -30.72 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 118.386 -1.326 . . . . 0.0 110.855 -178.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' O ' ' A' ' 79' ' ' ASP . 26.9 p 57.73 91.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 104.755 -2.313 . . . . 0.0 104.755 -176.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.548 ' O ' ' N ' ' A' ' 83' ' ' ALA . 5.1 pt -122.1 157.9 56.76 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -177.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.448 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 26.6 Cg_exo -35.93 -32.28 0.1 OUTLIER 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.744 1.629 . . . . 0.0 110.973 -173.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -46.9 -40.73 14.67 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 115.287 -0.87 . . . . 0.0 112.755 179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HB3' ' CG1' ' A' ' 105' ' ' VAL . 17.5 m-20 -71.53 24.32 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 123.72 0.638 . . . . 0.0 112.671 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.462 ' H ' ' C ' ' A' ' 83' ' ' ALA . 40.0 t -98.21 75.4 2.28 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 176.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 170.76 -164.39 37.57 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.797 -179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.421 ' O ' ' N ' ' A' ' 58' ' ' ASP . 0.6 OUTLIER -96.05 124.42 40.05 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 118.055 -1.458 . . . . 0.0 110.198 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.565 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 43.2 m-85 -109.71 94.19 4.89 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 179.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -106.84 167.28 9.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 114.513 -1.221 . . . . 0.0 109.263 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.81 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 9.0 t -130.59 137.9 49.87 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.829 -1.078 . . . . 0.0 110.018 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' HD11 ' A' ' 56' ' ' LEU . 5.0 t -120.02 119.62 60.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.544 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 39.0 p -101.61 127.7 48.22 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 63.3 m -126.94 139.12 53.28 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 119.24 -0.984 . . . . 0.0 112.458 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 96' ' ' SER . 24.4 p -129.98 155.25 80.92 Favored Pre-proline 0 N--CA 1.487 1.384 0 CA-C-N 112.43 -2.168 . . . . 0.0 106.99 179.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.595 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.7 Cg_exo -54.29 0.3 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.326 2.017 . . . . 0.0 112.153 -173.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.541 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.1 p -117.79 -39.46 3.12 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 119.277 -0.969 . . . . 0.0 110.876 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.3 -169.54 23.73 Favored Glycine 0 N--CA 1.495 2.569 0 C-N-CA 118.1 -2.0 . . . . 0.0 112.806 -179.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 68.2 m -139.52 151.62 46.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.798 -0.761 . . . . 0.0 111.507 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -134.57 148.44 50.47 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.536 HG22 ' CE1' ' A' ' 102' ' ' TYR . 90.2 m -132.02 149.54 52.39 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 117.725 -1.59 . . . . 0.0 113.865 -179.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.66 ' HB ' ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -133.26 152.23 51.93 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 113.17 -1.832 . . . . 0.0 107.921 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.797 ' H ' ' C ' ' A' ' 28' ' ' GLU . 7.1 m-85 -130.83 125.91 34.89 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 117.452 2.39 . . . . 0.0 117.452 -178.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 1.04 ' CE2' HG11 ' A' ' 29' ' ' VAL . 13.1 m-85 -109.76 108.0 18.19 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.25 124.38 28.32 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.648 HG11 ' CD2' ' A' ' 40' ' ' LEU . 99.4 t -122.3 128.83 75.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 117.166 -1.814 . . . . 0.0 110.279 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.1 p-10 -133.86 114.3 13.18 Favored 'General case' 0 C--N 1.303 -1.422 0 C-N-CA 118.141 -1.424 . . . . 0.0 112.42 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.52 HG13 ' O ' ' A' ' 107' ' ' VAL . 10.1 p -101.77 121.99 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 C-N-CA 118.428 -1.309 . . . . 0.0 110.694 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.304 -1.407 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.086 179.399 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.483 0.855 0 CA-C-O 120.952 0.313 . . . . 0.0 111.992 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 15' ' ' THR . 2.7 t -112.39 101.87 10.04 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.925 -0.71 . . . . 0.0 109.14 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.555 ' N ' HD12 ' A' ' 16' ' ' LEU . 4.2 mp -126.84 100.76 27.39 Favored Pre-proline 0 N--CA 1.488 1.427 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HA ' ' HE ' ' A' ' 45' ' ' ARG . 10.3 Cg_endo -76.3 -35.54 2.22 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.756 2.304 . . . . 0.0 111.552 -177.378 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -111.88 44.51 1.38 Allowed 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.934 -1.107 . . . . 0.0 111.732 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -91.88 52.05 1.94 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 105.852 -1.907 . . . . 0.0 105.852 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.706 ' HB1' ' O ' ' A' ' 43' ' ' ARG . . . -123.48 -140.48 0.31 Allowed 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.779 -178.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.505 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -79.61 -173.39 0.4 Allowed Pre-proline 0 N--CA 1.489 1.509 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.505 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 3.0 Cg_exo -67.46 34.24 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.794 1.663 . . . . 0.0 112.336 174.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.609 ' HE1' ' HB1' ' A' ' 20' ' ' ALA . 35.3 p-90 -113.71 152.79 30.01 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 118.789 -1.164 . . . . 0.0 110.978 179.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -160.11 39.97 0.46 Allowed Glycine 0 N--CA 1.484 1.864 0 N-CA-C 106.208 -2.757 . . . . 0.0 106.208 178.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 25' ' ' VAL . 10.4 p -79.87 130.91 65.33 Favored Pre-proline 0 N--CA 1.494 1.771 0 C-N-CA 118.915 -1.114 . . . . 0.0 112.078 -178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -84.6 46.21 1.86 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 123.131 2.554 . . . . 0.0 111.413 171.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.2 t -135.54 -59.31 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.655 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 65.1 mt-10 -136.57 -97.22 0.22 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 178.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.0 HG21 ' HB ' ' A' ' 101' ' ' THR . 0.9 OUTLIER -164.1 -71.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.227 176.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.869 ' N ' HG12 ' A' ' 29' ' ' VAL . 41.4 tt0 -146.88 104.13 3.68 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 113.264 -1.789 . . . . 0.0 112.578 -178.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 104' ' ' SER . 2.9 m -91.83 104.77 17.17 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.03 -1.441 . . . . 0.0 108.786 177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 59.9 tp -133.67 141.59 47.66 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 121.881 0.848 . . . . 0.0 112.758 -179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.725 ' H ' HD23 ' A' ' 33' ' ' LEU . 1.8 pt? -110.74 147.22 34.87 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.116 178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.427 HG12 ' N ' ' A' ' 35' ' ' HIS . 9.3 t -134.75 160.89 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 C-N-CA 119.444 -0.902 . . . . 0.0 111.181 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.427 ' N ' HG12 ' A' ' 34' ' ' VAL . 0.1 OUTLIER -79.98 174.26 6.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 119.293 -0.963 . . . . 0.0 111.467 -179.228 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 10.4 Cg_endo -79.49 108.5 2.32 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.693 2.262 . . . . 0.0 111.784 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 103.96 36.57 3.15 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.396 -1.081 . . . . 0.0 110.396 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.685 ' H ' ' HB3' ' A' ' 80' ' ' SER . 2.8 m-20 -123.52 -172.88 2.61 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.46 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -111.9 121.93 46.37 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.107 -1.406 . . . . 0.0 110.022 179.889 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.512 ' HB3' HG23 ' A' ' 77' ' ' VAL . 3.1 tp -119.07 132.95 56.06 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 114.241 -1.345 . . . . 0.0 109.82 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.599 ' NE2' ' N ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.92 140.29 50.17 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 118.899 -1.12 . . . . 0.0 112.612 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.778 HD12 ' CZ3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.82 104.24 8.23 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.401 179.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.706 ' O ' ' HB1' ' A' ' 20' ' ' ALA . 8.4 tpp85 -93.57 123.88 37.19 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.87 178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.475 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 4.1 t -92.01 -144.0 0.2 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.469 -1.696 . . . . 0.0 112.371 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.53 ' HE ' ' HA ' ' A' ' 17' ' ' PRO . 1.9 ptm180 -129.1 -175.03 3.43 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.829 -178.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.404 ' HA ' HG21 ' A' ' 50' ' ' VAL . 0.5 OUTLIER -157.61 151.06 23.71 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.751 -1.18 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 49' ' ' ASP . 4.8 ttt180 -135.47 176.4 8.71 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 117.116 -1.834 . . . . 0.0 111.276 -179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.47 ' C ' ' O ' ' A' ' 47' ' ' ARG . 41.2 m-20 -16.6 -48.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 125.294 1.621 . . . . 0.0 113.716 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 47' ' ' ARG . 38.3 t0 -152.39 48.55 0.76 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 117.888 -1.525 . . . . 0.0 112.96 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.488 ' CG1' ' H ' ' A' ' 47' ' ' ARG . 9.7 m -66.75 127.32 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 C-N-CA 118.542 -1.263 . . . . 0.0 108.211 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 0.2 OUTLIER -130.69 -22.97 2.62 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 113.84 -1.527 . . . . 0.0 109.336 -179.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 t -111.84 94.25 4.86 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.279 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.599 HG21 ' HA ' ' A' ' 73' ' ' GLU . 3.9 mp -113.1 94.1 2.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.844 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 27.7 m-20 -91.3 139.49 30.68 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 113.786 -1.552 . . . . 0.0 108.634 -179.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.778 ' CZ3' HD12 ' A' ' 42' ' ' LEU . 88.3 m95 -105.76 105.59 15.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.765 -1.939 . . . . 0.0 105.765 178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.532 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 1.3 mt -79.18 110.54 14.54 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 117.628 -1.629 . . . . 0.0 107.772 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.741 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 1.6 ttm-85 -79.23 143.68 35.09 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 -179.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 56.2 t0 63.16 -78.67 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 124.134 0.896 . . . . 0.0 108.584 179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -159.46 17.77 0.24 Allowed Glycine 0 N--CA 1.491 2.332 0 O-C-N 124.354 1.034 . . . . 0.0 110.7 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 14.4 p -143.12 153.48 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 C-N-CA 120.136 -0.626 . . . . 0.0 110.203 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.532 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -41.2 142.11 0.58 Allowed 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.741 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.01 131.94 6.21 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.384 1.088 . . . . 0.0 111.529 179.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.752 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p -162.06 104.85 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-N 112.91 -1.95 . . . . 0.0 107.497 177.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.636 ' HB2' ' CG2' ' A' ' 68' ' ' THR . 35.6 mt-10 -91.35 -134.0 0.13 Allowed 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 118.967 -1.093 . . . . 0.0 112.759 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.423 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 12.6 p 161.2 77.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 15.9 p30 178.51 -111.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.683 -1.144 . . . . 0.0 107.976 -178.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' N ' ' OD1' ' A' ' 66' ' ' ASN . 56.5 mtt180 -55.78 -25.69 42.31 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.636 ' CG2' ' HB2' ' A' ' 64' ' ' GLU . 15.1 t -118.19 147.09 43.71 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 118.909 -1.116 . . . . 0.0 108.114 178.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 mmt-85 -111.85 101.15 9.5 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 102.482 -3.155 . . . . 0.0 102.482 178.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.752 HG21 ' HA ' ' A' ' 63' ' ' VAL . 1.1 pp -86.41 87.21 2.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 C-N-CA 118.595 -1.242 . . . . 0.0 108.962 -179.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.611 ' O ' ' C ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -79.9 135.77 36.51 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 105.731 -1.951 . . . . 0.0 105.731 -178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.611 ' C ' ' O ' ' A' ' 71' ' ' THR . . . -16.7 -71.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.916 -1.135 . . . . 0.0 112.462 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.599 ' HA ' HG21 ' A' ' 53' ' ' ILE . 11.1 pt-20 -107.93 10.1 28.52 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' HB ' ' A' ' 71' ' ' THR . 74.4 tt0 -136.62 96.39 3.33 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 118.455 -1.298 . . . . 0.0 108.251 -179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.714 HG23 ' NE1' ' A' ' 55' ' ' TRP . 4.7 t -95.2 121.83 46.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 117.693 -1.603 . . . . 0.0 108.931 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -121.31 119.65 32.81 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 114.519 -1.219 . . . . 0.0 109.465 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.52 HG12 ' CB ' ' A' ' 68' ' ' THR . 4.1 m -107.04 112.55 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 N-CA-C 104.796 -2.298 . . . . 0.0 104.796 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.493 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -96.51 63.8 2.13 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 -177.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.433 ' O ' ' O ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -161.01 -41.82 0.04 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.473 -177.781 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.685 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 47.1 t 44.05 86.73 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.6 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 1.7 pt -138.9 179.45 1.3 Allowed Pre-proline 0 N--CA 1.493 1.675 0 CA-C-N 113.79 -1.55 . . . . 0.0 107.69 -178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.6 Cg_exo -27.9 -38.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.334 2.023 . . . . 0.0 114.268 165.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -54.55 -25.46 26.07 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.542 -0.863 . . . . 0.0 112.953 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -97.62 34.14 1.91 Allowed 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.552 -179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 56.7 p -98.47 76.98 2.3 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 119.539 -0.865 . . . . 0.0 110.644 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 166.92 -169.83 41.04 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.277 -1.916 . . . . 0.0 111.816 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.49 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 10.0 mp -96.91 127.28 42.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 117.202 -1.799 . . . . 0.0 110.46 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.635 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 17.1 m-85 -104.21 78.86 1.54 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -87.03 134.52 33.48 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -178.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.802 ' SG ' ' OG1' ' A' ' 101' ' ' THR . 1.7 p -105.34 135.38 46.82 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 116.112 -2.235 . . . . 0.0 110.139 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.495 HG22 HG23 ' A' ' 100' ' ' THR . 9.3 t -106.11 106.81 21.28 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 125.331 1.645 . . . . 0.0 107.679 178.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 53' ' ' ILE . 35.3 p -92.75 135.89 33.72 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.417 -2.438 . . . . 0.0 104.417 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -140.61 137.7 33.84 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 117.756 -1.578 . . . . 0.0 111.256 -178.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 96' ' ' SER . 28.1 p -134.48 155.2 79.89 Favored Pre-proline 0 N--CA 1.487 1.385 0 O-C-N 124.975 1.422 . . . . 0.0 108.145 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -46.79 -4.01 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.81 2.34 . . . . 0.0 113.081 179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 94' ' ' SER . 72.7 m -109.95 -43.5 3.98 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.381 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.33 -174.11 29.72 Favored Glycine 0 N--CA 1.496 2.635 0 C-N-CA 118.113 -1.994 . . . . 0.0 113.184 -179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 49.6 m -132.92 145.15 50.66 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 114.947 -0.626 . . . . 0.0 110.012 179.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -140.03 137.33 34.53 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.495 HG23 HG22 ' A' ' 91' ' ' VAL . 17.9 m -127.62 142.11 51.44 Favored 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 117.693 -1.603 . . . . 0.0 113.573 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.0 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.5 OUTLIER -119.16 163.49 16.98 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 112.83 -1.986 . . . . 0.0 109.991 179.859 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.73 ' C ' ' HB ' ' A' ' 29' ' ' VAL . 43.6 m-85 -126.42 93.08 3.7 Favored 'General case' 0 N--CA 1.499 1.987 0 C-N-CA 118.426 -1.31 . . . . 0.0 114.404 -179.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.7 ' CE1' HG11 ' A' ' 29' ' ' VAL . 76.7 m-85 -84.59 101.31 12.02 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 178.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.52 114.46 17.45 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 117.01 -1.876 . . . . 0.0 106.529 179.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -119.43 128.91 75.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.384 -1.326 . . . . 0.0 108.388 -179.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 11.9 p-10 -134.53 122.38 22.33 Favored 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 114.143 -1.39 . . . . 0.0 112.902 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 82' ' ' PRO . 14.5 p -80.37 139.81 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 118.213 -1.395 . . . . 0.0 107.795 177.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 22.5 t . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 122.311 1.053 . . . . 0.0 111.658 -178.46 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 N--CA 1.482 0.827 0 N-CA-C 110.938 -0.447 . . . . 0.0 110.938 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 47' ' ' ARG . 73.1 p -122.53 168.66 11.87 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.155 -1.018 . . . . 0.0 111.123 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' N ' HD12 ' A' ' 16' ' ' LEU . 5.6 mp -128.58 73.48 80.68 Favored Pre-proline 0 N--CA 1.488 1.47 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.522 ' O ' ' HD3' ' A' ' 45' ' ' ARG . 12.0 Cg_exo -50.82 -28.78 24.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.478 176.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.472 ' C ' HH11 ' A' ' 45' ' ' ARG . 8.8 pt-20 -133.69 90.56 2.72 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.094 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.681 ' N ' HH11 ' A' ' 45' ' ' ARG . 1.1 tm0? -105.35 50.59 0.78 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 122.182 0.991 . . . . 0.0 109.485 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.52 ' N ' ' NH1' ' A' ' 45' ' ' ARG . . . -160.56 -120.43 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.066 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.584 ' HB2' ' CZ3' ' A' ' 23' ' ' TRP . 65.6 mt-30 -116.17 162.82 24.14 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.418 ' HD2' ' HB3' ' A' ' 21' ' ' GLN . 9.5 Cg_endo -75.67 69.32 6.08 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.005 1.804 . . . . 0.0 111.829 -160.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.805 ' O ' HG22 ' A' ' 29' ' ' VAL . 1.1 p90 -129.0 58.73 1.59 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.922 -1.111 . . . . 0.0 112.209 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.99 87.27 0.54 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 108.47 -1.852 . . . . 0.0 108.47 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 28' ' ' GLU . 31.6 m -127.77 149.03 69.41 Favored Pre-proline 0 N--CA 1.492 1.625 0 C-N-CA 119.735 -0.786 . . . . 0.0 111.59 -178.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.411 ' HD2' ' HB ' ' A' ' 25' ' ' VAL . 14.9 Cg_exo -45.45 -39.11 16.61 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.917 2.412 . . . . 0.0 113.696 -154.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 ' C ' ' HB2' ' A' ' 102' ' ' TYR . 30.9 m -143.16 35.28 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 CA-C-O 122.313 1.054 . . . . 0.0 108.914 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.753 ' O ' HG23 ' A' ' 29' ' ' VAL . 79.4 mt-10 -151.23 163.29 39.21 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 113.056 -1.884 . . . . 0.0 107.633 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.098 HG21 ' HB ' ' A' ' 101' ' ' THR . 2.2 t -162.32 -71.97 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 CA-C-N 113.618 -1.628 . . . . 0.0 111.127 177.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.772 ' HB2' ' CD2' ' A' ' 103' ' ' PHE . 6.6 mt-10 -128.59 110.37 12.19 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.753 -1.567 . . . . 0.0 113.719 -178.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.516 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 68.7 p -96.14 108.71 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.35 178.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -117.17 133.44 55.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.239 -1.346 . . . . 0.0 112.118 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -112.26 124.5 52.59 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.474 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.48 172.74 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 C-N-CA 118.998 -1.081 . . . . 0.0 112.935 -178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.574 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.59 168.22 18.86 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.597 -0.841 . . . . 0.0 109.565 179.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.473 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 3.0 Cg_exo -56.88 105.07 0.16 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.401 2.067 . . . . 0.0 112.058 -161.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 107.36 46.91 1.03 Allowed Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.963 -1.113 . . . . 0.0 112.093 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.654 ' H ' ' HB2' ' A' ' 80' ' ' SER . 76.0 m-20 -129.8 -173.42 3.02 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 122.686 1.232 . . . . 0.0 114.058 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 39' ' ' LEU . 0.2 OUTLIER -113.01 117.26 31.54 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 113.16 -1.837 . . . . 0.0 110.612 179.624 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.642 HD23 HG21 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -114.32 132.26 56.24 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 114.191 -1.368 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.577 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -123.13 130.61 53.0 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.763 -1.175 . . . . 0.0 112.688 -179.127 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.771 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -129.03 113.95 15.8 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.475 ' HG2' ' HB2' ' A' ' 20' ' ' ALA . 12.9 ttt180 -108.5 120.92 43.82 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.776 -1.169 . . . . 0.0 112.42 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.759 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -80.84 -149.15 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 113.15 -1.841 . . . . 0.0 112.207 -179.5 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.681 HH11 ' N ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -148.48 -168.86 3.2 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-N 114.112 -1.403 . . . . 0.0 107.822 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.522 ' HA ' ' CG1' ' A' ' 50' ' ' VAL . 0.2 OUTLIER -152.78 148.27 27.03 Favored 'General case' 0 N--CA 1.496 1.852 0 C-N-CA 118.53 -1.268 . . . . 0.0 111.512 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.576 HH21 ' N ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -90.15 -93.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 117.13 -1.828 . . . . 0.0 109.683 -178.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.452 ' H ' ' HB3' ' A' ' 47' ' ' ARG . 3.5 t70 -97.31 -43.94 7.11 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 118.693 -1.203 . . . . 0.0 108.025 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.64 ' H ' ' HB2' ' A' ' 94' ' ' SER . 5.6 t70 -160.48 54.22 0.32 Allowed 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.747 -1.181 . . . . 0.0 111.747 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.618 ' C ' ' O ' ' A' ' 49' ' ' ASP . 3.3 m -17.02 122.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-O 121.889 0.852 . . . . 0.0 111.807 178.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.562 ' HG3' ' HA ' ' A' ' 94' ' ' SER . 16.6 mt-30 -111.1 -34.62 6.14 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.812 -1.922 . . . . 0.0 105.812 -179.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.439 ' HB2' ' OG ' ' A' ' 93' ' ' SER . 58.1 m -130.36 128.38 41.31 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 118.317 -1.353 . . . . 0.0 109.363 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 72' ' ' GLY . 16.7 mm -119.38 104.19 15.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 106.04 -1.837 . . . . 0.0 106.04 178.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -97.29 127.06 42.91 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 114.075 -1.42 . . . . 0.0 109.989 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.813 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 92.4 m95 -105.9 101.7 11.18 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 178.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.677 HD11 ' CG2' ' A' ' 91' ' ' VAL . 2.2 mt -78.67 104.99 9.65 Favored 'General case' 0 C--N 1.306 -1.294 0 C-N-CA 118.379 -1.328 . . . . 0.0 108.074 -177.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.576 ' CB ' HD22 ' A' ' 62' ' ' LEU . 1.8 tmt_? -79.14 143.24 35.66 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.529 ' HA ' ' HA3' ' A' ' 86' ' ' GLY . 9.9 t70 63.76 -78.6 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.67 17.51 0.2 Allowed Glycine 0 N--CA 1.49 2.278 0 O-C-N 124.416 1.072 . . . . 0.0 110.607 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 55.9 t -141.45 154.22 20.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.159 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.56 ' HA ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -47.22 139.41 6.19 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.251 1.024 . . . . 0.0 112.756 -179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.576 HD22 ' CB ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -160.51 173.93 14.82 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 113.551 -1.658 . . . . 0.0 111.141 178.847 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.765 ' HB ' HD13 ' A' ' 70' ' ' ILE . 8.2 m -152.63 -153.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-N 111.192 -2.731 . . . . 0.0 109.22 178.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.596 ' H ' HG21 ' A' ' 70' ' ' ILE . 11.2 pt-20 -42.33 140.35 1.21 Allowed 'General case' 0 N--CA 1.484 1.272 0 CA-C-O 121.835 0.826 . . . . 0.0 111.896 -179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.524 ' O ' ' CB ' ' A' ' 66' ' ' ASN . 23.6 t -139.06 78.56 1.68 Allowed 'General case' 0 N--CA 1.491 1.583 0 CA-C-N 114.032 -1.44 . . . . 0.0 107.212 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.524 ' CB ' ' O ' ' A' ' 65' ' ' SER . 14.1 t-20 80.17 130.22 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -178.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' C ' ' O ' ' A' ' 66' ' ' ASN . 27.2 mtm-85 20.76 54.18 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -179.132 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 64' ' ' GLU . 4.0 m -120.09 140.54 50.89 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.6 ttm-85 -110.09 92.91 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.495 -178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.765 HD13 ' HB ' ' A' ' 63' ' ' VAL . 11.0 pt -79.93 116.55 24.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 C-N-CA 118.406 -1.318 . . . . 0.0 108.21 178.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.845 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.0 p -112.89 87.11 2.51 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 105.153 -2.165 . . . . 0.0 105.153 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 53' ' ' ILE . . . -15.82 47.97 0.0 OUTLIER Glycine 0 N--CA 1.509 3.523 0 N-CA-C 117.684 1.834 . . . . 0.0 117.684 -177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.845 ' N ' ' O ' ' A' ' 71' ' ' THR . 9.0 tt0 -164.04 -43.7 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 123.675 1.702 . . . . 0.0 107.097 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB2' ' HG3' ' A' ' 43' ' ' ARG . 1.3 tm-20 -142.0 155.23 45.43 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 112.01 -2.359 . . . . 0.0 107.315 -178.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.666 HG23 ' NE1' ' A' ' 55' ' ' TRP . 8.7 t -121.86 125.58 73.43 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.686 0 C-N-CA 118.214 -1.394 . . . . 0.0 110.438 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -106.75 105.74 15.92 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 114.474 -1.239 . . . . 0.0 108.101 177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.642 HG21 HD23 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -92.15 100.7 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 N-CA-C 104.529 -2.396 . . . . 0.0 104.529 -179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.719 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -94.56 57.2 2.2 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.554 1.168 . . . . 0.0 108.047 -177.574 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' OD1' HG23 ' A' ' 81' ' ' ILE . 6.7 t70 -162.06 -36.15 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.466 -1.243 . . . . 0.0 110.045 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.654 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 1.9 m 43.4 84.01 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -178.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.654 ' H ' HD12 ' A' ' 81' ' ' ILE . 0.5 OUTLIER -125.43 173.42 4.96 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 -179.26 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.532 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -34.05 -28.0 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.164 1.909 . . . . 0.0 112.625 -178.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.562 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -50.6 -45.86 57.63 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.684 179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.641 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 59.2 m-20 -68.36 24.5 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.819 0.699 . . . . 0.0 112.202 -179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.512 ' H ' ' C ' ' A' ' 83' ' ' ALA . 82.6 p -98.12 68.87 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 C-N-CA 120.165 -0.614 . . . . 0.0 111.54 178.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.529 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 160.21 -159.49 30.82 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 118.051 -2.023 . . . . 0.0 111.625 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.472 ' N ' HD12 ' A' ' 87' ' ' LEU . 7.3 mp -98.93 130.39 45.3 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 117.252 -1.779 . . . . 0.0 110.977 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.68 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 14.9 m-85 -102.34 83.79 2.37 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 178.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.402 ' HB3' HD12 ' A' ' 56' ' ' LEU . . . -85.94 123.16 30.96 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.813 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 50.3 t -99.59 127.58 45.68 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.203 -1.399 . . . . 0.0 111.0 -177.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.677 ' CG2' HD11 ' A' ' 56' ' ' LEU . 2.0 t -105.77 119.5 55.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 125.387 1.68 . . . . 0.0 108.925 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.759 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 67.1 p -105.83 116.31 31.73 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.439 ' OG ' ' HB2' ' A' ' 52' ' ' SER . 89.1 p -118.11 121.65 41.09 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.361 -0.936 . . . . 0.0 109.011 -179.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.64 ' HB2' ' H ' ' A' ' 49' ' ' ASP . 1.6 p -131.8 162.88 53.71 Favored Pre-proline 0 N--CA 1.487 1.376 0 O-C-N 125.015 1.447 . . . . 0.0 108.9 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.486 ' HD3' ' CG ' ' A' ' 51' ' ' GLN . 3.2 Cg_exo -58.16 -3.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.2 1.933 . . . . 0.0 110.595 -167.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 94' ' ' SER . 95.1 p -110.07 -41.43 4.45 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.605 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.536 ' C ' HH21 ' A' ' 47' ' ' ARG . . . -160.48 -176.05 32.16 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 117.637 -2.22 . . . . 0.0 114.049 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.576 ' N ' HH21 ' A' ' 47' ' ' ARG . 55.4 p -135.64 131.09 35.33 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.452 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.535 ' HB3' ' NH1' ' A' ' 47' ' ' ARG . 14.6 t70 -139.04 156.87 46.86 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.6 m -134.58 141.58 46.69 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 118.13 -1.428 . . . . 0.0 112.407 -179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 1.098 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -119.73 145.03 46.92 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 113.585 -1.643 . . . . 0.0 109.358 -179.456 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.717 ' O ' ' N ' ' A' ' 29' ' ' VAL . 33.2 m-85 -110.73 108.02 17.76 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 -177.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.772 ' CD2' ' HB2' ' A' ' 30' ' ' GLU . 2.6 m-85 -94.21 104.31 16.32 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.551 -1.204 . . . . 0.0 108.265 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.516 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 14.2 p -79.62 119.46 22.61 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 116.359 -2.136 . . . . 0.0 105.426 179.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.68 ' CG2' ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -124.56 126.19 71.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.641 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -131.5 127.84 38.11 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.72 -1.192 . . . . 0.0 112.26 -179.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.512 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 9.2 p -114.85 126.48 72.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.975 178.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.1 t . . . . . 0 N--CA 1.489 1.497 0 CA-C-N 114.716 -1.129 . . . . 0.0 109.864 179.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo . . . . . 0 N--CA 1.481 0.791 0 N-CA-C 110.686 -0.544 . . . . 0.0 110.686 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 47.0 p -136.76 149.36 47.78 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.529 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 35.9 mt -109.52 97.38 27.03 Favored Pre-proline 0 C--N 1.305 -1.362 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.007 -179.477 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HG2' ' NH1' ' A' ' 43' ' ' ARG . 2.8 Cg_exo -50.98 -13.92 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 125.09 2.1 . . . . 0.0 113.124 -88.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 18.5 mp0 -87.3 -140.69 0.1 Allowed 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 119.478 -0.889 . . . . 0.0 108.882 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.67 ' NE2' ' C ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -151.07 -106.97 0.06 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 118.655 -1.218 . . . . 0.0 112.018 -178.393 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -150.58 -86.4 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.327 -0.949 . . . . 0.0 112.137 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.622 ' N ' ' CD ' ' A' ' 22' ' ' PRO . 85.9 mt-30 -79.33 -31.51 0.7 Allowed Pre-proline 0 N--CA 1.492 1.646 0 C-N-CA 118.938 -1.105 . . . . 0.0 113.2 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 21' ' ' GLN . 4.8 Cg_exo -70.09 20.48 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.516 1.477 . . . . 0.0 112.014 168.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.467 ' H ' ' C ' ' A' ' 21' ' ' GLN . 48.7 t-105 -143.06 -51.64 0.36 Allowed 'General case' 0 N--CA 1.492 1.641 0 C-N-CA 119.472 -0.891 . . . . 0.0 110.829 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.547 ' HA2' HG22 ' A' ' 101' ' ' THR . . . -79.71 142.14 24.31 Favored Glycine 0 N--CA 1.486 2.009 0 C-N-CA 118.763 -1.684 . . . . 0.0 110.228 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.562 HG23 ' H ' ' A' ' 28' ' ' GLU . 5.9 m -107.76 164.75 14.1 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.775 -0.77 . . . . 0.0 110.922 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -67.78 7.54 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.551 2.167 . . . . 0.0 111.362 169.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.463 ' H ' ' C ' ' A' ' 25' ' ' VAL . 57.6 t -114.73 -77.3 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.11 179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.724 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 30.6 mt-10 -156.1 -107.86 0.03 OUTLIER 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.891 HG11 ' CE2' ' A' ' 103' ' ' PHE . 37.3 t -161.89 -73.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 113.525 -1.67 . . . . 0.0 110.415 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' H ' ' HA ' ' A' ' 103' ' ' PHE . 84.4 tt0 -136.83 117.6 14.06 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 113.284 -1.78 . . . . 0.0 112.541 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.503 ' HA ' ' OG ' ' A' ' 104' ' ' SER . 28.3 p -103.06 103.19 13.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.312 -1.313 . . . . 0.0 107.499 177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 50.5 tp -127.38 150.74 49.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.489 1.292 . . . . 0.0 114.489 -178.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.474 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -107.45 139.42 41.98 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.398 -1.274 . . . . 0.0 108.919 178.859 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG11 ' OG ' ' A' ' 80' ' ' SER . 0.0 OUTLIER -130.48 163.39 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.279 -179.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 53.2 m170 -104.35 158.48 31.86 Favored Pre-proline 0 N--CA 1.493 1.678 0 C-N-CA 118.968 -1.093 . . . . 0.0 112.47 -178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -52.47 96.3 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.806 2.337 . . . . 0.0 111.551 175.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.77 53.78 1.02 Allowed Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.647 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' H ' ' HB2' ' A' ' 80' ' ' SER . 15.9 t70 -132.09 177.47 7.54 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 119.169 -1.013 . . . . 0.0 112.573 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.531 HD23 ' C ' ' A' ' 39' ' ' LEU . 6.2 tt -113.55 111.53 22.04 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.403 -1.272 . . . . 0.0 110.154 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.595 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.7 OUTLIER -117.83 134.96 54.41 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.887 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.595 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -123.5 133.27 54.04 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 118.81 -1.156 . . . . 0.0 112.906 -179.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.613 HD11 HG11 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -118.79 117.3 28.52 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 178.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.547 ' HD3' ' HB2' ' A' ' 74' ' ' GLU . 1.2 tpp180 -104.7 117.3 33.74 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.058 0.932 . . . . 0.0 111.807 -178.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.605 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 9.7 t -79.64 -153.08 0.08 Allowed 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.526 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.675 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -147.85 116.31 6.62 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.277 -0.969 . . . . 0.0 111.131 -179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.653 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -133.45 164.97 25.94 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 118.335 -1.346 . . . . 0.0 111.79 179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.45 HH11 ' HB2' ' A' ' 47' ' ' ARG . 36.0 ttm180 -157.18 -126.9 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 118.609 -1.236 . . . . 0.0 111.433 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -97.13 24.52 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.82 -0.752 . . . . 0.0 109.896 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -125.14 -75.33 0.6 Allowed 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.559 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 31.9 m -66.01 139.46 21.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 CA-C-O 122.084 0.945 . . . . 0.0 109.227 179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -125.58 -24.94 3.78 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-N 113.596 -1.638 . . . . 0.0 109.031 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.578 ' C ' HD12 ' A' ' 53' ' ' ILE . 44.0 t -115.14 124.55 51.77 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.791 -1.164 . . . . 0.0 108.794 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.6 HG12 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -109.25 111.17 34.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.5 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.39 131.52 47.44 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.81 ' CD1' HG23 ' A' ' 75' ' ' VAL . 96.7 m95 -100.94 111.09 23.22 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.285 -1.366 . . . . 0.0 108.546 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.579 HD11 HG21 ' A' ' 91' ' ' VAL . 37.4 mt -78.64 104.5 9.29 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 -178.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.498 ' CD ' HD22 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -79.76 124.51 28.67 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -179.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 51.6 t0 70.7 -67.59 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 124.039 0.837 . . . . 0.0 109.105 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -166.96 15.06 0.07 OUTLIER Glycine 0 N--CA 1.489 2.229 0 O-C-N 124.29 0.994 . . . . 0.0 111.372 178.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 55.3 t -136.74 142.75 37.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 C-N-CA 119.331 -0.948 . . . . 0.0 111.24 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.576 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -45.0 130.15 7.45 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.527 -179.585 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 HD22 ' CD ' ' A' ' 57' ' ' ARG . 0.3 OUTLIER -161.01 -167.08 1.72 Allowed 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 123.646 1.689 . . . . 0.0 112.356 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 ' HB ' HD13 ' A' ' 70' ' ' ILE . 34.8 m -160.28 -140.74 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-N 109.962 -3.29 . . . . 0.0 109.01 177.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.774 ' N ' HG21 ' A' ' 70' ' ' ILE . 10.8 pt-20 -43.67 153.05 0.13 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 122.65 1.214 . . . . 0.0 113.916 -179.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 p -105.46 -77.25 0.59 Allowed 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 112.276 -2.238 . . . . 0.0 109.597 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -123.66 -50.7 1.84 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.315 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.502 ' HB2' ' HB3' ' A' ' 79' ' ' ASP . 13.8 mmm-85 -134.28 73.13 1.48 Allowed 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 121.982 0.896 . . . . 0.0 109.076 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.718 ' HB ' ' HA ' ' A' ' 77' ' ' VAL . 5.8 p -132.95 158.15 43.37 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 117.704 -1.598 . . . . 0.0 109.324 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 10.9 ttm-85 -111.24 84.18 1.89 Allowed 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.877 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -81.83 120.94 34.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.337 -1.345 . . . . 0.0 111.32 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.611 ' C ' ' H ' ' A' ' 73' ' ' GLU . 17.0 p -119.23 148.0 43.61 Favored 'General case' 0 C--N 1.3 -1.561 0 C-N-CA 118.678 -1.209 . . . . 0.0 108.04 178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.483 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -52.75 12.17 0.01 OUTLIER Glycine 0 N--CA 1.491 2.33 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.375 179.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.611 ' H ' ' C ' ' A' ' 71' ' ' THR . 11.0 pt-20 -134.03 -33.48 1.03 Allowed 'General case' 0 N--CA 1.489 1.477 0 C-N-CA 119.329 -0.948 . . . . 0.0 109.665 178.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.547 ' HB2' ' HD3' ' A' ' 43' ' ' ARG . 4.5 tt0 -146.25 150.71 36.31 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.781 -1.168 . . . . 0.0 109.743 -179.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.877 HG22 HG22 ' A' ' 70' ' ' ILE . 2.1 t -105.7 111.36 34.6 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 N-CA-C 106.217 -1.771 . . . . 0.0 106.217 178.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -101.67 98.76 9.0 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 117.619 -1.632 . . . . 0.0 108.569 178.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.718 ' HA ' ' HB ' ' A' ' 68' ' ' THR . 3.0 m -88.03 99.75 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.705 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -93.7 56.52 2.37 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 -177.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.543 ' O ' ' C ' ' A' ' 80' ' ' SER . 34.9 p30 -161.5 -32.35 0.05 OUTLIER 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 113.36 -1.745 . . . . 0.0 112.132 -178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.672 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 3.1 m 37.49 78.81 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 106.143 -1.799 . . . . 0.0 106.143 -177.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.564 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -114.2 172.77 3.31 Favored Pre-proline 0 C--N 1.303 -1.43 0 CA-C-N 113.548 -1.66 . . . . 0.0 106.726 -178.225 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.564 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.0 Cg_exo -28.31 -48.76 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 121.529 1.486 . . . . 0.0 111.844 175.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -41.79 -34.96 0.71 Allowed 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.55 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 29.0 m-20 -66.04 8.05 0.24 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -178.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 4.0 m -98.02 78.02 2.5 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 118.649 -1.221 . . . . 0.0 110.286 176.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.39 -174.59 46.55 Favored Glycine 0 N--CA 1.492 2.392 0 C-N-CA 119.243 -1.456 . . . . 0.0 111.346 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.536 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 4.2 tp -89.41 117.8 28.6 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.805 -1.558 . . . . 0.0 109.764 -179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.72 ' CD1' ' HB ' ' A' ' 105' ' ' VAL . 20.1 m-85 -101.0 90.7 4.26 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -99.43 145.8 27.02 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 114.124 -1.398 . . . . 0.0 108.362 -178.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.574 ' HB3' ' CZ3' ' A' ' 55' ' ' TRP . 1.1 p -107.63 123.96 49.26 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 -178.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.579 HG21 HD11 ' A' ' 56' ' ' LEU . 15.8 t -111.11 120.91 62.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 C-N-CA 119.09 -1.044 . . . . 0.0 108.302 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.605 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 82.8 p -102.21 120.71 40.92 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 104.867 -2.272 . . . . 0.0 104.867 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.6 m -122.38 146.71 47.09 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 119.461 -0.896 . . . . 0.0 112.783 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 8.5 t -145.9 119.83 5.36 Favored Pre-proline 0 N--CA 1.489 1.513 0 CA-C-N 113.078 -1.873 . . . . 0.0 106.394 178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_endo -60.11 -1.71 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.766 2.31 . . . . 0.0 113.87 -112.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 94' ' ' SER . 64.8 m -110.29 -25.61 10.03 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.869 -0.733 . . . . 0.0 112.077 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -133.62 166.58 23.85 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.7 t -147.2 158.59 44.0 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 118.89 -1.124 . . . . 0.0 112.231 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.425 ' HB2' HH12 ' A' ' 45' ' ' ARG . 3.4 m-20 -128.95 143.46 50.89 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 92.5 m -130.12 140.56 50.78 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 117.617 -1.633 . . . . 0.0 113.628 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.732 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -122.58 144.33 49.17 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 112.951 -1.932 . . . . 0.0 105.794 179.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.727 ' O ' ' N ' ' A' ' 29' ' ' VAL . 12.9 m-85 -118.5 123.74 45.88 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -177.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.891 ' CE2' HG11 ' A' ' 29' ' ' VAL . 7.4 m-85 -107.66 103.1 12.31 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 177.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.503 ' OG ' ' HA ' ' A' ' 31' ' ' SER . 8.1 p -78.37 127.24 31.93 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 116.028 -2.269 . . . . 0.0 105.836 179.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.72 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 99.1 t -120.43 128.0 75.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 C-N-CA 117.855 -1.538 . . . . 0.0 107.768 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.55 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -128.36 124.16 35.7 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.341 -1.344 . . . . 0.0 111.47 -179.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -85.04 138.66 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 118.035 -1.466 . . . . 0.0 107.843 178.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.1 t . . . . . 0 N--CA 1.492 1.636 0 C-N-CA 119.218 -0.993 . . . . 0.0 112.22 -178.195 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.481 0.77 0 N-CA-C 111.001 -0.423 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.481 ' HA ' ' HG3' ' A' ' 47' ' ' ARG . 9.7 t -144.35 148.31 34.58 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 -179.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.631 ' HB2' ' HG ' ' A' ' 46' ' ' LEU . 4.7 mp -124.48 149.71 62.44 Favored Pre-proline 0 C--N 1.298 -1.663 0 C-N-CA 118.234 -1.386 . . . . 0.0 111.218 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -21.87 -33.03 0.0 OUTLIER 'Trans proline' 0 C--N 1.301 -1.957 1 C-N-CA 126.072 4.515 . . . . 0.0 114.485 -113.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.667 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 70.0 mm-40 -102.73 -113.34 0.22 Allowed 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 117.827 -1.549 . . . . 0.0 109.262 178.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.62 ' H ' ' HB3' ' A' ' 45' ' ' ARG . 20.0 mp0 -152.68 -96.36 0.05 Allowed 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.048 -1.061 . . . . 0.0 110.726 -178.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' HD2' ' A' ' 45' ' ' ARG . . . -160.24 -47.07 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.503 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.599 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 9.1 mp0 -122.0 -68.48 0.02 OUTLIER Pre-proline 0 N--CA 1.492 1.659 0 CA-C-N 115.386 -0.825 . . . . 0.0 112.118 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.599 ' HD3' ' HB2' ' A' ' 21' ' ' GLN . 9.6 Cg_endo -60.9 84.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 121.929 1.753 . . . . 0.0 112.013 178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.58 ' CD1' ' HG2' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -121.38 -88.44 0.62 Allowed 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.908 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -109.76 -57.36 0.52 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.674 ' CG2' ' H ' ' A' ' 28' ' ' GLU . 2.6 m -137.5 156.37 74.97 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.903 -0.719 . . . . 0.0 109.829 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -85.49 41.09 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 123.318 2.678 . . . . 0.0 110.717 148.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.0 t -129.49 -56.4 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 38.4 mt-10 -152.33 -113.59 0.04 OUTLIER 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 112.802 -1.999 . . . . 0.0 105.857 179.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.867 HG11 ' CE2' ' A' ' 103' ' ' PHE . 4.2 t -162.49 -81.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-N 113.066 -1.879 . . . . 0.0 110.961 177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.846 ' N ' HG12 ' A' ' 29' ' ' VAL . 8.0 tp10 -137.37 117.3 13.27 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 112.893 -1.958 . . . . 0.0 113.97 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.418 ' HA ' ' O ' ' A' ' 104' ' ' SER . 14.2 m -99.73 110.78 23.16 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.118 -1.401 . . . . 0.0 108.507 178.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 tp -124.75 145.47 49.7 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' H ' HD23 ' A' ' 33' ' ' LEU . 0.6 OUTLIER -110.25 130.76 55.49 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 113.633 -1.621 . . . . 0.0 109.808 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -136.36 166.16 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.22 -0.992 . . . . 0.0 111.856 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.578 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -132.42 165.24 37.72 Favored Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.675 179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' CD ' ' CB ' ' A' ' 35' ' ' HIS . 5.0 Cg_endo -62.72 84.73 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.67 2.246 . . . . 0.0 112.519 -151.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 137.31 32.62 0.23 Allowed Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.899 -1.143 . . . . 0.0 112.17 179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -117.0 177.51 4.68 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 118.692 -1.203 . . . . 0.0 113.562 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.3 OUTLIER -105.24 113.12 26.52 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 113.519 -1.673 . . . . 0.0 108.556 178.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.549 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -114.28 135.33 54.18 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 114.075 -1.421 . . . . 0.0 108.257 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.549 ' N ' HD12 ' A' ' 40' ' ' LEU . 3.1 pt20 -122.28 169.15 11.21 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.739 -1.185 . . . . 0.0 113.299 -178.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.639 HD12 ' HB ' ' A' ' 75' ' ' VAL . 6.2 mt -147.94 97.52 2.81 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.37 -1.287 . . . . 0.0 107.69 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.2 tpp180 -99.46 114.59 27.63 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 118.807 -1.157 . . . . 0.0 110.308 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.624 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 9.1 t -81.33 -156.35 0.14 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 113.896 -1.502 . . . . 0.0 111.959 -177.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.667 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -137.5 114.84 11.01 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.084 -1.416 . . . . 0.0 108.885 -179.436 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.653 ' HB3' HD11 ' A' ' 53' ' ' ILE . 0.7 OUTLIER -131.62 161.87 31.68 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 116.832 -1.947 . . . . 0.0 111.139 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -145.79 -171.78 3.77 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 118.326 -1.349 . . . . 0.0 110.0 -179.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 51.7 p-10 -69.04 31.38 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.106 -1.038 . . . . 0.0 110.272 178.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.61 ' H ' ' C ' ' A' ' 47' ' ' ARG . 35.1 m-20 -127.82 -64.66 0.96 Allowed 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 17.3 m -75.03 146.11 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 C-N-CA 119.364 -0.934 . . . . 0.0 109.759 179.78 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.501 ' HG3' ' C ' ' A' ' 50' ' ' VAL . 12.5 mt-30 -135.13 -19.5 1.73 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 113.643 -1.617 . . . . 0.0 110.421 -179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.6 p -115.61 100.03 7.76 Favored 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.963 -179.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.653 HD11 ' HB3' ' A' ' 46' ' ' LEU . 2.5 mt -102.15 111.67 32.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.328 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.492 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -97.48 136.47 37.85 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 113.241 -1.799 . . . . 0.0 107.513 180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.796 ' CG ' HG21 ' A' ' 75' ' ' VAL . 94.7 m95 -104.2 104.19 14.07 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.628 ' CD1' HG23 ' A' ' 91' ' ' VAL . 4.5 mp -79.59 107.87 12.69 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.32 -1.352 . . . . 0.0 107.725 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.618 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -79.18 143.24 35.59 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 119.063 -1.055 . . . . 0.0 108.411 -179.219 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.617 ' HB2' ' CZ ' ' A' ' 57' ' ' ARG . 60.8 t0 64.48 -77.65 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.524 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.26 16.66 0.21 Allowed Glycine 0 N--CA 1.49 2.282 0 O-C-N 124.525 1.141 . . . . 0.0 110.34 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 56' ' ' LEU . 59.8 t -140.19 149.88 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.941 -0.704 . . . . 0.0 111.077 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.591 ' HA ' ' HG ' ' A' ' 56' ' ' LEU . 3.2 tm0? -44.01 130.11 5.94 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.969 -1.014 . . . . 0.0 113.383 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.618 HD22 ' CB ' ' A' ' 57' ' ' ARG . 11.2 tp -149.58 137.44 20.32 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 122.648 1.213 . . . . 0.0 112.925 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.559 ' HA ' HG21 ' A' ' 70' ' ' ILE . 2.8 p -163.01 94.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 CA-C-N 112.675 -2.057 . . . . 0.0 106.996 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.421 ' O ' ' CG1' ' A' ' 70' ' ' ILE . 23.2 mm-40 -97.08 -145.21 0.3 Allowed 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 118.397 -1.321 . . . . 0.0 112.513 -178.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 5.4 t -151.54 -163.27 1.71 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.4 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.435 HD22 ' N ' ' A' ' 66' ' ' ASN . 2.9 m120 38.53 -115.75 0.16 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.635 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 39.0 mtm-85 -37.12 -37.01 0.15 Allowed 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.111 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.605 ' HB ' HG12 ' A' ' 77' ' ' VAL . 0.1 OUTLIER -114.41 117.43 31.01 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.487 -0.779 . . . . 0.0 108.95 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -98.07 93.32 6.22 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 104.222 -2.51 . . . . 0.0 104.222 178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.634 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -91.31 90.52 3.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 C-N-CA 119.076 -1.05 . . . . 0.0 111.178 -178.674 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.625 ' O ' ' N ' ' A' ' 73' ' ' GLU . 2.6 p -85.07 146.38 27.19 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 115.323 -2.551 . . . . 0.0 108.826 -179.644 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.531 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -43.4 0.94 0.01 OUTLIER Glycine 0 N--CA 1.493 2.464 0 CA-C-N 114.953 -1.021 . . . . 0.0 114.595 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.625 ' N ' ' O ' ' A' ' 71' ' ' THR . 11.6 pt-20 -141.86 -25.33 0.68 Allowed 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 118.982 -1.087 . . . . 0.0 111.777 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -140.78 125.28 17.78 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.456 -0.898 . . . . 0.0 108.668 -177.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 55' ' ' TRP . 31.9 t -106.07 118.0 52.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.966 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -117.19 120.31 37.87 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.189 -1.404 . . . . 0.0 112.52 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.605 HG12 ' HB ' ' A' ' 68' ' ' THR . 0.0 OUTLIER -105.19 115.21 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 178.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.556 ' HD3' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -97.58 51.13 1.07 Allowed 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.261 -0.976 . . . . 0.0 111.284 -176.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -161.39 -34.59 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 118.137 -1.425 . . . . 0.0 110.839 -179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.515 ' OG ' ' O ' ' A' ' 80' ' ' SER . 1.3 p 55.07 94.93 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 -177.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.565 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 10.6 pt -138.88 159.12 68.39 Favored Pre-proline 0 N--CA 1.489 1.501 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 -178.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 33.6 Cg_exo -34.03 -36.62 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 121.769 1.646 . . . . 0.0 111.296 -168.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.56 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -38.8 -42.81 0.86 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.951 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.462 ' HB3' HG23 ' A' ' 105' ' ' VAL . 9.7 m-20 -81.15 38.98 0.49 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 124.304 1.003 . . . . 0.0 111.06 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.418 ' H ' ' C ' ' A' ' 83' ' ' ALA . 25.5 p -98.61 69.79 1.89 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 113.497 -1.683 . . . . 0.0 110.518 177.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 164.63 -159.15 32.1 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 117.653 -2.213 . . . . 0.0 112.396 -179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.504 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 8.4 mp -101.21 129.1 47.08 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 117.622 -1.631 . . . . 0.0 111.322 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.557 ' CE1' HG21 ' A' ' 105' ' ' VAL . 14.0 m-85 -101.54 92.34 4.85 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 178.194 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -95.0 132.96 39.29 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 -179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.83 ' SG ' ' CG2' ' A' ' 101' ' ' THR . 13.9 p -97.29 127.17 43.02 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 116.811 -1.955 . . . . 0.0 107.809 -178.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.628 HG23 ' CD1' ' A' ' 56' ' ' LEU . 39.3 t -109.16 111.1 34.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.574 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 73.1 p -91.21 132.14 36.3 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 104.289 -2.485 . . . . 0.0 104.289 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.53 135.26 47.76 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 118.299 -1.36 . . . . 0.0 111.978 -178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 96' ' ' SER . 41.1 p -129.49 150.73 76.44 Favored Pre-proline 0 N--CA 1.486 1.34 0 N-CA-C 105.942 -1.873 . . . . 0.0 105.942 177.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.487 ' CD ' ' NE2' ' A' ' 51' ' ' GLN . 7.5 Cg_exo -50.96 1.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.325 2.017 . . . . 0.0 112.518 -178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 94' ' ' SER . 14.4 p -114.08 -44.92 3.1 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.244 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.409 ' N ' ' OG ' ' A' ' 96' ' ' SER . . . -160.67 -173.54 29.38 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.882 -1.628 . . . . 0.0 111.428 -179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 35.7 t -138.15 158.0 45.19 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 120.056 -0.657 . . . . 0.0 110.861 179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.56 ' CG ' HE21 ' A' ' 21' ' ' GLN . 17.3 t70 -140.7 143.91 35.31 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.513 ' OG1' HG22 ' A' ' 91' ' ' VAL . 35.3 m -126.29 138.8 53.64 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 118.11 -1.436 . . . . 0.0 114.133 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.83 ' CG2' ' SG ' ' A' ' 90' ' ' CYS . 1.8 p -117.03 165.3 13.52 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 112.692 -2.049 . . . . 0.0 107.829 179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.708 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 46.5 m-85 -135.22 111.08 9.38 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.867 ' CE2' HG11 ' A' ' 29' ' ' VAL . 20.6 m-85 -98.49 105.21 17.32 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 176.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.418 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.7 OUTLIER -78.3 121.09 23.97 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 104.802 -2.296 . . . . 0.0 104.802 178.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -127.3 124.71 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 C-N-CA 117.749 -1.581 . . . . 0.0 108.375 -179.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.53 121.06 21.6 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.463 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.435 HG11 ' O ' ' A' ' 81' ' ' ILE . 15.0 p -111.58 128.82 67.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 C-N-CA 118.033 -1.467 . . . . 0.0 111.724 178.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 30.2 t . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 114.33 -1.304 . . . . 0.0 109.611 179.135 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo . . . . . 0 N--CA 1.482 0.808 0 CA-C-O 121.191 0.413 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.431 ' OG1' ' N ' ' A' ' 16' ' ' LEU . 0.1 OUTLIER -136.52 168.81 18.76 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 16' ' ' LEU . 4.4 mp -122.57 125.31 26.49 Favored Pre-proline 0 C--N 1.299 -1.617 0 CA-C-N 114.663 -1.153 . . . . 0.0 108.208 -179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -30.88 -17.81 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 1 C-N-CA 126.463 4.776 . . . . 0.0 116.747 -111.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.656 ' HB2' ' HA ' ' A' ' 45' ' ' ARG . 10.6 mp0 -79.41 -126.0 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.576 HE21 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -160.29 -107.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.378 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.516 ' H ' ' CG ' ' A' ' 19' ' ' GLN . . . -135.7 -31.0 0.96 Allowed 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 115.352 -0.84 . . . . 0.0 109.786 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.548 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 71.1 mt-30 -113.87 160.53 31.81 Favored Pre-proline 0 N--CA 1.492 1.636 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.507 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HD2' ' HB3' ' A' ' 21' ' ' GLN . 20.3 Cg_exo -49.75 142.42 25.29 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.133 1.889 . . . . 0.0 111.348 -166.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 20.4 p-90 -121.04 -8.62 9.31 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.7 -0.8 . . . . 0.0 111.496 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -84.83 -69.58 1.36 Allowed Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.086 -1.531 . . . . 0.0 110.774 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.446 ' CG2' HG23 ' A' ' 27' ' ' VAL . 16.5 m -141.49 160.73 55.77 Favored Pre-proline 0 N--CA 1.491 1.601 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.819 -179.717 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -77.95 33.41 0.46 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.599 2.2 . . . . 0.0 111.692 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.446 HG23 ' CG2' ' A' ' 25' ' ' VAL . 0.0 OUTLIER -143.35 -67.3 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 CA-C-O 121.721 0.772 . . . . 0.0 109.646 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.721 ' O ' HG23 ' A' ' 29' ' ' VAL . 81.8 mt-10 -122.1 -104.95 0.38 Allowed 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 105.124 -2.176 . . . . 0.0 105.124 179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.968 HG21 ' HB ' ' A' ' 101' ' ' THR . 5.0 t -163.06 -76.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.911 176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.699 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.5 tt0 -135.65 118.15 15.84 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-N 113.151 -1.841 . . . . 0.0 113.433 -177.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.443 ' HA ' ' O ' ' A' ' 104' ' ' SER . 8.7 m -99.27 108.01 20.46 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-N 113.789 -1.55 . . . . 0.0 109.054 177.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 27.0 mt -120.52 130.49 54.27 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 122.047 0.927 . . . . 0.0 113.494 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.622 ' CB ' HD21 ' A' ' 106' ' ' ASN . 1.7 pp -102.71 130.2 49.57 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.726 -1.124 . . . . 0.0 109.031 178.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.95 167.54 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.522 -179.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.515 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 2.2 m80 -119.19 165.94 15.75 Favored Pre-proline 0 N--CA 1.491 1.616 0 C-N-CA 119.351 -0.939 . . . . 0.0 110.45 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 12.2 Cg_exo -54.9 108.62 0.31 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.356 2.037 . . . . 0.0 111.053 -170.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 90.17 52.63 2.51 Favored Glycine 0 N--CA 1.492 2.381 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.545 -179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.551 ' H ' ' HB2' ' A' ' 80' ' ' SER . 9.6 t70 -130.28 177.7 7.13 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.239 -0.984 . . . . 0.0 111.774 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.7 mt -103.83 116.49 32.38 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.677 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 41' ' ' GLN . 1.3 tp -124.07 134.69 53.34 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.724 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.582 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.54 141.13 49.65 Favored 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 118.733 -1.187 . . . . 0.0 112.763 -179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.746 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -125.55 118.69 26.28 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 178.75 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.12 120.65 42.35 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.345 1.069 . . . . 0.0 112.541 -179.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.492 ' SG ' ' CG2' ' A' ' 92' ' ' THR . 0.5 OUTLIER -81.96 -160.01 0.33 Allowed 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.037 -1.892 . . . . 0.0 109.385 -179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.656 ' HA ' ' HB2' ' A' ' 18' ' ' GLU . 2.3 mtm105 -127.25 132.2 50.42 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.616 -1.174 . . . . 0.0 108.265 179.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.561 ' HB2' HD13 ' A' ' 16' ' ' LEU . 0.1 OUTLIER -120.86 153.83 36.64 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 116.677 -2.009 . . . . 0.0 110.516 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 49' ' ' ASP . 14.0 ttt180 -160.08 171.33 19.49 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 118.236 -1.385 . . . . 0.0 111.196 179.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -55.36 11.49 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 CA-C-N 115.31 -0.859 . . . . 0.0 113.18 179.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.589 ' H ' ' C ' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -120.97 -76.94 0.58 Allowed 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 179.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.3 m -50.57 131.48 10.7 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 C-N-CA 119.256 -0.978 . . . . 0.0 109.572 178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.578 HE21 ' HD3' ' A' ' 95' ' ' PRO . 31.6 mt-30 -123.88 -24.52 4.43 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 113.945 -1.479 . . . . 0.0 108.821 -179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.663 ' C ' HD12 ' A' ' 53' ' ' ILE . 57.5 m -118.11 127.01 53.37 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 118.55 -1.26 . . . . 0.0 108.293 -179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.663 HD12 ' C ' ' A' ' 52' ' ' SER . 1.7 mp -113.1 112.75 41.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.479 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.73 130.81 48.2 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 179.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.772 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.6 m95 -102.23 105.13 15.75 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.911 -1.515 . . . . 0.0 106.911 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.58 HD11 HG21 ' A' ' 91' ' ' VAL . 3.4 mt -79.34 107.9 12.45 Favored 'General case' 0 C--N 1.307 -1.275 0 C-N-CA 117.963 -1.495 . . . . 0.0 107.929 -178.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 52.5 ttp180 -79.41 146.17 32.94 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 87' ' ' LEU . 55.9 t0 63.62 -77.84 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.198 0.937 . . . . 0.0 108.849 179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.49 18.55 0.18 Allowed Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.211 -1.156 . . . . 0.0 110.211 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.5 m -145.58 157.62 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 120.321 -0.552 . . . . 0.0 110.235 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.562 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -43.19 139.06 1.99 Allowed 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.88 -179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -157.69 131.9 8.24 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.793 1.282 . . . . 0.0 110.722 179.369 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.744 ' CG2' HD13 ' A' ' 70' ' ' ILE . 1.9 p -162.49 98.09 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.525 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.548 ' O ' HD11 ' A' ' 70' ' ' ILE . 34.7 mt-10 -91.69 -111.03 0.09 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -177.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.521 ' HB2' ' O ' ' A' ' 64' ' ' GLU . 7.6 t 167.68 -164.93 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.385 -1.28 . . . . 0.0 108.043 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 67' ' ' ARG . 11.3 t-20 29.95 -122.14 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 124.045 0.841 . . . . 0.0 112.579 -179.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 66' ' ' ASN . 8.5 mtp85 -31.62 -38.76 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 CA-C-O 121.404 0.621 . . . . 0.0 112.309 -179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.506 ' OG1' ' HB2' ' A' ' 64' ' ' GLU . 34.1 p -115.56 97.38 6.11 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 104.546 -2.39 . . . . 0.0 104.546 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 16.1 ttp180 -79.91 90.06 5.32 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 -177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.744 HD13 ' CG2' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -84.21 102.09 9.68 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 CA-C-N 113.242 -1.799 . . . . 0.0 110.649 -179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.621 ' C ' ' H ' ' A' ' 73' ' ' GLU . 7.1 p -101.32 145.28 29.1 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 116.292 -2.163 . . . . 0.0 106.641 177.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.473 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -51.82 11.3 0.01 OUTLIER Glycine 0 N--CA 1.491 2.366 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.321 179.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.2 pt-20 -136.42 -30.5 0.92 Allowed 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.287 178.476 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -149.57 147.35 28.05 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 118.355 -1.338 . . . . 0.0 109.119 -178.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.663 HG23 ' CD1' ' A' ' 55' ' ' TRP . 2.8 t -107.93 117.49 53.66 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 C-N-CA 118.541 -1.264 . . . . 0.0 107.787 179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -111.11 106.69 15.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 124.644 1.215 . . . . 0.0 110.591 179.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 40' ' ' LEU . 15.7 m -102.07 115.28 43.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.578 HH21 ' HB3' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -101.63 51.15 0.84 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -177.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.437 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 13.7 t0 -161.17 -30.54 0.05 Allowed 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 117.742 -1.583 . . . . 0.0 112.239 -178.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.551 ' HB2' ' H ' ' A' ' 38' ' ' ASP . 48.8 m 49.11 83.28 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.309 -1.356 . . . . 0.0 107.501 -177.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.64 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 46.7 pt -129.62 173.84 5.27 Favored Pre-proline 0 N--CA 1.49 1.559 0 N-CA-C 105.056 -2.201 . . . . 0.0 105.056 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.64 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 34.7 Cg_exo -40.96 -35.23 1.64 Allowed 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.199 1.266 . . . . 0.0 111.323 -161.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -45.49 -32.24 2.12 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.533 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 67.2 m-20 -83.72 14.24 4.07 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 -178.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 34.4 t -98.48 73.76 2.12 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 176.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.18 -163.02 36.8 Favored Glycine 0 N--CA 1.493 2.438 0 C-N-CA 119.059 -1.543 . . . . 0.0 110.596 -179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.471 ' N ' HD12 ' A' ' 87' ' ' LEU . 7.8 mp -102.82 131.55 49.62 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 117.239 -1.784 . . . . 0.0 111.357 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.495 ' CE1' HG21 ' A' ' 105' ' ' VAL . 15.9 m-85 -103.85 91.25 3.91 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 105.406 -2.072 . . . . 0.0 105.406 177.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -92.19 126.77 37.41 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.316 -2.476 . . . . 0.0 104.316 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.772 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 47.0 t -97.23 129.93 44.51 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 118.099 -1.44 . . . . 0.0 108.863 -178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.58 HG21 HD11 ' A' ' 56' ' ' LEU . 48.9 t -115.15 118.98 60.48 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 124.969 1.418 . . . . 0.0 108.093 179.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.492 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 50.6 p -98.92 122.91 42.78 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.401 -2.444 . . . . 0.0 104.401 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 16.2 m -122.26 140.44 52.62 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.975 -178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.536 ' O ' ' N ' ' A' ' 96' ' ' SER . 9.3 p -132.84 156.28 80.25 Favored Pre-proline 0 N--CA 1.488 1.447 0 CA-C-N 113.223 -1.808 . . . . 0.0 107.308 178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.578 ' HD3' HE21 ' A' ' 51' ' ' GLN . 7.9 Cg_exo -53.96 -1.64 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.461 2.107 . . . . 0.0 112.147 -172.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.536 ' N ' ' O ' ' A' ' 94' ' ' SER . 35.1 t -116.56 -39.67 3.3 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.147 -1.021 . . . . 0.0 110.733 179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.25 -167.6 21.02 Favored Glycine 0 N--CA 1.494 2.565 0 C-N-CA 118.255 -1.926 . . . . 0.0 112.308 -179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 12.2 t -146.74 153.57 40.39 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.222 -0.991 . . . . 0.0 111.0 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -133.23 148.09 51.99 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 91.1 m -130.76 144.26 51.32 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 117.942 -1.503 . . . . 0.0 114.059 -179.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.968 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -126.07 138.7 53.73 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 112.668 -2.06 . . . . 0.0 107.365 179.588 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.702 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 4.0 m-85 -110.02 114.48 28.03 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.283 1.957 . . . . 0.0 116.283 -177.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.735 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 12.0 m-85 -100.53 101.48 12.42 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.443 ' O ' ' HA ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -78.36 125.08 28.85 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 116.631 -2.028 . . . . 0.0 106.292 179.035 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.495 HG21 ' CE1' ' A' ' 88' ' ' TYR . 0.7 OUTLIER -127.54 134.5 65.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 118.474 -1.29 . . . . 0.0 108.756 -179.431 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.622 HD21 ' CB ' ' A' ' 33' ' ' LEU . 7.1 p-10 -133.19 122.2 23.64 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.378 -1.283 . . . . 0.0 112.331 -178.501 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.3 p -111.51 119.53 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 C-N-CA 118.494 -1.282 . . . . 0.0 111.108 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.4 t . . . . . 0 N--CA 1.49 1.562 0 CA-C-N 115.114 -0.948 . . . . 0.0 110.827 179.248 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo . . . . . 0 N--CA 1.482 0.83 0 CA-C-O 121.11 0.379 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.488 HG23 ' N ' ' A' ' 16' ' ' LEU . 12.1 t -106.62 -164.77 1.02 Allowed 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.76 ' HB3' ' HB2' ' A' ' 46' ' ' LEU . 5.2 tt -156.78 115.92 2.05 Favored Pre-proline 0 C--N 1.299 -1.593 0 C-N-CA 118.645 -1.222 . . . . 0.0 109.602 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.493 ' CD ' HD23 ' A' ' 16' ' ' LEU . 57.6 Cg_endo -96.11 -19.45 0.25 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 124.261 3.307 . . . . 0.0 116.384 -107.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.528 ' CB ' ' NE2' ' A' ' 19' ' ' GLN . 2.7 mp0 -78.32 -4.07 46.14 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.715 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 22.5 mp0 -152.46 90.22 1.48 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 105.018 -2.216 . . . . 0.0 105.018 177.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.482 ' O ' ' CZ ' ' A' ' 45' ' ' ARG . . . -118.47 -132.8 0.32 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.913 -179.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.578 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 35.8 mt-30 -79.84 -66.21 0.27 Allowed Pre-proline 0 N--CA 1.488 1.463 0 C-N-CA 118.936 -1.105 . . . . 0.0 110.094 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.3 Cg_endo -58.31 11.43 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.046 1.831 . . . . 0.0 112.669 178.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.635 ' CG ' ' HA ' ' A' ' 19' ' ' GLN . 52.3 t-105 -98.7 -16.21 19.08 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.886 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -93.74 101.84 2.81 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 108.66 -1.776 . . . . 0.0 108.66 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.594 HG23 ' HD2' ' A' ' 26' ' ' PRO . 6.3 p -79.89 141.05 54.62 Favored Pre-proline 0 N--CA 1.491 1.581 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.001 -179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.594 ' HD2' HG23 ' A' ' 25' ' ' VAL . 3.0 Cg_endo -55.11 -0.97 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.755 2.304 . . . . 0.0 112.154 178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.591 ' H ' HG22 ' A' ' 25' ' ' VAL . 59.2 t -103.35 -77.16 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.673 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 80.4 mt-10 -147.16 -104.89 0.09 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 106.016 -1.846 . . . . 0.0 106.016 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.873 HG11 ' CE2' ' A' ' 103' ' ' PHE . 5.4 t -162.63 -73.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 113.912 -1.495 . . . . 0.0 110.523 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.659 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.8 tt0 -137.41 115.43 11.58 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 113.136 -1.847 . . . . 0.0 112.431 -178.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 m -99.52 103.78 15.55 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 114.198 -1.364 . . . . 0.0 107.494 177.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.408 HD23 HD13 ' A' ' 40' ' ' LEU . 43.4 tp -114.47 138.67 50.3 Favored 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 122.104 0.954 . . . . 0.0 113.262 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.458 HD23 ' N ' ' A' ' 33' ' ' LEU . 0.3 OUTLIER -109.44 129.04 55.57 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.906 179.868 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.98 169.94 19.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 119.479 -0.889 . . . . 0.0 112.302 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.566 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -133.37 168.89 15.63 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 119.604 -0.838 . . . . 0.0 109.855 179.417 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 80' ' ' SER . 8.1 Cg_exo -55.46 110.09 0.5 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.479 2.12 . . . . 0.0 111.837 -172.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.96 33.91 1.76 Allowed Glycine 0 N--CA 1.489 2.192 0 C-N-CA 120.041 -1.076 . . . . 0.0 110.572 179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -130.88 167.31 19.16 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.512 HD12 ' N ' ' A' ' 39' ' ' LEU . 6.0 mp -109.87 119.62 39.9 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 107.598 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.571 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -120.78 135.96 55.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.192 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -135.68 150.52 49.61 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 118.623 -1.231 . . . . 0.0 113.272 -179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.789 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -129.83 122.8 29.45 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 178.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.511 ' HG2' ' NE2' ' A' ' 19' ' ' GLN . 6.2 tpt180 -104.66 124.68 49.78 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.109 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 92' ' ' THR . 1.1 t -84.06 170.62 13.71 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 114.422 -1.263 . . . . 0.0 112.333 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.715 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 18.9 ttm-85 -79.93 132.69 36.11 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 112.629 -2.078 . . . . 0.0 108.868 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.76 ' HB2' ' HB3' ' A' ' 16' ' ' LEU . 83.9 mt -121.95 144.39 48.89 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 116.906 -1.918 . . . . 0.0 109.927 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 49' ' ' ASP . 9.5 mtp180 -151.37 171.33 17.66 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.257 -1.377 . . . . 0.0 110.402 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -76.61 24.9 0.14 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 178.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.622 ' H ' ' C ' ' A' ' 47' ' ' ARG . 28.8 m-20 -128.35 -66.76 0.83 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.155 179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' CG2' ' H ' ' A' ' 47' ' ' ARG . 34.2 m -55.09 135.14 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 CA-C-O 122.351 1.072 . . . . 0.0 110.252 179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.497 HE21 ' HD3' ' A' ' 95' ' ' PRO . 29.2 mt-30 -130.74 -22.32 2.67 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.063 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 56.9 m -118.81 126.94 52.98 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 106.371 -1.714 . . . . 0.0 106.371 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.594 HG23 ' SG ' ' A' ' 44' ' ' CYS . 37.2 mm -121.14 112.65 36.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.043 -1.063 . . . . 0.0 108.575 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.452 ' ND2' ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -101.09 139.86 36.19 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 114.396 -1.275 . . . . 0.0 108.232 179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.789 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.2 m95 -108.66 106.7 16.87 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.789 HD11 ' CG2' ' A' ' 91' ' ' VAL . 0.6 OUTLIER -78.61 109.09 12.51 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.174 -1.41 . . . . 0.0 107.498 -178.058 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.611 HH22 ' HB1' ' A' ' 83' ' ' ALA . 2.3 ttm-85 -79.28 139.75 37.78 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 118.889 -1.124 . . . . 0.0 108.468 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.526 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 43.3 t0 65.43 -71.44 0.08 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 124.471 1.107 . . . . 0.0 109.693 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -160.77 11.2 0.14 Allowed Glycine 0 N--CA 1.49 2.268 0 O-C-N 124.224 0.952 . . . . 0.0 111.432 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.5 t -142.19 148.09 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 C-N-CA 119.483 -0.887 . . . . 0.0 111.648 -179.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.569 ' CA ' HD23 ' A' ' 56' ' ' LEU . 4.7 tm0? -36.06 135.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.89 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.588 HD22 ' HB2' ' A' ' 57' ' ' ARG . 0.4 OUTLIER -160.13 148.63 17.03 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-O 123.173 1.463 . . . . 0.0 114.276 179.617 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.65 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.5 p -162.53 113.8 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 CA-C-N 110.847 -2.888 . . . . 0.0 107.13 177.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.594 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 0.4 OUTLIER -96.56 -144.6 0.28 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.449 -1.301 . . . . 0.0 111.633 -178.692 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 57.9 m -162.08 -50.7 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.2 -179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.499 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 3.6 m120 -92.2 145.05 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 119.671 -0.812 . . . . 0.0 109.341 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.499 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 52.3 mtt85 76.01 -38.8 0.35 Allowed 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 -179.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.594 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 2.5 t -126.11 150.66 48.06 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.497 179.142 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.447 ' NE ' ' NH2' ' A' ' 78' ' ' ARG . 8.3 mtp85 -113.63 95.4 5.32 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 104.544 -2.391 . . . . 0.0 104.544 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.691 HG22 HG22 ' A' ' 75' ' ' VAL . 0.8 OUTLIER -90.21 93.95 4.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.148 -1.021 . . . . 0.0 109.95 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.624 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.4 p -87.9 147.75 24.93 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 116.076 -2.25 . . . . 0.0 109.963 -179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.592 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -42.35 1.06 0.01 OUTLIER Glycine 0 N--CA 1.493 2.454 0 CA-C-N 114.219 -1.355 . . . . 0.0 114.675 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.624 ' N ' ' O ' ' A' ' 71' ' ' THR . 6.2 pt-20 -151.29 -16.77 0.2 Allowed 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.069 -1.052 . . . . 0.0 111.85 178.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 71' ' ' THR . 40.6 tt0 -141.03 128.87 21.72 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.595 -178.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.691 HG23 ' NE1' ' A' ' 55' ' ' TRP . 34.3 t -110.13 121.35 62.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 C-N-CA 117.763 -1.575 . . . . 0.0 109.163 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -118.75 128.01 54.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 124.702 1.251 . . . . 0.0 110.395 179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 77' ' ' VAL . 17.2 m -112.97 125.34 70.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 N-CA-C 103.607 -2.738 . . . . 0.0 103.607 177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.1 OUTLIER -106.51 55.71 0.66 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.246 -1.382 . . . . 0.0 111.262 -176.593 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -161.65 -35.33 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.035 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.578 ' C ' HG21 ' A' ' 107' ' ' VAL . 73.8 m 54.54 83.5 0.08 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 -177.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 47.1 pt -146.7 174.5 3.35 Favored Pre-proline 0 N--CA 1.493 1.693 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.628 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 32.7 Cg_exo -42.62 -29.19 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.383 1.389 . . . . 0.0 112.133 -160.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.611 ' HB1' HH22 ' A' ' 57' ' ' ARG . . . -54.0 -23.96 15.22 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.463 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 6.9 m-20 -97.18 28.05 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -179.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 77.9 p -98.7 74.75 2.1 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.436 177.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 173.51 -172.4 45.18 Favored Glycine 0 N--CA 1.494 2.534 0 C-N-CA 118.194 -1.955 . . . . 0.0 111.939 -179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.501 ' N ' ' HA ' ' A' ' 58' ' ' ASP . 20.7 mt -94.14 123.2 37.37 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 117.336 -1.746 . . . . 0.0 110.023 -179.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.603 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 12.7 m-85 -101.66 90.12 3.93 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 178.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -97.99 133.29 42.67 Favored 'General case' 0 C--N 1.298 -1.658 0 N-CA-C 105.945 -1.872 . . . . 0.0 105.945 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.778 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 32.1 t -103.2 136.17 43.48 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 118.047 -1.461 . . . . 0.0 109.922 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.789 ' CG2' HD11 ' A' ' 56' ' ' LEU . 6.6 t -114.5 118.94 60.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.285 1.616 . . . . 0.0 108.145 179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 44' ' ' CYS . 59.6 p -101.17 126.72 47.91 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 59.5 m -124.44 138.78 54.32 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.087 0.867 . . . . 0.0 111.649 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 96' ' ' SER . 21.8 p -131.38 154.5 81.93 Favored Pre-proline 0 N--CA 1.487 1.379 0 CA-C-N 113.003 -1.908 . . . . 0.0 107.024 178.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' HD3' HE21 ' A' ' 51' ' ' GLN . 8.2 Cg_exo -52.4 -0.63 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.388 2.059 . . . . 0.0 112.371 -174.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.546 ' N ' ' O ' ' A' ' 94' ' ' SER . 71.2 p -117.56 -39.38 3.16 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.162 -1.015 . . . . 0.0 110.917 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.27 -169.26 23.34 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 118.131 -1.985 . . . . 0.0 112.894 -179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 61.8 m -139.23 149.65 44.6 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.921 -0.711 . . . . 0.0 111.308 179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -137.26 149.34 47.06 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.2 m -131.59 147.46 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.786 -179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.815 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.09 132.89 47.47 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 112.895 -1.957 . . . . 0.0 107.092 179.471 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.673 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 2.8 m-85 -108.71 114.34 28.06 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.873 ' CE2' HG11 ' A' ' 29' ' ' VAL . 32.6 m-85 -101.37 100.55 11.05 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.54 125.82 29.89 Favored 'General case' 0 C--N 1.299 -1.624 0 C-N-CA 116.655 -2.018 . . . . 0.0 106.756 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.483 ' CG2' ' CD2' ' A' ' 88' ' ' TYR . 0.6 OUTLIER -125.99 129.3 72.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 118.547 -1.261 . . . . 0.0 108.088 -179.85 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.1 OUTLIER -135.45 122.47 21.36 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.229 -178.987 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.578 HG21 ' C ' ' A' ' 80' ' ' SER . 15.0 p -115.61 133.38 62.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 C-N-CA 117.444 -1.702 . . . . 0.0 111.703 178.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.489 1.51 0 CA-C-N 114.024 -1.444 . . . . 0.0 109.601 179.355 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 N--CA 1.481 0.736 0 CA-C-O 121.011 0.338 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 36.5 m -112.7 144.83 41.55 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.682 HD13 ' HD3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -107.88 95.68 15.42 Favored Pre-proline 0 C--N 1.302 -1.484 0 C-N-CA 118.34 -1.344 . . . . 0.0 109.974 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.682 ' HD3' HD13 ' A' ' 16' ' ' LEU . 17.1 Cg_endo -69.71 55.46 1.26 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.759 2.973 . . . . 0.0 111.921 -94.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.738 ' CG ' ' HA ' ' A' ' 45' ' ' ARG . 2.7 mm-40 -104.43 -110.78 0.26 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.669 HE21 ' HB3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -149.32 -91.7 0.07 Allowed 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 118.842 -1.143 . . . . 0.0 110.353 179.568 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -160.19 -109.71 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.648 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.605 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 34.9 tt0 -98.45 -42.25 0.24 Allowed Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 119.116 -1.033 . . . . 0.0 112.276 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' HD3' ' HB3' ' A' ' 21' ' ' GLN . 4.2 Cg_endo -76.4 90.06 1.22 Allowed 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 121.76 1.64 . . . . 0.0 109.761 174.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.465 ' HA ' ' HE3' ' A' ' 23' ' ' TRP . 0.0 OUTLIER -109.91 -76.52 0.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.331 -0.948 . . . . 0.0 110.878 -179.342 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.79 -70.02 0.57 Allowed Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.282 -1.437 . . . . 0.0 110.744 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.513 HG22 ' HA ' ' A' ' 29' ' ' VAL . 22.5 m -132.36 157.92 77.0 Favored Pre-proline 0 N--CA 1.491 1.592 0 C-N-CA 119.526 -0.87 . . . . 0.0 110.535 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -74.94 10.95 1.54 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.511 2.14 . . . . 0.0 111.911 178.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 48.8 t -134.06 -87.07 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 119.334 -0.946 . . . . 0.0 110.25 -179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.638 ' HA ' ' CD1' ' A' ' 102' ' ' TYR . 48.7 mt-10 -80.05 -118.59 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG21 ' HB ' ' A' ' 101' ' ' THR . 3.4 t -162.3 -74.37 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 CA-C-N 113.107 -1.861 . . . . 0.0 110.474 177.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.7 ' N ' HG12 ' A' ' 29' ' ' VAL . 40.3 tt0 -137.65 106.81 6.03 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 113.41 -1.723 . . . . 0.0 111.248 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 104' ' ' SER . 56.7 m -105.52 104.72 14.49 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.6 mt -122.37 145.12 48.56 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.858 1.313 . . . . 0.0 114.363 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.565 ' HB3' HD21 ' A' ' 106' ' ' ASN . 0.2 OUTLIER -105.19 127.46 52.93 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 112.97 -1.923 . . . . 0.0 108.942 179.208 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.76 176.73 8.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 C-N-CA 119.527 -0.869 . . . . 0.0 112.199 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.93 168.76 7.59 Favored Pre-proline 0 N--CA 1.492 1.661 0 CA-C-N 114.954 -1.021 . . . . 0.0 110.132 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -77.48 78.94 3.33 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.18 1.92 . . . . 0.0 112.496 -168.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 79' ' ' ASP . . . 142.13 34.24 0.1 Allowed Glycine 0 N--CA 1.491 2.356 0 C-N-CA 118.992 -1.575 . . . . 0.0 111.543 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.56 ' CG ' ' H ' ' A' ' 39' ' ' LEU . 20.9 t70 -125.84 -171.73 2.45 Favored 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 122.248 1.023 . . . . 0.0 112.34 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 5.6 mp -109.34 121.64 45.62 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 113.67 -1.604 . . . . 0.0 109.061 -179.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.574 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.2 OUTLIER -126.91 141.16 51.88 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 113.659 -1.609 . . . . 0.0 109.846 -179.202 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.574 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -137.46 146.25 44.08 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 118.707 -1.197 . . . . 0.0 113.429 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.783 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.1 OUTLIER -128.71 113.91 15.95 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.87 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 4.9 ttp180 -104.12 123.99 48.27 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.397 -0.921 . . . . 0.0 109.927 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.586 ' O ' ' HG3' ' A' ' 18' ' ' GLU . 1.3 t -78.61 -140.64 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.659 -177.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.738 ' HA ' ' CG ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -160.25 98.82 1.31 Allowed 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.345 -179.403 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.624 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -127.79 169.81 13.46 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 116.655 -2.018 . . . . 0.0 111.833 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' C ' ' H ' ' A' ' 49' ' ' ASP . 16.2 mtt180 -149.3 -157.23 0.8 Allowed 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.126 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.99 30.54 0.17 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.45 -0.9 . . . . 0.0 108.95 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 47' ' ' ARG . 2.9 m-20 -122.36 -74.23 0.62 Allowed 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.476 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 16.5 m -71.53 146.41 11.64 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.255 0 C-N-CA 119.427 -0.909 . . . . 0.0 108.965 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.602 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 17.7 mt-30 -132.96 -20.25 2.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.877 -1.51 . . . . 0.0 110.019 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.444 ' O ' HD13 ' A' ' 53' ' ' ILE . 45.6 t -112.44 121.29 44.42 Favored 'General case' 0 C--N 1.306 -1.29 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.625 ' CG1' ' O ' ' A' ' 72' ' ' GLY . 25.1 mm -115.5 110.31 31.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -101.46 134.62 44.27 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 113.929 -1.487 . . . . 0.0 108.844 -179.508 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.824 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 95.9 m95 -105.63 105.26 15.21 Favored 'General case' 0 C--N 1.303 -1.416 0 C-N-CA 117.803 -1.559 . . . . 0.0 107.233 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.537 ' CD2' ' HA ' ' A' ' 61' ' ' GLN . 3.0 mt -79.85 108.59 13.54 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 118.351 -1.34 . . . . 0.0 108.468 -178.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.782 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 61.2 ttt-85 -79.6 147.94 31.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' HA ' ' H ' ' A' ' 87' ' ' LEU . 48.8 t0 63.94 -78.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 124.122 0.889 . . . . 0.0 108.614 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -161.88 18.16 0.17 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.993 -1.243 . . . . 0.0 109.993 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 27.7 m -146.2 157.71 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 CA-C-O 121.273 0.559 . . . . 0.0 111.05 -179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.537 ' HA ' ' CD2' ' A' ' 56' ' ' LEU . 68.0 tp60 -37.91 137.18 0.51 Allowed 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.782 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.1 OUTLIER -160.18 134.92 7.69 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.845 1.307 . . . . 0.0 112.839 178.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.723 ' N ' HD13 ' A' ' 62' ' ' LEU . 1.8 p -162.07 95.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 CA-C-N 111.879 -2.419 . . . . 0.0 106.38 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.65 ' HB3' ' CG2' ' A' ' 68' ' ' THR . 3.9 tp10 -97.42 -145.12 0.3 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.781 -1.167 . . . . 0.0 113.905 -177.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.539 ' O ' ' C ' ' A' ' 66' ' ' ASN . 8.4 p -164.15 -70.02 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 114.119 -1.401 . . . . 0.0 110.232 -178.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.719 HD22 ' H ' ' A' ' 66' ' ' ASN . 1.6 m-80 -4.13 -79.78 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.425 -1.261 . . . . 0.0 113.519 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 53.6 mtt180 -114.79 8.98 16.21 Favored 'General case' 0 N--CA 1.494 1.734 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.661 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.65 ' CG2' ' HB3' ' A' ' 64' ' ' GLU . 3.6 t -126.11 150.73 48.01 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.268 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -118.23 94.22 4.42 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 104.137 -2.542 . . . . 0.0 104.137 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.688 HG22 HG22 ' A' ' 75' ' ' VAL . 1.0 OUTLIER -89.54 109.61 20.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.453 -1.299 . . . . 0.0 110.695 -179.214 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.577 ' C ' ' H ' ' A' ' 73' ' ' GLU . 2.4 p -105.09 147.52 27.81 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 116.533 -2.067 . . . . 0.0 109.171 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.625 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.12 10.01 0.01 OUTLIER Glycine 0 N--CA 1.491 2.3 0 CA-C-N 114.384 -1.28 . . . . 0.0 114.181 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.577 ' H ' ' C ' ' A' ' 71' ' ' THR . 10.5 pt-20 -139.9 -29.15 0.73 Allowed 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.056 -1.057 . . . . 0.0 110.543 178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -151.31 148.86 28.68 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -178.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.697 HG23 ' NE1' ' A' ' 55' ' ' TRP . 29.3 t -115.9 125.54 73.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 C-N-CA 118.277 -1.369 . . . . 0.0 109.297 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -113.4 131.82 55.85 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.425 -1.31 . . . . 0.0 110.064 178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.7 t -118.93 125.61 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 105.242 -2.133 . . . . 0.0 105.242 178.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -109.49 51.28 0.76 Allowed 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 118.592 -1.243 . . . . 0.0 111.509 -177.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.442 ' O ' ' N ' ' A' ' 37' ' ' GLY . 48.7 t0 -162.23 -32.5 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.831 -179.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 27.4 p 39.39 65.99 0.62 Allowed 'General case' 0 N--CA 1.489 1.525 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.821 -177.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -100.41 -164.11 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' ILE . 32.2 Cg_exo -28.61 -28.6 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 121.618 1.545 . . . . 0.0 111.105 150.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' CB ' HG13 ' A' ' 81' ' ' ILE . . . -50.18 -46.96 54.73 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.687 -1.205 . . . . 0.0 110.053 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.605 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 8.1 p-10 -97.95 44.19 1.05 Allowed 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 118.202 -1.399 . . . . 0.0 112.778 -179.032 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.0 t -98.66 66.07 1.63 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.517 177.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 172.31 -174.38 45.48 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 118.718 -1.706 . . . . 0.0 111.834 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.549 ' H ' ' HA ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -91.11 125.9 36.03 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 117.733 -1.587 . . . . 0.0 109.361 -179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.61 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 14.9 m-85 -101.03 89.79 3.94 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.98 132.18 38.71 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.824 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 51.3 t -103.67 127.09 51.16 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 118.269 -1.372 . . . . 0.0 109.04 -178.102 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.537 HG21 HD11 ' A' ' 56' ' ' LEU . 60.5 t -112.02 119.37 59.91 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 125.839 1.962 . . . . 0.0 108.299 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.569 HG22 HD12 ' A' ' 53' ' ' ILE . 34.7 p -99.62 129.82 45.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.3 m -127.07 138.53 53.23 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.177 -1.009 . . . . 0.0 112.235 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 96' ' ' SER . 8.9 p -125.71 168.74 13.02 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 126.018 2.074 . . . . 0.0 106.445 178.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.602 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.6 Cg_exo -55.11 -10.3 2.8 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.227 1.951 . . . . 0.0 112.078 -162.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 94' ' ' SER . 22.7 t -160.01 28.49 0.18 Allowed 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.628 -1.229 . . . . 0.0 111.47 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.46 151.0 21.45 Favored Glycine 0 N--CA 1.492 2.424 0 C-N-CA 119.088 -1.529 . . . . 0.0 111.305 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 78.6 p -133.76 137.74 45.36 Favored 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.549 179.706 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -131.14 137.98 49.28 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 87.6 m -128.06 141.44 51.5 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 117.846 -1.542 . . . . 0.0 113.344 -179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.918 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -125.98 145.14 50.42 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 112.735 -2.03 . . . . 0.0 107.202 179.7 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.641 ' O ' ' N ' ' A' ' 29' ' ' VAL . 1.2 m-85 -117.31 119.09 34.07 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 117.477 2.399 . . . . 0.0 117.477 -177.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.834 ' CZ ' HG11 ' A' ' 29' ' ' VAL . 9.9 m-85 -105.97 101.17 10.68 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 31' ' ' SER . 59.2 m -78.75 127.15 31.69 Favored 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 115.579 -2.448 . . . . 0.0 106.456 178.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 84' ' ' ASP . 1.9 t -124.41 119.96 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 C-N-CA 117.945 -1.502 . . . . 0.0 107.698 179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.605 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 6.6 p-10 -129.12 127.62 41.8 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 114.592 1.331 . . . . 0.0 114.592 -178.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.466 HG13 ' O ' ' A' ' 107' ' ' VAL . 7.6 p -98.81 129.58 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 107.408 -1.331 . . . . 0.0 107.408 176.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 13.6 m . . . . . 0 N--CA 1.491 1.601 0 C-N-CA 118.668 -1.213 . . . . 0.0 111.393 179.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.482 0.822 0 N-CA-C 110.71 -0.535 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.62 ' HA ' ' HB2' ' A' ' 47' ' ' ARG . 0.5 OUTLIER -160.23 141.83 12.59 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.832 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB2' ' O ' ' A' ' 46' ' ' LEU . 40.0 mt -113.9 112.2 47.77 Favored Pre-proline 0 C--N 1.302 -1.487 0 CA-C-O 122.945 1.355 . . . . 0.0 111.445 -179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -104.88 -11.07 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 123.494 2.796 . . . . 0.0 114.954 -100.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.694 ' HB2' ' NE2' ' A' ' 19' ' ' GLN . 12.3 mt-10 -79.55 15.99 1.18 Allowed 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.163 -1.415 . . . . 0.0 110.877 -178.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.694 ' NE2' ' HB2' ' A' ' 18' ' ' GLU . 8.3 mp0 -146.59 67.96 1.17 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 119.459 -0.896 . . . . 0.0 110.163 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.92 -76.08 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.053 -1.059 . . . . 0.0 109.057 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.651 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 40.3 mt-30 -138.47 -65.21 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.116 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.651 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 4.8 Cg_endo -58.56 71.8 0.05 OUTLIER 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.303 2.002 . . . . 0.0 111.16 168.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.513 ' CE2' ' O ' ' A' ' 18' ' ' GLU . 29.0 t-105 -160.06 -33.42 0.06 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.338 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.6 121.26 7.16 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 107.506 -2.238 . . . . 0.0 107.506 179.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.629 HG23 ' N ' ' A' ' 28' ' ' GLU . 6.7 m -109.85 161.56 23.77 Favored Pre-proline 0 N--CA 1.491 1.619 0 C-N-CA 118.796 -1.162 . . . . 0.0 112.167 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_endo -64.21 -7.09 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.714 2.276 . . . . 0.0 111.049 167.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 28' ' ' GLU . 4.7 t -97.29 -77.0 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.743 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 4.0 pt-20 -160.36 -108.6 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.724 -1.125 . . . . 0.0 108.107 179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.87 HG11 ' CE2' ' A' ' 103' ' ' PHE . 20.4 t -162.23 -76.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 CA-C-N 113.738 -1.574 . . . . 0.0 111.17 177.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.628 ' N ' HG12 ' A' ' 29' ' ' VAL . 16.4 tp10 -136.2 125.65 25.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 113.388 -1.733 . . . . 0.0 113.301 -178.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 104' ' ' SER . 18.7 m -101.88 107.14 18.22 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.185 -1.825 . . . . 0.0 108.924 177.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 40' ' ' LEU . 13.0 tp -117.08 131.67 56.86 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 122.087 0.946 . . . . 0.0 113.405 -179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.552 ' CB ' HD21 ' A' ' 106' ' ' ASN . 0.4 OUTLIER -103.12 131.07 50.41 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 114.621 -1.172 . . . . 0.0 110.314 179.488 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.414 ' HB ' ' OG ' ' A' ' 80' ' ' SER . 0.1 OUTLIER -137.26 161.65 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 C-N-CA 119.403 -0.919 . . . . 0.0 112.121 -179.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.599 ' N ' ' ND1' ' A' ' 35' ' ' HIS . 0.0 OUTLIER -131.06 165.08 37.74 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.162 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -52.47 110.59 0.47 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.401 2.067 . . . . 0.0 111.632 -171.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 113.22 35.38 1.64 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.304 -1.119 . . . . 0.0 110.304 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 80' ' ' SER . 84.5 m-20 -131.8 166.28 21.92 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.411 HD12 ' C ' ' A' ' 38' ' ' ASP . 10.7 mp -109.14 115.79 30.7 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 112.943 -1.935 . . . . 0.0 108.103 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 41' ' ' GLN . 0.3 OUTLIER -118.26 136.07 53.9 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.434 -1.257 . . . . 0.0 109.022 -179.506 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.572 ' N ' HD12 ' A' ' 40' ' ' LEU . 0.0 OUTLIER -131.8 149.74 52.37 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.495 -1.282 . . . . 0.0 113.566 -179.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.715 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.7 mt -123.14 122.21 37.88 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 113.826 -1.534 . . . . 0.0 107.05 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.502 ' O ' ' CZ ' ' A' ' 103' ' ' PHE . 1.4 mpt_? -105.97 116.38 31.84 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.267 -0.973 . . . . 0.0 110.673 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.69 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -86.73 -173.97 4.74 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 114.385 -1.28 . . . . 0.0 109.707 -179.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.484 ' C ' HD23 ' A' ' 46' ' ' LEU . 6.5 tmm_? -103.72 124.6 49.17 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.828 -1.533 . . . . 0.0 109.701 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -132.35 143.45 49.86 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 117.282 -1.767 . . . . 0.0 108.213 179.45 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.62 ' HB2' ' HA ' ' A' ' 15' ' ' THR . 1.5 ptm180 -160.85 -161.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.578 -1.249 . . . . 0.0 109.793 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.557 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 36.0 t70 -83.2 34.5 0.47 Allowed 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 118.908 -1.117 . . . . 0.0 109.162 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.443 ' O ' ' HB2' ' A' ' 94' ' ' SER . 2.2 m-20 -135.96 -70.16 0.48 Allowed 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.641 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.426 ' C ' ' HG3' ' A' ' 51' ' ' GLN . 33.3 m -68.57 144.91 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 CA-C-O 122.134 0.969 . . . . 0.0 110.778 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.579 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 14.4 mt-30 -131.09 -23.39 2.46 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 113.482 -1.69 . . . . 0.0 109.243 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.73 ' C ' HD12 ' A' ' 53' ' ' ILE . 42.1 t -110.64 123.87 50.82 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.425 -1.31 . . . . 0.0 108.236 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -119.58 100.56 9.83 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 54' ' ' ASN . 0.0 OUTLIER -96.35 136.15 37.24 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 -179.674 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.78 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 96.1 m95 -106.24 106.07 16.41 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 118.591 -1.244 . . . . 0.0 108.852 -179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.727 HD11 ' CG2' ' A' ' 91' ' ' VAL . 1.1 mt -79.09 111.4 15.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 118.36 -1.336 . . . . 0.0 109.008 -178.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.79 ' H ' ' HB2' ' A' ' 62' ' ' LEU . 13.9 ttp85 -83.75 142.63 30.55 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 87' ' ' LEU . 11.4 t70 63.85 -76.87 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -163.34 17.38 0.13 Allowed Glycine 0 N--CA 1.491 2.305 0 O-C-N 124.295 0.997 . . . . 0.0 110.879 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 61' ' ' GLN . 58.2 t -142.75 146.95 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.584 -0.847 . . . . 0.0 112.046 -179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CA ' HD23 ' A' ' 56' ' ' LEU . 2.8 tm0? -33.87 129.48 0.33 Allowed 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 115.108 -0.951 . . . . 0.0 112.147 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.79 ' HB2' ' H ' ' A' ' 57' ' ' ARG . 0.0 OUTLIER -151.27 137.78 18.66 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.736 1.255 . . . . 0.0 112.689 179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.874 ' HA ' HG21 ' A' ' 70' ' ' ILE . 1.3 p -162.51 104.49 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 CA-C-N 112.091 -2.322 . . . . 0.0 107.771 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' N ' HG12 ' A' ' 70' ' ' ILE . 36.0 mt-10 -85.43 -139.03 0.08 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.314 -0.954 . . . . 0.0 111.717 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 47.5 t -151.21 -67.85 0.18 Allowed 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.588 -179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 67' ' ' ARG . 2.2 m120 -98.95 159.42 14.97 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.907 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 66' ' ' ASN . 53.2 mtt-85 71.43 -49.98 0.69 Allowed 'General case' 0 N--CA 1.498 1.942 0 CA-C-O 121.588 0.709 . . . . 0.0 110.055 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.564 ' CB ' HG12 ' A' ' 77' ' ' VAL . 40.2 p -117.65 95.6 5.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 104.931 -2.248 . . . . 0.0 104.931 179.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' NH1' ' NH2' ' A' ' 78' ' ' ARG . 15.1 mtp-105 -81.88 108.3 15.29 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 -178.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.976 HG22 HG22 ' A' ' 75' ' ' VAL . 0.9 OUTLIER -96.2 93.57 3.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 114.98 -1.009 . . . . 0.0 110.14 -179.242 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 73' ' ' GLU . 4.1 p -88.58 147.2 24.71 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 115.772 -2.371 . . . . 0.0 108.301 -179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.5 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -50.61 10.82 0.01 OUTLIER Glycine 0 N--CA 1.492 2.395 0 CA-C-N 115.038 -0.983 . . . . 0.0 113.899 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.607 ' H ' ' C ' ' A' ' 71' ' ' THR . 7.5 pt-20 -142.45 -27.5 0.61 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.264 -0.975 . . . . 0.0 110.805 178.083 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.46 ' HG3' ' C ' ' A' ' 73' ' ' GLU . 86.2 mt-10 -149.09 144.63 26.79 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 118.382 -1.327 . . . . 0.0 109.189 -178.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.976 HG22 HG22 ' A' ' 70' ' ' ILE . 3.1 t -107.17 121.98 60.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -119.32 108.59 14.79 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 118.88 -1.128 . . . . 0.0 111.467 179.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.564 HG12 ' CB ' ' A' ' 68' ' ' THR . 28.3 m -104.6 117.8 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 N-CA-C 105.534 -2.024 . . . . 0.0 105.534 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.529 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -103.89 56.24 0.73 Allowed 'General case' 0 N--CA 1.495 1.818 0 C-N-CA 119.054 -1.058 . . . . 0.0 111.36 -177.101 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 80' ' ' SER . 0.4 OUTLIER -161.42 -34.5 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 C-N-CA 117.385 -1.726 . . . . 0.0 112.609 -179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.479 ' HB3' ' O ' ' A' ' 79' ' ' ASP . 29.6 t 59.57 80.96 0.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 -177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.573 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 4.6 pt -129.43 165.43 32.78 Favored Pre-proline 0 N--CA 1.491 1.597 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 -178.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.573 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 37.1 Cg_exo -34.66 -31.65 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 121.727 1.618 . . . . 0.0 112.802 -177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -55.74 -22.43 23.92 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.592 ' HB2' ' HB ' ' A' ' 107' ' ' VAL . 7.6 m-20 -97.25 25.62 5.42 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.453 -0.899 . . . . 0.0 113.234 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 107' ' ' VAL . 80.3 p -98.44 78.07 2.39 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.941 177.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 169.95 -171.68 43.49 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 118.534 -1.793 . . . . 0.0 111.328 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.455 ' HB2' ' O ' ' A' ' 58' ' ' ASP . 4.5 mp -92.74 127.6 38.3 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 117.543 -1.663 . . . . 0.0 109.949 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.528 ' CZ ' ' HG3' ' A' ' 57' ' ' ARG . 7.3 m-85 -104.53 86.62 2.54 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.91 128.97 40.5 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.78 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 20.5 t -104.08 132.41 50.36 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.005 -178.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.727 ' CG2' HD11 ' A' ' 56' ' ' LEU . 11.6 t -111.58 122.1 65.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 125.751 1.907 . . . . 0.0 109.041 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.645 ' CG2' ' SG ' ' A' ' 44' ' ' CYS . 69.3 p -105.45 130.41 53.54 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 105.469 -2.049 . . . . 0.0 105.469 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 12.6 t -128.57 139.96 52.03 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.292 -0.963 . . . . 0.0 112.319 -178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.519 ' CB ' ' CD ' ' A' ' 95' ' ' PRO . 5.8 p -124.19 172.28 6.01 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 126.275 2.234 . . . . 0.0 106.909 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.579 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 7.1 Cg_exo -55.83 -12.57 7.06 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.147 1.898 . . . . 0.0 111.661 -160.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.468 ' N ' ' O ' ' A' ' 94' ' ' SER . 20.7 t -159.97 30.74 0.18 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.565 -1.254 . . . . 0.0 111.417 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -160.44 146.94 13.24 Favored Glycine 0 N--CA 1.493 2.452 0 C-N-CA 119.136 -1.507 . . . . 0.0 111.014 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 34.9 t -134.2 136.43 43.71 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.781 -0.768 . . . . 0.0 110.733 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -136.81 139.45 41.76 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 93.6 m -124.38 146.98 48.54 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 118.877 -1.129 . . . . 0.0 113.653 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.706 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.38 131.08 50.4 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 113.075 -1.875 . . . . 0.0 106.982 179.421 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.743 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 3.0 m-85 -106.58 116.14 31.42 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 -177.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.87 ' CE2' HG11 ' A' ' 29' ' ' VAL . 25.6 m-85 -104.89 97.93 7.73 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' SER . 8.3 p -78.87 130.75 35.99 Favored 'General case' 0 C--N 1.299 -1.628 0 C-N-CA 116.421 -2.111 . . . . 0.0 106.984 179.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.526 HG23 ' O ' ' A' ' 84' ' ' ASP . 0.7 OUTLIER -127.7 137.28 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 C-N-CA 119.331 -0.948 . . . . 0.0 108.828 -179.286 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.552 HD21 ' CB ' ' A' ' 33' ' ' LEU . 8.5 p-10 -131.58 122.35 25.93 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.477 -1.238 . . . . 0.0 113.426 -178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.592 ' HB ' ' HB2' ' A' ' 84' ' ' ASP . 4.6 p -105.06 118.35 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.774 178.587 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.412 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.379 178.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo . . . . . 0 N--CA 1.481 0.739 0 N-CA-C 111.428 -0.258 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.659 HG21 ' HA ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -117.41 143.11 46.34 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 105.941 -1.874 . . . . 0.0 105.941 -179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.625 ' CB ' ' HB2' ' A' ' 46' ' ' LEU . 6.8 mp -108.12 122.31 41.03 Favored Pre-proline 0 C--N 1.299 -1.621 0 C-N-CA 119.104 -1.038 . . . . 0.0 110.736 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' C ' ' H ' ' A' ' 19' ' ' GLN . 35.2 Cg_endo -92.62 3.32 3.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 127.258 3.241 . . . . 0.0 114.798 -106.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.507 ' C ' ' CD ' ' A' ' 19' ' ' GLN . 31.5 mt-10 -79.21 6.48 9.66 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.607 ' CB ' ' HB2' ' A' ' 45' ' ' ARG . 20.5 mp0 -150.4 95.32 2.24 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 113.297 -1.774 . . . . 0.0 108.206 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.659 ' HA ' HG21 ' A' ' 15' ' ' THR . . . -92.85 -77.66 0.44 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.429 -1.308 . . . . 0.0 108.764 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.61 ' CB ' ' CD ' ' A' ' 22' ' ' PRO . 17.1 mm-40 -139.76 -64.81 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.548 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.375 179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.61 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 7.0 Cg_endo -63.59 30.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.312 -1.355 0 C-N-CA 121.823 1.682 . . . . 0.0 113.231 174.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.539 ' CD1' ' HG3' ' A' ' 19' ' ' GLN . 25.3 t-105 -108.19 -22.92 12.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -108.15 124.2 7.39 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 106.486 -2.646 . . . . 0.0 106.486 178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.578 HG23 ' N ' ' A' ' 28' ' ' GLU . 6.6 m -107.98 163.69 16.41 Favored Pre-proline 0 N--CA 1.493 1.68 0 C-N-CA 118.933 -1.107 . . . . 0.0 112.658 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_endo -63.71 -4.79 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.828 2.352 . . . . 0.0 110.953 166.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.428 ' C ' ' HG3' ' A' ' 28' ' ' GLU . 60.7 t -101.8 -84.84 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.744 ' CA ' ' HB2' ' A' ' 102' ' ' TYR . 89.1 mt-10 -151.01 -105.98 0.06 Allowed 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.918 HG11 ' CE2' ' A' ' 103' ' ' PHE . 11.0 t -162.02 -74.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.149 177.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' N ' HG12 ' A' ' 29' ' ' VAL . 38.0 tt0 -139.2 117.09 11.61 Favored 'General case' 0 N--CA 1.487 1.399 0 CA-C-N 113.62 -1.627 . . . . 0.0 112.496 -177.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.1 m -99.22 105.07 17.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 114.109 -1.405 . . . . 0.0 109.421 178.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 37.4 mt -123.73 145.57 48.91 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-O 122.194 0.997 . . . . 0.0 113.612 -179.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.468 ' HB3' HD21 ' A' ' 106' ' ' ASN . 2.7 pp -107.81 137.96 44.89 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 114.679 -1.146 . . . . 0.0 109.639 178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 40' ' ' LEU . 0.1 OUTLIER -123.46 162.01 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.279 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . 0.412 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 44.7 m170 -103.65 158.14 32.47 Favored Pre-proline 0 N--CA 1.49 1.555 0 C-N-CA 119.133 -1.027 . . . . 0.0 110.984 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 35' ' ' HIS . 14.1 Cg_exo -49.04 115.65 1.81 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.365 2.043 . . . . 0.0 111.319 -179.128 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 79' ' ' ASP . . . 78.73 51.79 5.34 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.79 -179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' H ' ' HB3' ' A' ' 80' ' ' SER . 1.4 m-20 -136.39 170.52 15.9 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.648 -179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' HA ' ' HA ' ' A' ' 78' ' ' ARG . 11.1 mp -91.23 123.42 34.66 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 113.526 -1.67 . . . . 0.0 112.149 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -132.72 136.23 46.25 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 113.565 -1.652 . . . . 0.0 109.095 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.42 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -140.15 151.55 45.36 Favored 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 117.768 -1.573 . . . . 0.0 114.452 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.877 HD12 ' CE3' ' A' ' 55' ' ' TRP . 0.0 OUTLIER -130.77 126.21 35.78 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 113.99 -1.459 . . . . 0.0 107.299 178.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.594 ' NE ' ' HB2' ' A' ' 74' ' ' GLU . 0.1 OUTLIER -104.11 123.82 47.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 123.934 0.772 . . . . 0.0 111.66 -179.278 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.754 ' HB2' ' CZ2' ' A' ' 55' ' ' TRP . 7.3 t -95.2 170.96 9.03 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-N 114.51 -1.223 . . . . 0.0 111.776 -179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.761 ' CZ ' ' HB3' ' A' ' 45' ' ' ARG . 8.9 ttp-105 -88.74 135.79 33.34 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 111.923 -2.399 . . . . 0.0 112.075 -178.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.625 ' HB2' ' CB ' ' A' ' 16' ' ' LEU . 71.3 mt -111.36 145.76 38.3 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 117.121 -1.831 . . . . 0.0 106.608 177.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.654 ' C ' ' H ' ' A' ' 49' ' ' ASP . 23.2 mtt180 -146.88 160.47 42.27 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 117.452 -1.699 . . . . 0.0 111.579 179.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -71.49 25.34 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 119.135 -1.026 . . . . 0.0 108.826 178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.654 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.0 t0 -131.32 -69.3 0.63 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.63 ' HA ' ' CB ' ' A' ' 94' ' ' SER . 17.3 m -52.42 144.64 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.742 0.782 . . . . 0.0 109.947 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.538 ' NE2' ' HD3' ' A' ' 95' ' ' PRO . 55.7 mt-30 -129.57 -26.54 2.49 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.199 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.604 ' C ' HD12 ' A' ' 53' ' ' ILE . 50.1 m -122.86 134.68 54.38 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.111 -1.036 . . . . 0.0 108.884 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.604 HD12 ' C ' ' A' ' 52' ' ' SER . 1.6 mp -112.38 115.22 49.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.474 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.94 128.55 49.7 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.877 ' CE3' HD12 ' A' ' 42' ' ' LEU . 98.0 m95 -101.17 103.99 15.06 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.645 HD11 HG21 ' A' ' 91' ' ' VAL . 1.0 OUTLIER -78.95 109.75 13.52 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 118.021 -1.472 . . . . 0.0 107.952 -177.391 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.652 ' CB ' HD22 ' A' ' 62' ' ' LEU . 0.3 OUTLIER -79.69 135.64 36.59 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 119.463 -0.895 . . . . 0.0 109.158 -179.427 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' N ' ' A' ' 87' ' ' LEU . 35.6 t70 68.7 -73.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 123.866 0.729 . . . . 0.0 109.427 179.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -162.55 15.76 0.13 Allowed Glycine 0 N--CA 1.489 2.225 0 O-C-N 124.272 0.982 . . . . 0.0 110.738 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 p -142.43 146.05 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 C-N-CA 119.385 -0.926 . . . . 0.0 111.427 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.552 ' HA ' HD23 ' A' ' 56' ' ' LEU . 2.0 tm0? -40.47 126.44 2.29 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-N 114.855 -1.066 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.652 HD22 ' CB ' ' A' ' 57' ' ' ARG . 5.5 tp -146.12 142.0 28.08 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-O 122.931 1.348 . . . . 0.0 112.935 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.672 HG22 HD13 ' A' ' 70' ' ' ILE . 2.5 p -162.86 95.34 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.354 178.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.583 ' O ' ' CD1' ' A' ' 70' ' ' ILE . 0.0 OUTLIER -97.12 -137.78 0.27 Allowed 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 114.344 1.238 . . . . 0.0 114.344 -177.653 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 50.9 p -164.46 -165.71 0.99 Allowed 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.079 -179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.409 ' N ' HD22 ' A' ' 66' ' ' ASN . 3.1 m120 42.92 -111.74 0.19 Allowed 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 120.216 -0.594 . . . . 0.0 111.591 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.449 ' CD ' ' H ' ' A' ' 67' ' ' ARG . 4.3 mpt_? -40.68 -36.23 0.58 Allowed 'General case' 0 N--CA 1.495 1.779 0 CA-C-O 121.383 0.611 . . . . 0.0 110.81 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -114.69 126.65 55.11 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.86 93.01 5.56 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 104.315 -2.476 . . . . 0.0 104.315 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.672 HD13 HG22 ' A' ' 63' ' ' VAL . 3.9 pt -81.85 119.91 32.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 114.496 -1.229 . . . . 0.0 112.338 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 ' C ' ' H ' ' A' ' 73' ' ' GLU . 0.2 OUTLIER -116.69 137.77 51.94 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 117.527 -1.669 . . . . 0.0 106.837 176.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' O ' ' CG1' ' A' ' 53' ' ' ILE . . . -48.9 6.25 0.01 OUTLIER Glycine 0 N--CA 1.493 2.453 0 CA-C-N 115.158 -0.928 . . . . 0.0 113.961 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.585 ' H ' ' C ' ' A' ' 71' ' ' THR . 18.9 pt-20 -136.79 -24.83 1.13 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 119.429 -0.908 . . . . 0.0 109.957 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.594 ' HB2' ' NE ' ' A' ' 43' ' ' ARG . 43.9 tt0 -146.87 150.31 34.99 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.712 HG23 ' CD1' ' A' ' 55' ' ' TRP . 0.9 OUTLIER -117.97 120.42 64.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 178.237 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -113.14 116.02 29.19 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.872 -1.531 . . . . 0.0 110.727 179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -104.46 121.8 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 102.263 -3.236 . . . . 0.0 102.263 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.664 ' CD ' ' O ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -113.66 52.0 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 117.403 -1.719 . . . . 0.0 111.433 -177.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.455 ' O ' ' HA2' ' A' ' 37' ' ' GLY . 3.3 t70 -160.02 -21.43 0.06 Allowed 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.312 -1.355 . . . . 0.0 112.126 -178.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.591 ' HB3' ' H ' ' A' ' 38' ' ' ASP . 37.6 t 53.69 80.96 0.1 Allowed 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.112 -179.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.601 ' HB ' ' CD ' ' A' ' 82' ' ' PRO . 46.8 pt -136.8 172.18 7.41 Favored Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 105.734 -1.951 . . . . 0.0 105.734 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.601 ' CD ' ' HB ' ' A' ' 81' ' ' ILE . 27.4 Cg_exo -42.32 -28.99 1.06 Allowed 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.652 1.568 . . . . 0.0 112.048 -155.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 81' ' ' ILE . . . -51.6 -34.29 36.68 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.691 ' O ' ' HA ' ' A' ' 106' ' ' ASN . 36.7 p30 -73.91 12.25 0.72 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 90.8 p -98.64 66.87 1.7 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.877 -1.129 . . . . 0.0 110.773 177.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 58' ' ' ASP . . . 171.94 -173.21 45.07 Favored Glycine 0 N--CA 1.492 2.416 0 C-N-CA 118.118 -1.992 . . . . 0.0 111.715 -179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.585 ' N ' HD12 ' A' ' 87' ' ' LEU . 8.6 mp -91.27 124.34 35.39 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 117.762 -1.575 . . . . 0.0 110.416 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.525 ' HB3' HD13 ' A' ' 42' ' ' LEU . 12.2 m-85 -99.84 92.5 5.33 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 102' ' ' TYR . . . -93.27 132.44 37.46 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 118.312 -1.355 . . . . 0.0 107.477 -179.02 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.594 ' CB ' ' CZ3' ' A' ' 55' ' ' TRP . 0.4 OUTLIER -97.02 117.29 30.87 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 -178.855 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.645 HG21 HD11 ' A' ' 56' ' ' LEU . 48.6 t -110.08 122.14 64.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 125.085 1.49 . . . . 0.0 108.647 179.494 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.499 ' CB ' HG11 ' A' ' 50' ' ' VAL . 81.2 p -98.14 122.49 41.36 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 104.135 -2.543 . . . . 0.0 104.135 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.9 m -128.31 146.88 50.63 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.459 -0.896 . . . . 0.0 112.14 -177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.63 ' CB ' ' HA ' ' A' ' 50' ' ' VAL . 1.5 t -160.63 129.86 3.19 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 113.547 -1.661 . . . . 0.0 106.659 177.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.538 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 10.1 Cg_endo -63.66 2.98 0.76 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.94 2.426 . . . . 0.0 113.295 -120.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 94' ' ' SER . 28.9 t -107.95 -25.41 11.2 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.216 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -150.43 175.55 29.42 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.838 -1.173 . . . . 0.0 111.129 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.1 p -156.49 157.22 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.772 -0.771 . . . . 0.0 111.141 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -136.75 141.89 43.0 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.472 ' OG1' HG22 ' A' ' 91' ' ' VAL . 95.1 m -127.3 143.65 51.19 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 114.498 1.295 . . . . 0.0 114.498 -178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.595 HG22 ' CG2' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -123.56 128.77 50.2 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 105.378 -2.082 . . . . 0.0 105.378 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.744 ' HB2' ' CA ' ' A' ' 28' ' ' GLU . 12.8 m-85 -105.29 112.59 25.76 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 -177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.918 ' CE2' HG11 ' A' ' 29' ' ' VAL . 62.0 m-85 -100.5 101.52 12.48 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.431 ' HA ' ' HA ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -78.54 127.25 31.88 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 117.104 -1.838 . . . . 0.0 108.179 179.531 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.506 ' HB ' ' CD2' ' A' ' 88' ' ' TYR . 40.6 t -120.09 124.6 73.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.691 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 1.6 p-10 -130.94 135.49 47.71 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.54 -1.209 . . . . 0.0 112.926 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.432 ' HB ' ' OD1' ' A' ' 84' ' ' ASP . 3.9 p -79.68 137.86 20.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.378 -1.329 . . . . 0.0 107.757 177.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 N--CA 1.49 1.528 0 C-N-CA 119.18 -1.008 . . . . 0.0 111.979 -178.547 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.462 -0.245 . . . . 0.0 111.462 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 6.7 t -140.19 147.09 39.58 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.072 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 46' ' ' LEU . 5.6 mp -114.93 121.17 35.81 Favored Pre-proline 0 C--N 1.303 -1.454 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.538 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.635 ' C ' ' H ' ' A' ' 19' ' ' GLN . 74.2 Cg_endo -105.54 -34.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.312 -1.393 0 O-C-N 127.589 3.415 . . . . 0.0 114.188 -109.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.593 ' O ' ' CE2' ' A' ' 23' ' ' TRP . 64.8 mt-10 -78.84 17.85 0.68 Allowed 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.64 ' CB ' ' HA ' ' A' ' 45' ' ' ARG . 15.6 mp0 -158.16 92.55 1.17 Allowed 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 104.53 -2.396 . . . . 0.0 104.53 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' H ' ' CB ' ' A' ' 23' ' ' TRP . . . -143.57 -135.48 0.09 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 119.484 -0.886 . . . . 0.0 110.407 -179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.598 ' C ' ' H ' ' A' ' 23' ' ' TRP . 5.5 mm100 -79.93 -60.49 0.5 Allowed Pre-proline 0 N--CA 1.49 1.568 0 C-N-CA 119.293 -0.963 . . . . 0.0 110.507 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 21' ' ' GLN . 9.1 Cg_endo -62.92 25.69 0.06 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.044 1.83 . . . . 0.0 112.407 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.598 ' H ' ' C ' ' A' ' 21' ' ' GLN . 52.0 t-105 -121.79 -14.52 8.09 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' HG22 ' A' ' 101' ' ' THR . . . -107.09 127.79 8.97 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 107.622 -2.191 . . . . 0.0 107.622 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.604 HG23 ' N ' ' A' ' 28' ' ' GLU . 5.9 m -106.24 161.41 22.92 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 119.093 -1.043 . . . . 0.0 111.734 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -58.21 -14.09 18.41 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.638 2.225 . . . . 0.0 110.911 169.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.6 t -93.86 -82.11 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.709 ' CB ' ' HB2' ' A' ' 102' ' ' TYR . 23.2 mt-10 -153.0 -104.34 0.05 OUTLIER 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.793 HG11 ' CE2' ' A' ' 103' ' ' PHE . 2.8 t -161.92 -69.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 114.125 -1.398 . . . . 0.0 110.734 177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.663 ' N ' HG12 ' A' ' 29' ' ' VAL . 10.6 tp10 -146.02 120.8 9.89 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 112.869 -1.969 . . . . 0.0 111.562 -178.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 8.3 p -92.56 112.32 24.23 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 112.869 -1.969 . . . . 0.0 107.613 177.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.41 119.8 40.4 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.255 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.591 ' N ' HD12 ' A' ' 33' ' ' LEU . 5.6 mp -107.0 112.58 25.61 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.038 -1.437 . . . . 0.0 107.698 179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.479 HG12 ' OD2' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -130.1 179.11 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 C-N-CA 119.294 -0.963 . . . . 0.0 112.347 -178.197 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' HIS . . . . . . . . . . . . . 60.6 m170 -114.5 158.26 40.53 Favored Pre-proline 0 N--CA 1.489 1.502 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.932 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -57.69 84.75 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.217 1.945 . . . . 0.0 111.367 179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.629 ' N ' ' HA ' ' A' ' 80' ' ' SER . . . 156.57 -6.8 0.22 Allowed Glycine 0 N--CA 1.492 2.398 0 C-N-CA 119.245 -1.455 . . . . 0.0 112.923 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.479 ' OD2' HG12 ' A' ' 34' ' ' VAL . 35.5 m-20 -96.15 -168.2 1.71 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.504 HD23 ' N ' ' A' ' 39' ' ' LEU . 0.4 OUTLIER -129.74 132.17 46.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 112.045 -2.343 . . . . 0.0 107.135 179.607 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.576 HD22 HG11 ' A' ' 105' ' ' VAL . 1.8 pp -124.67 139.3 53.99 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 113.719 -1.582 . . . . 0.0 110.413 -178.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -117.96 140.88 49.11 Favored 'General case' 0 N--CA 1.494 1.743 0 C-N-CA 118.595 -1.242 . . . . 0.0 113.257 -179.48 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.628 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 1.9 mt -118.41 117.86 30.2 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 105.666 -1.976 . . . . 0.0 105.666 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.09 121.06 44.34 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 118.783 -1.167 . . . . 0.0 112.304 -179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.754 ' SG ' HG23 ' A' ' 53' ' ' ILE . 0.5 OUTLIER -89.92 170.43 10.38 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 113.951 -1.477 . . . . 0.0 109.926 179.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.64 ' HA ' ' CB ' ' A' ' 19' ' ' GLN . 0.0 OUTLIER -90.87 141.38 28.88 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-N 113.689 -1.596 . . . . 0.0 110.664 -178.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.64 ' HB2' ' HB2' ' A' ' 16' ' ' LEU . 5.2 mt -129.12 139.37 51.98 Favored 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 116.33 -2.148 . . . . 0.0 109.665 179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.591 ' C ' ' H ' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -160.72 172.85 16.34 Favored 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 117.374 -1.73 . . . . 0.0 111.841 179.349 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.563 ' N ' ' HG3' ' A' ' 47' ' ' ARG . 2.5 t70 -59.76 16.83 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 115.132 -0.94 . . . . 0.0 112.654 179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.591 ' H ' ' C ' ' A' ' 47' ' ' ARG . 30.1 m-20 -125.94 -70.26 0.74 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 179.169 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' HA ' ' HB2' ' A' ' 94' ' ' SER . 25.1 m -54.39 133.25 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.814 0.816 . . . . 0.0 109.656 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.52 ' HG3' ' O ' ' A' ' 49' ' ' ASP . 47.6 mt-30 -124.18 -25.62 4.12 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 114.1 -1.409 . . . . 0.0 108.793 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 41.7 t -118.82 127.05 53.16 Favored 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.754 HG23 ' SG ' ' A' ' 44' ' ' CYS . 46.1 mm -110.93 111.0 34.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 106.544 -1.65 . . . . 0.0 106.544 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.504 HD22 ' HB ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -102.24 138.39 39.24 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 106.671 -1.603 . . . . 0.0 106.671 -179.527 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . 0.802 ' CZ3' ' HB2' ' A' ' 90' ' ' CYS . 93.5 m95 -103.13 114.61 29.04 Favored 'General case' 0 C--N 1.3 -1.587 0 C-N-CA 118.37 -1.332 . . . . 0.0 109.261 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.605 HD11 ' CG2' ' A' ' 91' ' ' VAL . 73.4 mt -77.9 93.34 4.38 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.712 ' HG2' ' CE2' ' A' ' 88' ' ' TYR . 4.7 tmm_? -80.39 146.27 31.58 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.51 -1.292 . . . . 0.0 107.51 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 87' ' ' LEU . 32.6 t70 62.01 -72.95 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.353 1.033 . . . . 0.0 109.647 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' 57' ' ' ARG . . . -169.38 22.2 0.09 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 178.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG12 ' N ' ' A' ' 61' ' ' GLN . 53.3 t -149.1 160.64 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 C-N-CA 119.865 -0.734 . . . . 0.0 110.358 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.593 ' O ' ' HG3' ' A' ' 61' ' ' GLN . 0.0 OUTLIER -52.54 131.82 34.5 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.898 -1.121 . . . . 0.0 110.866 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.627 ' CD2' ' H ' ' A' ' 63' ' ' VAL . 1.0 OUTLIER -161.63 -164.93 1.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-O 124.087 1.899 . . . . 0.0 113.108 179.831 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.692 ' HB ' HD13 ' A' ' 70' ' ' ILE . 27.2 m -160.42 -140.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 CA-C-N 109.278 -3.601 . . . . 0.0 107.938 178.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.659 ' N ' HG21 ' A' ' 70' ' ' ILE . 15.8 pt-20 -65.75 139.75 58.38 Favored 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.415 -0.914 . . . . 0.0 109.751 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 49.6 m -110.61 -59.57 1.93 Allowed 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 113.856 -1.52 . . . . 0.0 109.943 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -123.22 -60.83 1.47 Allowed 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.781 -0.768 . . . . 0.0 109.756 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.461 ' HB2' ' CD1' ' A' ' 81' ' ' ILE . 14.0 mmt85 -130.34 74.74 1.61 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.451 -0.9 . . . . 0.0 111.183 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.428 ' OG1' ' HA ' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -143.92 139.92 29.42 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 118.01 -1.476 . . . . 0.0 108.275 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 27.1 ttt-85 -100.25 84.61 2.85 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.692 HD13 ' HB ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -79.19 119.04 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 118.727 -1.189 . . . . 0.0 112.505 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 73' ' ' GLU . 1.2 p -111.14 144.42 40.31 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 118.355 -1.338 . . . . 0.0 107.712 177.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.586 ' O ' ' HB ' ' A' ' 53' ' ' ILE . . . -44.37 4.45 0.01 OUTLIER Glycine 0 N--CA 1.495 2.63 0 CA-C-N 114.924 -1.034 . . . . 0.0 115.501 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 71' ' ' THR . 12.1 pt-20 -146.51 -25.42 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 119.407 -0.917 . . . . 0.0 111.222 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.48 ' O ' HG23 ' A' ' 71' ' ' THR . 24.8 tt0 -141.73 141.38 33.27 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 -178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.718 HG23 ' NE1' ' A' ' 55' ' ' TRP . 25.0 t -117.28 122.42 69.92 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 C-N-CA 118.181 -1.407 . . . . 0.0 110.308 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -102.11 102.66 13.15 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 124.506 1.129 . . . . 0.0 108.53 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.521 ' HB ' ' CG ' ' A' ' 40' ' ' LEU . 3.3 t -104.37 142.7 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 119.526 -0.869 . . . . 0.0 109.048 -177.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.661 ' CD ' ' N ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -83.73 115.04 22.01 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 117.755 -1.578 . . . . 0.0 107.849 178.866 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' HA ' ' HB3' ' A' ' 84' ' ' ASP . 3.5 t70 -79.45 47.17 0.8 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 123.716 1.722 . . . . 0.0 108.357 179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.629 ' HA ' ' N ' ' A' ' 37' ' ' GLY . 43.4 t -123.93 -7.11 7.84 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 112.091 -2.322 . . . . 0.0 110.014 178.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.588 ' HB ' ' HD2' ' A' ' 82' ' ' PRO . 2.4 pt -132.91 167.92 20.51 Favored Pre-proline 0 N--CA 1.488 1.46 0 C-N-CA 118.559 -1.256 . . . . 0.0 110.127 -179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' HB ' ' A' ' 81' ' ' ILE . 31.2 Cg_exo -29.86 -37.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 C-N-CA 121.88 1.72 . . . . 0.0 112.726 170.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.552 ' O ' ' CZ ' ' A' ' 88' ' ' TYR . . . -45.89 -21.06 0.1 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.64 ' CG ' ' HB ' ' A' ' 107' ' ' VAL . 3.2 p30 -97.24 3.48 51.36 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 32.7 t -99.21 78.21 2.21 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 167.74 -177.67 41.97 Favored Glycine 0 N--CA 1.496 2.645 0 C-N-CA 118.265 -1.921 . . . . 0.0 112.563 179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.492 ' HB3' ' O ' ' A' ' 58' ' ' ASP . 2.7 tt -88.32 118.97 28.3 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 117.781 -1.568 . . . . 0.0 107.397 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.712 ' CE2' ' HG2' ' A' ' 57' ' ' ARG . 59.0 m-85 -109.63 87.75 2.58 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 122.518 1.152 . . . . 0.0 108.609 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.454 ' HB3' ' HB2' ' A' ' 56' ' ' LEU . . . -104.52 169.14 8.64 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-N 113.592 -1.64 . . . . 0.0 106.838 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' CYS . . . . . 0.802 ' HB2' ' CZ3' ' A' ' 55' ' ' TRP . 37.2 t -135.69 146.05 47.36 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 119.098 -1.041 . . . . 0.0 109.645 179.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.605 ' CG2' HD11 ' A' ' 56' ' ' LEU . 56.8 t -123.49 126.63 73.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 113.937 -1.483 . . . . 0.0 108.954 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.504 HG22 ' SG ' ' A' ' 44' ' ' CYS . 46.3 p -100.98 121.34 41.59 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 104.188 -2.523 . . . . 0.0 104.188 179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 3.5 m -124.52 147.75 48.18 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.003 -1.079 . . . . 0.0 113.215 -177.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.503 ' HB2' ' HA ' ' A' ' 50' ' ' VAL . 13.5 t -148.38 117.05 4.04 Favored Pre-proline 0 N--CA 1.489 1.522 0 CA-C-N 113.131 -1.849 . . . . 0.0 107.009 178.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.483 ' HD3' ' NE2' ' A' ' 51' ' ' GLN . 6.1 Cg_endo -62.41 -1.65 2.64 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.653 2.236 . . . . 0.0 113.249 -105.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 94' ' ' SER . 56.4 m -110.25 -26.4 9.63 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.824 -0.75 . . . . 0.0 111.823 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.68 162.8 20.77 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.937 -1.265 . . . . 0.0 109.937 -179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 15.8 t -150.88 157.71 43.24 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 118.87 -1.132 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -130.62 145.32 51.88 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.406 HG23 ' O ' ' A' ' 90' ' ' CYS . 92.2 m -130.28 151.59 50.62 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 117.957 -1.497 . . . . 0.0 114.708 -178.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.751 ' HB ' HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -132.15 139.08 48.29 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.658 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.709 ' HB2' ' CB ' ' A' ' 28' ' ' GLU . 3.2 m-85 -120.68 117.84 28.56 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.339 1.978 . . . . 0.0 116.339 -179.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.793 ' CE2' HG11 ' A' ' 29' ' ' VAL . 9.5 m-85 -103.1 104.97 15.18 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 177.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 14.2 m -78.11 126.53 30.94 Favored 'General case' 0 C--N 1.299 -1.59 0 C-N-CA 117.124 -1.831 . . . . 0.0 106.324 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.627 ' HB ' ' CD1' ' A' ' 88' ' ' TYR . 96.9 t -122.72 123.76 69.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 C-N-CA 118.618 -1.233 . . . . 0.0 110.826 -178.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.614 ' HA ' ' O ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -137.41 131.78 32.51 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.062 -1.055 . . . . 0.0 113.106 -179.573 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.64 ' HB ' ' CG ' ' A' ' 84' ' ' ASP . 2.9 p -108.88 132.31 57.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 118.237 -1.385 . . . . 0.0 109.518 176.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.489 1.513 0 C-N-CA 119.553 -0.859 . . . . 0.0 109.691 179.077 . . . . . . . . 0 0 . 1 stop_ save_